OOIR: Observatory of International Research

Papers

(The median citation count of Circulation is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)

Article	Citations
Heart Rate Variability	9706
PhysioBank, PhysioToolkit, and PhysioNet	7982
Prediction of Coronary Heart Disease Using Risk Factor Categories	6216
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.	5430
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.	5290
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association	4694
Markers of Inflammation and Cardiovascular Disease	4411
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines	4083
Definition of Metabolic Syndrome	3647
Impact of Atrial Fibrillation on the Risk of Death	3197
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.	3112
Heart Disease and Stroke Statistics—2014 Update	2964
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.	2620
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults	2591
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease	2485
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease	2459
Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery	2452
Cardiovascular neural regulation explored in the frequency domain.	2412
Coronary Plaque Disruption	2338
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Associati	2231
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies	2228
Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis	2220
Atrial Fibrillation Begets Atrial Fibrillation	2176
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.	2107
The stunned myocardium: prolonged, postischemic ventricular dysfunction.	2062
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk	2045
Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures	2032
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction	1956
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.	1916
From Vulnerable Plaque to Vulnerable Patient	1901
Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution	1825
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function	1777
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease	1753
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis	1733
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.	1708
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.	1701
Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells	1683
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events	1669
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy	1668
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention	1647
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)	1646
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome	1607
Air Pollution and Cardiovascular Disease	1571
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises	1567
Novel Modulator for Endothelial Adhesion Molecules	1552
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans	1545
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.	1530
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals	1527
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men	1522
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults	1521
Hemodynamic Patterns of Age-Related Changes in Blood Pressure	1460
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.	1451
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four con	1450
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction	1449
Lifetime Risk for Development of Atrial Fibrillation	1435
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease	1421
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality	1360
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction	1336
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans	1330
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease	1330
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary	1323
Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors	1321
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults	1316
Diabetes and Cardiovascular Disease	1313
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators	1306
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Tas	1305
Brugada Syndrome: Report of the Second Consensus Conference	1303
Total Excitation of the Isolated Human Heart	1302
Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States	1302
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease	1293
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.	1280
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men	1276
Transluminal Treatment of Arteriosclerotic Obstruction	1275
Genotype-Phenotype Correlation in the Long-QT Syndrome	1269
Atherogenesis: a postprandial phenomenon.	1267
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update	1266
Sudden Cardiac Death	1260
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults	1254
Molecular Bases of the Acute Coronary Syndromes	1249
Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway	1245
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.	1236
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors	1224
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention	1212
Impact of Reduced Heart Rate Variability on Risk for Cardiac Events	1211
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions	1199
TIMI Frame Count	1199
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction	1195
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism	1191
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.	1191
Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.	1190
Left Ventricular Remodeling After Myocardial Infarction	1188
Clopidogrel for Coronary Stenting	1186
Quantification of Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles Administered as a Constant Venous Infusion	1178
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.	1170
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells	1168
Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion S	1163
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent	1151
Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance	1149
An updated coronary risk profile. A statement for health professionals.	1147
Right ventricular dysplasia: a report of 24 adult cases.	1147
Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports	1146
Stroke Prevention in Atrial Fibrillation Study. Final results.	1136
Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?	1135
Atherosclerosis: Basic Mechanisms	1132
Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures	1132
AHA Dietary Guidelines	1127
Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population	1123
Lifetime Risk for Developing Congestive Heart Failure	1117
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure	1108
Frequency domain measures of heart period variability and mortality after myocardial infarction.	1100
Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation	1098
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo	1096
Executive Summary: Heart Disease and Stroke Statistics—2014 Update	1095
Socioeconomic factors and cardiovascular disease: a review of the literature.	1091
Canadian Implantable Defibrillator Study (CIDS)	1080
Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells	1075
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study	1072
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.	1057
Depression and 18-Month Prognosis After Myocardial Infarction	1055
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women	1038
Prognostic Value of Coronary Vascular Endothelial Dysfunction	1032
Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?	1032
Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, t	1030
Ischemic Mitral Regurgitation	1024
Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction	1021
Role of Endothelial Dysfunction in Atherosclerosis	1007
Promotion of Atrial Fibrillation by Heart Failure in Dogs	1003
Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction	998
Human blood pressure determination by sphygmomanometry.	997
Inflammation as a Risk Factor for Atrial Fibrillation	992
Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms	990
The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.	987
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).	987
Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance	986
Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction	986
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.	985
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes	982
Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.	979
Color Doppler assessment of mitral regurgitation with orthogonal planes.	978
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation	977
Imaging Atherosclerotic Plaque Inflammation With [ ¹⁸ F]-Fluorodeoxyglucose Positron Emission Tomography	976
Coronary Artery Calcium Area by Electron-Beam Computed Tomography and Coronary Atherosclerotic Plaque Area	975
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Grou	971
Overweight in Children and Adolescents	970
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins	970
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction	969
Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest	969
The Pathology of Hypertensive Pulmonary Vascular Disease	965
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction	953
Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure	952
The Epidemiology of Venous Thromboembolism	950
Circadian variation and triggers of onset of acute cardiovascular disease.	946
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein	946
Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care	946
Nonpenetrating Traumatic Injury of the Aorta	942
Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure	942
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.	941
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives	938
Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease	937
Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations	935
Mutations in the Cardiac Ryanodine Receptor Gene ( hRyR2 ) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia	932
Metabolic Syndrome	930
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.	929
Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia	929
An overview of randomized trials of rehabilitation with exercise after myocardial infarction.	924
Long-term Consequences of Kawasaki Disease	924
Characterization of Human Atherosclerosis by Optical Coherence Tomography	924
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.	924
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.	923
Isolated noncompaction of left ventricular myocardium. A study of eight cases.	922
Angiographic Assessment of Myocardial Reperfusion in Patients Treated With Primary Angioplasty for Acute Myocardial Infarction	922
Approaches to Sudden Death from Coronary Heart Disease	916
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.	916
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation	916
Incidence of and Risk Factors for Atrial Fibrillation in Older Adults	916
Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium	915
Angiographic Patterns of In-Stent Restenosis	914
Differentiation of Human Embryonic Stem Cells to Cardiomyocytes	904
Systolic Time Intervals in Heart Failure in Man	901
Diabetes and Vascular Disease	899
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.	899
Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages	898
Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure	897
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis	896
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk	891
Hypertrophic Cardiomyopathy	890
State of Disparities in Cardiovascular Health in the United States	888
Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases	888
Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization	885
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.	883
Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure	883
Unstable angina. A classification.	875
High-Sensitivity C-Reactive Protein	873
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure	871
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure	871
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels	861
Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia	857
Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction.	856
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study	856
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises	855
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis	855
Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance	853
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.	852
Patterns and Mechanisms of In-Stent Restenosis	852
Current Perspectives on Statins	850
Incremental Prognostic Value of Myocardial Perfusion Single Photon Emission Computed Tomography for the Prediction of Cardiac Death	849
Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in to	846
Spectrum of Mutations in Long-QT Syndrome Genes	846
Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?	841
From Vulnerable Plaque to Vulnerable Patient	838
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article	834
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.	829
The Electrocardiogram in Population Studies	826
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases	825
Diabetes and cardiovascular risk factors: the Framingham study.	823
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.	823
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.	823
Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia	822
Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man	821
Congenital Heart Disease in 56,109 Births Incidence and Natural History	820
Coronary Plaque Erosion Without Rupture Into a Lipid Core	820
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.	810
Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal	810
Endothelial Function	807
Survival in Primary Pulmonary Hypertension	805
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction	804
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure	802
An Accurate, Clinically Practical System For Spatial Vectorcardiography	800
Effect of Pacing Chamber and Atrioventricular Delay on Acute Systolic Function of Paced Patients With Congestive Heart Failure	800
Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart	797
The VIVA Trial	796
Cardiac troponin I. A marker with high specificity for cardiac injury.	795
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events	795
Myocardial Strain by Doppler Echocardiography	792
Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice	788
Cardiovascular Magnetic Resonance Assessment of Human Myocarditis	787
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure	785
Nifedipine	783
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.	783
Circadian variation in the frequency of sudden cardiac death.	783
Catheter Technique for Recording His Bundle Activity in Man	779
Sleep Apnea in 81 Ambulatory Male Patients With Stable Heart Failure	778
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions	775
Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated With ST-Segment Elevation	772
Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease	772
Linear Ablation Lesions for Control of Unmappable Ventricular Tachycardia in Patients With Ischemic and Nonischemic Cardiomyopathy	772
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation	771
Constitutive Expression of phVEGF ₁₆₅ After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia	768
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men	768
Our Preoccupation With Coronary Luminology	767
Noninvasive determination of age-related changes in the human arterial pulse.	766
Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP)	764
Association of Atrial Fibrillation and Obstructive Sleep Apnea	764
Postoperative Course and Hemodynamic Profile After the Arterial Switch Operation in Neonates and Infants	761
Aging, Habitual Exercise, and Dynamic Arterial Compliance	757
Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation	754
Sympathovagal Balance	751
Predictors of Atrial Fibrillation After Coronary Artery Surgery	751
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt.	750
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.	748
Aortocoronary Saphenous Vein Graft Disease	746
Diagnostic criteria for the long QT syndrome. An update.	744
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population	740
The prevalence of peripheral arterial disease in a defined population.	739
Left Atrial Size and the Risk of Stroke and Death	739
Randomized, Controlled Trial of Long-Term Moderate Exercise Training in Chronic Heart Failure	739
Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium	739
Prospective Study of Asymptomatic Valvular Aortic Stenosis	739
Endothelial Cell Senescence in Human Atherosclerosis	738
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States	738
Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure	737
Physiological Analysis of Middle-Aged and Old Former Athletes	733
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus	730
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2	730
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.	729
Effects of age and aerobic capacity on arterial stiffness in healthy adults.	725
A Self-Fulfilling Prophecy	725
Statin Therapy Accelerates Reendothelialization	723
Coronary Artery Calcification: Pathophysiology, Epidemiology, Imaging Methods, and Clinical Implications	722
Impact of Obesity on Plasma Natriuretic Peptide Levels	721
Aortic input impedance in normal man: relationship to pressure wave forms.	720
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis	720
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes	719
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.	719
Exercise and Heart Failure	714
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.	713
Primary pulmonary hypertension: natural history and the importance of thrombosis.	713
Clinical Implications of the ‘No Reflow’ Phenomenon	713
Reliable Noninvasive Coronary Angiography With Fast Submillimeter Multislice Spiral Computed Tomography	712
Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients	712
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.	712
Cytokines and Cytokine Receptors in Advanced Heart Failure	711
Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale	710
Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction	710
Insights Into Causal Pathways for Ischemic Heart Disease	706
Prevalence of the Metabolic Syndrome in American Adolescents	706
Detection of Coronary Artery Stenoses With Thin-Slice Multi-Detector Row Spiral Computed Tomography and Multiplanar Reconstruction	705
β-Adrenergic Receptor Blockade in Chronic Heart Failure	704
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction	704
Supravalvular Aortic Stenosis	703
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.	702
Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome	701
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.	700
Congestive Heart Failure in the Community	700
Continuous measurement of left ventricular volume in animals and humans by conductance catheter.	700
Cellular Basis for the Normal T Wave and the Electrocardiographic Manifestations of the Long-QT Syndrome	698
Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.	698
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.	697
In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography	697
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock	696
Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting	695
Improvement of Postnatal Neovascularization by Human Adipose Tissue-Derived Stem Cells	692
Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.	691
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.	691
Catheter Ablation for Paroxysmal Atrial Fibrillation	690
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombol	689
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques	689
Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.	689
Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.	687
Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work.	686
Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.	685
Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation	685
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises	684
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion	684
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.	683
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction	683
Left Ventricular Hypertrophy	681
Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography.	679
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure	679
Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure	678
Gene Therapy for Myocardial Angiogenesis	678
Mechanism of myocardial "stunning".	677
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.	677
Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality	677
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.	675
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart	675
Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation	675
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.	674
A Focal Source of Atrial Fibrillation Treated by Discrete Radiofrequency Ablation	674
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients	673
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels	672
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.	671
Inflammatory Markers and Onset of Cardiovascular Events	671
Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease	671
Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?	669
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations	669
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.	667
The long QT syndrome. Prospective longitudinal study of 328 families.	665
Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community.	664
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure	664
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease	663
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation	662
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus	660
Diagnosis and Treatment of Fetal Cardiac Disease	659
Bone Formation and Inflammation in Cardiac Valves	658
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month	657
Birth Weight and Adult Hypertension, Diabetes Mellitus, and Obesity in US Men	657
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis	656
Oxidative Stress and Cardiovascular Injury	655
Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction	655
Elevated Levels of C-Reactive Protein and Interleukin-6 in Patients With Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure	654
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article	654
Effects of adenosine on human coronary arterial circulation.	652
Improved Left Ventricular Mechanics From Acute VDD Pacing in Patients With Dilated Cardiomyopathy and Ventricular Conduction Delay	652
Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.	651
Detection of Calcified and Noncalcified Coronary Atherosclerotic Plaque by Contrast-Enhanced, Submillimeter Multidetector Spiral Computed Tomography	648
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy	647
TAXUS I	647
High-density mapping of electrically induced atrial fibrillation in humans.	646
Hypertriglyceridemic Waist	646
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease	645
B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure	645
Chronic Rapid Atrial Pacing	644
Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty	641
Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea	640
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)	639
Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury	638
Resistin Is an Inflammatory Marker of Atherosclerosis in Humans	637
Catecholaminergic Polymorphic Ventricular Tachycardia in Children	637
Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review	637
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function.	635
Emerging Epidemic of Cardiovascular Disease in Developing Countries	634
Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging	634
Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase	634
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure	631
Hypertrophy of the Heart	629
Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins	629
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure	629
C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction	625
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.	625
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations.	625
Bidirectional Relation Between Inflammation and Coagulation	623
Interobserver variability in coronary angiography.	621
Regular Physical Exercise Corrects Endothelial Dysfunction and Improves Exercise Capacity in Patients With Chronic Heart Failure	621
Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease	620
Aneurysmal coronary artery disease.	620
Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction	620
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.	620
Mechanism Linking T-Wave Alternans to the Genesis of Cardiac Fibrillation	619
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiova	619
Complete Isolation of Left Atrium Surrounding the Pulmonary Veins	618
Clinical Management of Metabolic Syndrome	617
Thoracic and Abdominal Aortic Aneurysms	615
The Athlete’s Heart	615
Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries	615
Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome	615
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis	614
Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea	614
Pravastatin and the Development of Diabetes Mellitus	614
Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients	613
Essential Hypertension	612
Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions	612
Hyperventilation-Induced Hypotension During Cardiopulmonary Resuscitation	611
Risk Factors for Venous Thromboembolism	610
Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.	610
Akt Promotes Survival of Cardiomyocytes In Vitro and Protects Against Ischemia-Reperfusion Injury in Mouse Heart	610
Platelet aggregation in partially obstructed vessels and its elimination with aspirin.	609
Identification of Patients at Increased Risk of First Unheralded Acute Myocardial Infarction by Electron-Beam Computed Tomography	609
Stent Thrombosis in the Modern Era	609
Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG	609
Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model	607
Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function	605
Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci	603
Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction.	603
Guide to the Assessment of Physical Activity: Clinical and Research Applications	603
Coronary Anomalies	602
Pathology of Acute and Chronic Coronary Stenting in Humans	602
Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes	602
Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window.	601
Arrhythmogenic Right Ventricular Cardiomyopathy	600
Regular Aerobic Exercise Prevents and Restores Age-Related Declines in Endothelium-Dependent Vasodilation in Healthy Men	600
Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic Drugs	600
Impact of Diabetes on Cardiac Structure and Function	600
Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation	600
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus	598
Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis	598
Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins	598
Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes	597
Ambient Pollution and Heart Rate Variability	595
One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent	595
Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators	594
Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies	594
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of cli	593
Initial and 6-Month Results of Biodegradable Poly- l -Lactic Acid Coronary Stents in Humans	593
Fractional Flow Reserve	593
Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events	593
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines	592
Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance Imaging	591
Lipoprotein(a) and Coronary Heart Disease	590
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.	590
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction	590
Proposed Diagnostic Criteria for the Brugada Syndrome	587
Relationship Between Spectral Components of Cardiovascular Variabilities and Direct Measures of Muscle Sympathetic Nerve Activity in Humans	586
Stability and Instability: Two Faces of Coronary Atherosclerosis	585
Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure	585
Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.	585
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Proje	585
The problem of valve prosthesis-patient mismatch.	584
Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation.	584
C-Reactive Protein as a Cardiovascular Risk Factor	583
Exercise Myocardial Perfusion SPECT in Patients Without Known Coronary Artery Disease	583
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article	582
Adrenergic effects on the biology of the adult mammalian cardiocyte.	580
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells	579
Intravascular Ultrasound	576
Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality	576
Estimation of Infarct Size in Man and its Relation to Prognosis	575
Technique and Results of Linear Ablation at the Mitral Isthmus	575
Restenosis after successful coronary angioplasty in patients with single-vessel disease.	574
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension	573
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis	573
Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α _v β ₃ -Integrin–Targeted Nanoparticles	573
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.	572
Healed Plaque Ruptures and Sudden Coronary Death	571
Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve	569
In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction	569
Delayed Development of Ventricular Ectopic Rhythms following Experimental Coronary Occlusion	568
Therapeutic Hypothermia After Cardiac Arrest	568
QT interval prolongation as predictor of sudden death in patients with myocardial infarction.	567
Selecting Patients With Atrial Fibrillation for Anticoagulation	567
Cellular Basis for the Electrocardiographic J Wave	565
Oxidative Stress and Cardiovascular Injury	565
Sudden Death as a Complication of Anomalous Left Coronary Origin From the Anterior Sinus of Valsalva	565
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation.	564
The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.	563
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure	563
Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue	563
Arterial Remodeling After Coronary Angioplasty	562
Symptoms of Depression, Acute Myocardial Infarction, and Total Mortality in a Community Sample	561
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.	561
Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia	561
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity	560
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency	560
Assessing Adiposity	560
Inhalation of Fine Particulate Air Pollution and Ozone Causes Acute Arterial Vasoconstriction in Healthy Adults	559
Epidemiology of Hypertrophic Cardiomyopathy–Related Death	557
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy	557
Low Heart Rate Variability in a 2-Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality From Several Causes	557
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels	555
Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.	554
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke	554
Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation.	553
Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype	553
Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy	552
Long QT Syndrome Patients With Mutations of the SCN5A and HERG Genes Have Differential Responses to Na ⁺	552
Cardiovascular Complications of Cancer Therapy	551
Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography	551
Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.	550
Stable Microreentrant Sources as a Mechanism of Atrial Fibrillation in the Isolated Sheep Heart	550
Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure	550
Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.	550
Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.	550
Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection	550
Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease	550
Recurrent sustained ventricular tachycardia. 1. Mechanisms.	548
Ethnic Differences in Coronary Calcification	548
Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitativ	548
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.	548
Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China.	548
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo	546
Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome	545
Chronic Heart Failure in the United States	544
Estimating Effectiveness of Cardiac Arrest Interventions	544
Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease	544
T ⁻⁷⁸⁶ →C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm	544
Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-α Promote Progressive Left Ventricular Dysfunction and Remodeling in Rats	544
Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children	544
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article	544
Diagnostic efficiency of troponin T measurements in acute myocardial infarction.	543
National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines	543
Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques.	543
Endothelial Dysfunction in Pulmonary Hypertension	542
Intracoronary Stenting and Angiographic Results	542
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.	542
Mechanisms and Models in Heart Failure	541
Ischemic Stroke Subtype Incidence Among Whites, Blacks, and Hispanics	541
Endothelial Function	540
Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations.	540
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.	540
Evidence for Possible Involvement of 5-HT _2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications	540
Renal Insufficiency and Heart Failure	539
Effective arterial elastance as index of arterial vascular load in humans.	539
Noninvasive Diagnosis of Ischemia-Induced Wall Motion Abnormalities With the Use of High-Dose Dobutamine Stress MRI	538
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.	537
Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)	536
Preoperative Renal Risk Stratification	535
Short-Term Clinical Outcome of Patients With Acute Pulmonary Embolism, Normal Blood Pressure, and Echocardiographic Right Ventricular Dysfunction	535
Aging, Progenitor Cell Exhaustion, and Atherosclerosis	534
Multiple Atherosclerotic Plaque Rupture in Acute Coronary Syndrome	533
Nonpenetrating Traumatic Injury of the Heart	532
Resistance Exercise in Individuals With and Without Cardiovascular Disease	532
Results of coronary artery surgery in patients with poor left ventricular function (CASS).	531
Guidelines for the Management of Patients With Valvular Heart Disease	531
New Markers of Inflammation and Endothelial Cell Activation	530
Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis.	530
Extent and Direction of Arterial Remodeling in Stable Versus Unstable Coronary Syndromes	530
Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey	530
In Vivo Formation of 8-Iso-Prostaglandin F _2α and Platelet Activation in Diabetes Mellitus	530
Aspirin	529
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties	529
Endothelium-dependent vasodilation is attenuated in patients with heart failure.	528
Slow conduction in the infarcted human heart. 'Zigzag' course of activation.	528
Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events	528
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries	528
Trends and Disparities in Coronary Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States	527
Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes	526
Lewis A. Conner Memorial Lecture	525
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block	525
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction	525
Alterations of skeletal muscle in chronic heart failure.	524
Abdominal Aortic Aneurysm Expansion	524
Transient Limb Ischemia Induces Remote Ischemic Preconditioning In Vivo	524
Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction	524
Mitochondrial ATP-Dependent Potassium Channels	522
Low Penetrance in the Long-QT Syndrome	522
Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease	522
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.	521
Sudden death in young athletes.	521
Role of Superoxide in Angiotensin II–Induced but Not Catecholamine-Induced Hypertension	521
N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients	521
Left Atrial Volume	521
Detection of Transposition of the Great Arteries in Fetuses Reduces Neonatal Morbidity and Mortality	519
Chest Compression Rates During Cardiopulmonary Resuscitation Are Suboptimal	519
C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages	518
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes	518
American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease	517
Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs	517
Roles for Insulin Receptor, PI3-Kinase, and Akt in Insulin-Signaling Pathways Related to Production of Nitric Oxide in Human Vascular Endothelial Cells	517
Mechanoelectrical Interaction in Tetralogy of Fallot	516
Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction	516
National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).	515
Exercise Capacity and the Risk of Death in Women	515
Apoptosis in Human Acute Myocardial Infarction	514
VEGF Gene Delivery to Myocardium	514
Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes	514
Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound.	513
Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease	512
Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application.	512
Echocardiographic detection of coronary artery disease during dobutamine infusion.	512
High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction	512
High Glucose Increases Nitric Oxide Synthase Expression and Superoxide Anion Generation in Human Aortic Endothelial Cells	511
Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations.	511
Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell	511
Statement on Exercise: Benefits and Recommendations for Physical Activity Programs for All Americans	511
Cardiovascular Health in Childhood	510
Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia	508
Short QT Syndrome	507
Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation.	506
Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus	506
Elective Stenting of the Extracranial Carotid Arteries	504
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.	504
Immediate and Late Clinical Outcomes of Carotid Artery Stenting in Patients With Symptomatic and Asymptomatic Carotid Artery Stenosis	504
Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate.	503
Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia	503
Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention	503
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia	503
Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome	503
Valve Repair Improves the Outcome of Surgery for Mitral Regurgitation	502
Mapping and Ablation of Idiopathic Ventricular Fibrillation	502
Sodium Channel Blockers Identify Risk for Sudden Death in Patients With ST-Segment Elevation and Right Bundle Branch Block but Structurally Normal Hearts	500
Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation	500
Defining Diastolic Heart Failure	499
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction.	499
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.	499
A critical review of the systolic time intervals.	498
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.	498
Angiotensin-Converting Enzyme in the Human Heart	498
Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation	498
1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations	498
Assessment of Myocardial Perfusion in Coronary Artery Disease by Magnetic Resonance	497
Endogenous Nitric Oxide Synthase Inhibitor	496
Age-Dependent Impairment of Angiogenesis	496
Activation of the Complement System During and After Cardiopulmonary Bypass Surgery	496
Angiotensin-Converting Enzyme Inhibitors	495
B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure	495
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans	495
Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias	495
Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease	494
Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy	493
Hypertrophic Cardiomyopathy	492
Prognostic Value of Nocturnal Cheyne-Stokes Respiration in Chronic Heart Failure	492
Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects.	492
Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia	492
Permanent, Direct His-Bundle Pacing	491
Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony.	490
Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy	490
Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery	490
ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article	490
Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta	489
Noninvasive Doppler determination of cardiac output in man. Clinical validation.	488
Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure	488
Triggering Myocardial Infarction by Marijuana	487
Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease	487
Resveratrol, a Polyphenolic Phytoalexin Present in Red Wine, Enhances Expression and Activity of Endothelial Nitric Oxide Synthase	487
Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients	487
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.	487
Tissue Doppler Imaging Is Superior to Strain Rate Imaging and Postsystolic Shortening on the Prediction of Reverse Remodeling in Both Ischemic and Nonischemic Heart Failure After Cardiac Resynchroniza	487
Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix	486
Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation	485
Aortic Stenosis	483
Alterations of Left Ventricular Myocardial Characteristics Associated With Obesity	483
Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor	483
Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo	483
Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.	482
American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood	482
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels	481
Birth Weight and Adult Hypertension and Obesity in Women	481
Lipoprotein-Associated Phospholipase A ₂ , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Athe	481
Vitamin C Improves Endothelium-Dependent Vasodilation by Restoring Nitric Oxide Activity in Essential Hypertension	480
A Novel Method for Nonfluoroscopic Catheter-Based Electroanatomical Mapping of the Heart	480
Glycemic Control and Heart Failure Among Adult Patients With Diabetes	480
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women	480
Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis.	479
ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article	479
Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease.	478
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.	478
Prevention Conference V	478
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.	477
Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes	477
Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.	477
The Measurement of the Q-T Interval of the Electrocardiogram	476
Resistin Promotes Endothelial Cell Activation	476
Mutation in the KCNQ1 Gene Leading to the Short QT-Interval Syndrome	476
National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study	476
Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator	476
Clinical Characterization of Left Ventricular Noncompaction in Children	476
Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts.	475
Ventricular Function	475
Electrical Remodeling of the Atria in Congestive Heart Failure	475
Aging and Endothelial Function in Normotensive Subjects and Patients With Essential Hypertension	474
C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study	474
Determinants of the Degree of Functional Mitral Regurgitation in Patients With Systolic Left Ventricular Dysfunction	474
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on C	474
Triglyceride Concentration and Ischemic Heart Disease	472
Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells	471
Effects of Ramipril and Vitamin E on Atherosclerosis	471
Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction	471
Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction	471
Does fish oil lower blood pressure? A meta-analysis of controlled trials.	469
Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes	469
Transforming Growth Factor-β Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats	468
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography.	468
Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure.	467
Endothelial Regulation of Vasomotion in ApoE-Deficient Mice	467
Left Ventricular Volumes and Ejection Fraction by Echocardiography	466
Norepinephrine Stimulates Apoptosis in Adult Rat Ventricular Myocytes by Activation of the β-Adrenergic Pathway	466
Improved Surgical Outcome After Fetal Diagnosis of Hypoplastic Left Heart Syndrome	466
Impairment of Endothelium-Dependent Vasodilation of Resistance Vessels in Patients With Obstructive Sleep Apnea	466
Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes	465
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.	465
Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease	465
Detection of Coronary Artery Stenoses by Contrast-Enhanced, Retrospectively Electrocardiographically-Gated, Multislice Spiral Computed Tomography	465
Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Si	465
Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction	464
Structural Changes of Atrial Myocardium due to Sustained Atrial Fibrillation in the Goat	462
Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State	462
Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice	462
Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease	462
Complications and validity of pulmonary angiography in acute pulmonary embolism.	462
ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary	462
Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects.	461
Advantages and applications of the centerline method for characterizing regional ventricular function.	461
Congenital coronary arteriovenous fistula. Report of 13 patients, review of the literature and delineation of management.	460
Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction	460
Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial Infarction	460
Aortic Dissection: New Frontiers in Diagnosis and Management	459
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.	459
Insulin Sensitivity and Atherosclerosis	459
Beat-to-Beat QT Interval Variability	459
Left ventricular volume from paired biplane two-dimensional echocardiography.	459
Pathophysiology and Prevention of Atrial Fibrillation	459
Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice	457
Microbubbles Targeted to Intercellular Adhesion Molecule-1 Bind to Activated Coronary Artery Endothelial Cells	457
Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?	456
The end-systolic pressure-volume relation of the ventricle: definition, modifications and clinical use.	455
Quinidine Syncope	455
Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000	455
Experimental and Clinical Studies on Lactate and Pyruvate as Indicators of the Severity of Acute Circulatory Failure (Shock)	455
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells	455
Clinical Correlates and Heritability of Flow-Mediated Dilation in the Community	455
Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women	455
Angiogenesis Gene Therapy	455
Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors.	454
Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure	454
Right Bundle-Branch Block and ST-Segment Elevation in Leads V ₁ Through V ₃	454
Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy	454
Mechanisms Underlying Very-Low-Frequency RR-Interval Oscillations in Humans	453
Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.	453
Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart Disease	453
Diagnosis and Management of Infective Endocarditis and Its Complications	451
Report of the Conference on Low Blood Cholesterol: Mortality Associations.	450
Morphological Predictors of Restenosis After Coronary Stenting in Humans	449
Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation	449
Triggering of Acute Myocardial Infarction Onset by Episodes of Anger	449
Low-Gradient Aortic Stenosis	449
Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease	448
Myocardial Gd-DTPA Kinetics Determine MRI Contrast Enhancement and Reflect the Extent and Severity of Myocardial Injury After Acute Reperfused Infarction	448
Measurement of Left Ventricular Wall Thickness and Mass by Echocardiography	446
Fractal Correlation Properties of R-R Interval Dynamics and Mortality in Patients With Depressed Left Ventricular Function After an Acute Myocardial Infarction	446
Risk Factors, Angiographic Patterns, and Outcomes in Patients With Ventricular Septal Defect Complicating Acute Myocardial Infarction	446
A Method of Photographing Fluorescence in Circulating Blood in the Human Retina	445
Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography.	444
Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats	444
Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.	444
Clinical Significance of Mitral Regurgitation After Acute Myocardial Infarction	444
Hyperhomocyst(e)inemia Is Associated With Impaired Endothelium-Dependent Vasodilation in Humans	443
A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex.	443
Exercise Standards	443
Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure.	443
Obesity Accelerates the Progression of Coronary Atherosclerosis in Young Men	443
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.	443
Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis	443
Novel Mechanism for Endothelial Dysfunction	442
Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein	442
Ischemic Heart Disease, Atherosclerosis, and Longevity	441
Cardiogenic Shock Complicating Acute Myocardial Infarction	441
Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells	441
Coronary artery imaging with intravascular high-frequency ultrasound.	441
Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart	441
Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease	441
Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201.	441
Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins	441
Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog.	441
Relation between echocardiographically determined left atrial size and atrial fibrillation.	440
Effects of Continuous Positive Airway Pressure on Cardiovascular Outcomes in Heart Failure Patients With and Without Cheyne-Stokes Respiration	440
Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens.	440
Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography.	440
ACC/AHA Guidelines for the Clinical Application of Echocardiography	440
Intermittent Claudication	438
Clinical classification of cardiac deaths.	437
Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty.	437
Characterization of Left Ventricular Activation in Patients With Heart Failure and Left Bundle-Branch Block	437
High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults	437
Arteriographic evidence of coronary arterial spasm in acute myocardial infarction.	436
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.	436
Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study.	436
Management of Deep Vein Thrombosis and Pulmonary Embolism	436
American College of Cardiology/American Heart Association Expert Consensus Document on Electron-Beam Computed Tomography for the Diagnosis and Prognosis of Coronary Artery Disease	436
Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone.	435
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice	435
Echocardiographic measurements in normal subjects from infancy to old age.	434
Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography.	434
Effects of aging, sex, and physical training on cardiovascular responses to exercise.	434
Clinical Prevention of Sudden Cardiac Death by n-3 Polyunsaturated Fatty Acids and Mechanism of Prevention of Arrhythmias by n-3 Fish Oils	434
Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease	434
Asymmetric Septal Hypertrophy	433
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction	433
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress.	432
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits	431
Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin	431
Myocardial Protection by Brief Ischemia in Noncardiac Tissue	430
Left Ventricular Remodeling After Primary Coronary Angioplasty	430
Anomalous Origin of the Left Coronary Artery from the Pulmonary Trunk	430
Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man.	430
Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts	430
Elevated Levels of Interleukin-6 in Unstable Angina	429
Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease	429
Medial Localization of Mineralization-Regulating Proteins in Association With Mönckeberg’s Sclerosis	429
Developmental and Neurological Status of Children at 4 Years of Age After Heart Surgery With Hypothermic Circulatory Arrest or Low-Flow Cardiopulmonary Bypass	429
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)	429
Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia	429
Demonstration of Dual A-V Nodal Pathways in Patients with Paroxysmal Supraventricular Tachycardia	428
Evidence for Increased Collagenolysis by Interstitial Collagenases-1 and -3 in Vulnerable Human Atheromatous Plaques	427
Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy.	426
Doppler Estimation of Left Ventricular Filling Pressure in Sinus Tachycardia	426
Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling	426
Patterns of Calcification in Coronary Artery Disease	426
Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor	425
Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community	425
Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.	425
Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension	425
Synergistic Effect of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor on Angiogenesis In Vivo	425
Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.	425
Early Statin Treatment in Patients With Acute Coronary Syndrome	425
Sex Differences in Coronary Heart Disease	424
It’s Time for a Change to a Troponin Standard	424
Multiple Mechanisms in the Long-QT Syndrome	424
Magnetic Resonance Images Lipid, Fibrous, Calcified, Hemorrhagic, and Thrombotic Components of Human Atherosclerosis In Vivo	424
Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection	424
Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium.	424
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association	424
Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease	423
Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular Dysfunction	423
Helical and retrograde secondary flow patterns in the aortic arch studied by three-directional magnetic resonance velocity mapping.	423
Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction	423
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes	423
Beneficial Effects of Leukocyte Depletion of Transfused Blood on Postoperative Complications in Patients Undergoing Cardiac Surgery	422
Echocardiographic assessment of a normal adult aging population.	421
Mental Stress Induces Transient Endothelial Dysfunction in Humans	421
Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis	421
Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure	421
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure	421
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations	421
Social Support, Depression, and Mortality During the First Year After Myocardial Infarction	420
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism	420
Abciximab Facilitates the Rate and Extent of Thrombolysis	420
Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers	419
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.	419
Visualization of Fibrous Cap Thickness and Rupture in Human Atherosclerotic Carotid Plaque In Vivo With High-Resolution Magnetic Resonance Imaging	419
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors	419
Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events	419
Uric Acid and Survival in Chronic Heart Failure	419
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure	419
Diminished Baroreflex Sensitivity in High Blood Pressure	418
Cocaine-Related Aortic Dissection in Perspective	418
PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells	418
Novel Index for Invasively Assessing the Coronary Microcirculation	418
Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques	418
Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis	418
Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension.	417
Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α	417
Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease	417
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.	417
Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI)	417
N -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Art	417
Cardiovascular Disease in Women	416
Variability in the analysis of coronary arteriograms.	415
Postconditioning Inhibits Mitochondrial Permeability Transition	415
The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations.	415
Evaluation of Different Ventricular Pacing Sites in Patients With Severe Heart Failure	415
Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy	415
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes	415
Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina Pectoris	414
Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy	414
ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol	414
Regulation of Endothelial Constitutive Nitric Oxide Synthase Gene Expression in Endothelial Cells and In Vivo	414
Catheter Ablation of Accessory Pathways, Atrioventricular Nodal Reentrant Tachycardia, and the Atrioventricular Junction	414
Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test.	413
Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction	413
Familial lipoprotein disorders in patients with premature coronary artery disease.	413
ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary	413
Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.	412
Noninvasive Detection of Myocardial Ischemia From Perfusion Reserve Based on Cardiovascular Magnetic Resonance	412
Neurohormonal interactions and adaptations in congestive heart failure.	410
Circadian variation of transient myocardial ischemia in patients with coronary artery disease.	410
Prediction of Long-Term Prognosis in 12 169 Men Referred for Cardiac Rehabilitation	410
Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases	410
Maximal coronary flow and the concept of coronary vascular reserve.	409
Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels	409
Systemic Infection Related to Endocarditis on Pacemaker Leads	409
QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest.	409
C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function	409
Practice Standards for Electrocardiographic Monitoring in Hospital Settings	409
Adaptation and Maladaptation of the Heart in Diabetes: Part I	408
Five- to fifteen-year follow-up after Fontan operation.	408
Platelet-Derived CD40L	407
Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.	407
Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan	407
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury	406
Prolonged Endoplasmic Reticulum Stress in Hypertrophic and Failing Heart After Aortic Constriction	406
Estrogen modulates responses of atherosclerotic coronary arteries.	405
Sympathetic Neural Activation in Visceral Obesity	405
Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension	405
Changes in the Serum Cholesterol and Blood Clotting Time in Men Subjected to Cyclic Variation of Occupational Stress	405
Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertro	405
N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes	404
Depression, Psychotropic Medication, and Risk of Myocardial Infarction	404
Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy	404
Selective Cine Coronary Arteriography	403
A Longitudinal Study of Coronary Heart Disease	403
ECG T-Wave Patterns in Genetically Distinct Forms of the Hereditary Long QT Syndrome	403
Predicting Sudden Death in the Population	402
Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm.	402
Purple Grape Juice Improves Endothelial Function and Reduces the Susceptibility of LDL Cholesterol to Oxidation in Patients With Coronary Artery Disease	402
Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.	402
Quantitative Assessment of Intrinsic Regional Myocardial Deformation by Doppler Strain Rate Echocardiography in Humans	402
High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women	402
Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients.	402
Primary Pulmonary Hypertension	401
Modulation of Vascular Inflammation In Vitro and In Vivo by Peroxisome Proliferator–Activated Receptor-γ Activators	401
Structural basis of end-stage failure in ischemic cardiomyopathy in humans.	401
Structural Abnormalities of Great Arterial Walls in Congenital Heart Disease	401
Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes	401
Apoptosis in Human Atherosclerosis and Restenosis	400
Non surgical coronary artery recanalization in acute transmural myocardial infarction.	400
Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic	400
Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques	400
Abdominal Aortic Calcific Deposits Are an Important Predictor of Vascular Morbidity and Mortality	400
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy	399
Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia.	399
Contrast Media–Enhanced Magnetic Resonance Imaging Visualizes Myocardial Changes in the Course of Viral Myocarditis	399
Endothelin in human congestive heart failure.	399
Noninvasive In Vivo Human Coronary Artery Lumen and Wall Imaging Using Black-Blood Magnetic Resonance Imaging	399
Changes in Cardiac Output with Age	398
Endothelins and Endothelin Receptor Antagonists	398
Echolucent Plaques Are Associated With High Risk of Ischemic Cerebrovascular Events in Carotid Stenosis	398
Impact of Valve Prosthesis-Patient Mismatch on Short-Term Mortality After Aortic Valve Replacement	398
Short- and Long-Term Black Tea Consumption Reverses Endothelial Dysfunction in Patients With Coronary Artery Disease	398
Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women	398
Relationship Between Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute Myocardial Infarction	398
Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse.	397
Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”	397
Meta-Analysis of Wine and Beer Consumption in Relation to Vascular Risk	396
Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet Therapy in Unplanned and Elective Coronary Stenting	396
Cardiomyocyte Stiffness in Diastolic Heart Failure	395
Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina	395
Constrictive Pericarditis in the Modern Era	395
Assessment of Survival in Patients With Primary Pulmonary Hypertension	395
Optical Coherence Tomography for Optical Biopsy	395
Insights From Three-Dimensional Echocardiography Into the Mechanism of Functional Mitral Regurgitation	395
The Impact of Calcification on the Biomechanical Stability of Atherosclerotic Plaques	394
Phased-Array Intracardiac Echocardiography Monitoring During Pulmonary Vein Isolation in Patients With Atrial Fibrillation	394
Comparison of In Vivo Tissue Temperature Profile and Lesion Geometry for Radiofrequency Ablation With a Saline-Irrigated Electrode Versus Temperature Control in a Canine Thigh Muscle Preparation	394
Smooth Muscle Progenitor Cells in Human Blood	393
Prolonged Antibiotic Prophylaxis After Cardiovascular Surgery and Its Effect on Surgical Site Infections and Antimicrobial Resistance	393
Arginine Vasopressin in Advanced Vasodilatory Shock	393
Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm.	393
Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease.	392
Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients	392
Prognosis of Aortic Intramural Hematoma With and Without Penetrating Atherosclerotic Ulcer	392
Intraoperative detection of myocardial ischemia in high-risk patients: electrocardiography versus two-dimensional transesophageal echocardiography.	392
Overweight and Hypertension	391
Opposing Effects of β ₁ - and β ₂ -Adrenergic Receptors on Cardiac Myocyte Apoptosis	391
Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes	391
Physical Training Improves Endothelial Function in Patients With Chronic Heart Failure	390
Altered Cardiovascular Variability in Obstructive Sleep Apnea	390
Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.	390
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction.	390
Electrical Stimulation of the Heart in Patients with Ventricular Tachycardia	389
Idiopathic Hypertrophic Subaortic Stenosis	389
The effect of aortic valve replacement on survival.	389
Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke	389
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.	389
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro	389
The role of the exercise test in the evaluation of patients for ischemic heart disease.	389
Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial	389
Update on Myocardial Bridging	388
Signaling Pathways in Reactive Oxygen Species–Induced Cardiomyocyte Apoptosis	388
Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans	388
Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction.	388
C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle	388
Effect of Different Intensities of Exercise on Endothelium-Dependent Vasodilation in Humans	388
Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography.	388
Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chron	388
Autonomic Tone Variations Before the Onset of Paroxysmal Atrial Fibrillation	387
Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study.	387
Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.	387
Clinical Effects of β-Adrenergic Blockade in Chronic Heart Failure	387
Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H Oxidase	387
Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.	386
Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure	386
Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions	386
Intake of Mercury From Fish, Lipid Peroxidation, and the Risk of Myocardial Infarction and Coronary, Cardiovascular, and Any Death in Eastern Finnish Men	386
Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)	386
Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.	385
Significance of the Sinus-Node Recovery Time	385
Physical Activity and Coronary Heart Disease in Men	385
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.	385
Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis	385
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria	385
Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase	384
Prognostic Significance of Small-Artery Structure in Hypertension	384
Mortality Associated With Congenital Heart Defects in the United States	383
Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome	382
Interferon-β Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction	382
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Superior Vena Cava	382
Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins	382
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk	382
Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction	382
Salt, volume and the prevention of hypertension.	382
Treatment of torsade de pointes with magnesium sulfate.	382
Cilostazol Has Beneficial Effects in Treatment of Intermittent Claudication	382
Modulation of Endothelium-Dependent Flow-Mediated Dilatation of the Brachial Artery by Sex and Menstrual Cycle	382
Soluble P-Selectin and the Risk of Future Cardiovascular Events	381
Coronary-prone behavior and coronary heart disease: a critical review. The review panel on coronary-prone behavior and coronary heart disease.	381
Prospective study of phobic anxiety and risk of coronary heart disease in men.	381
Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages	381
Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans	380
Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion.	380
Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest	380
Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy	380
Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique.	380
Sympathetic Nerve Activity in End-Stage Renal Disease	380
Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999	380
Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic	380
Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?	379
Pulmonary Vein Anatomy in Patients Undergoing Catheter Ablation of Atrial Fibrillation	379
Endothelial Function Testing as a Biomarker of Vascular Disease	378
Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.	378
Pregnancy-Associated Cardiomyopathy	378
Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker	378
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia	378
Heart Failure and Death After Myocardial Infarction in the Community	378
Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure	378
Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans	378
Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques.	378
Cardiac hypertrophy. Mechanical, neural, and endocrine dependence.	377
Molecular Basis of Restenosis and Drug-Eluting Stents	377
From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death	377
Right Ventricular Enlargement on Chest Computed Tomography	377
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease	377
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis	377
Sleep Apnea and Heart Failure	376
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.	376
Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.	376
Sequential Versus Simultaneous Biventricular Resynchronization for Severe Heart Failure	376
Diagnosis and therapy of Kawasaki disease in children.	376
Inactivation of the Lysyl Oxidase Gene Lox Leads to Aortic Aneurysms, Cardiovascular Dysfunction, and Perinatal Death in Mice	376
Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans	376
Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes	376
Cardiovascular Preparticipation Screening of Competitive Athletes	376
Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease	375
Effect of Aging and Physical Activity on Left Ventricular Compliance	375
Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques	375
Management of Patients With Atrial Fibrillation	375
Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial Ischemia-Reperfusion	375
Investigation of Chronic Venous Insufficiency	374
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.	374
Evidence of Improving Prognosis in Heart Failure	374
Detrimental Ventricular Remodeling in Patients With Congenital Complete Heart Block and Chronic Right Ventricular Apical Pacing	374
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.	374
Sleep Apnea and Heart Failure	373
The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response.	373
Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease	373
Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death	373
Lower Incidence of Thrombus Formation With Cryoenergy Versus Radiofrequency Catheter Ablation	373
Premature Atrial Stimulation as a Key to the Understanding of Sinoatrial Conduction in Man	373
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-flu	373
Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome	373
Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis	372
Extracellular Matrix Remodeling in Heart Failure	372
Selective Potentiation of Peripheral Chemoreflex Sensitivity in Obstructive Sleep Apnea	372
Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure.	372
Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry.	372
Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes	372
Intracoronary γ-Radiation Therapy After Angioplasty Inhibits Recurrence in Patients With In-Stent Restenosis	372
Outcome after a "perfect" Fontan operation.	371
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.	371
Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors	370
Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide Synthase	370
Altered Titin Expression, Myocardial Stiffness, and Left Ventricular Function in Patients With Dilated Cardiomyopathy	370
Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study	369
Benefit of exercise conditioning for patients with peripheral arterial disease.	369
Natural Course of Peripartum Cardiomyopathy	369
Homocyst(e)ine, Diet, and Cardiovascular Diseases	369
Effects of Treatment on Morbidity in Hypertension	369
Inhibition of mTOR Signaling With Rapamycin Regresses Established Cardiac Hypertrophy Induced by Pressure Overload	369
Previous Angina Alters In-Hospital Outcome in TIMI 4	369
Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells	369
Mapping and Ablation of Ventricular Fibrillation Associated With Long-QT and Brugada Syndromes	369
Editorial	368
A Method for Determining Left Ventricular Mass in Man	368
Progress Study of 590 Consecutive Nonsurgical Cases of Coronary Disease Followed 5-9 Years	368
Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart Failure	368
Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentrant tachycardia.	368
Myocardial 'stunning' in man.	367
Inflammation and Thrombosis	367
Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By Aspirin	367
Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults	367
A prospective study of nutritional factors and hypertension among US men.	367
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α _v β ₃	367
A Common Variant of the Endothelial Nitric Oxide Synthase (Glu ²⁹⁸ →Asp) Is a Major Risk Factor for Coronary Artery Disease in the UK	367
Slow Ventricular Activation in Acute Myocardial Infarction	366
Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?	366
Insights into the pathogenesis of acute ischemic syndromes.	366
Monoclonal T-Cell Proliferation and Plaque Instability in Acute Coronary Syndromes	366
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.	366
Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor-κB Activation in Human Endothelial Cells	366
Endothelial Function	365
Antioxidant Vitamin C Improves Endothelial Dysfunction in Chronic Smokers	365
Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?	365
Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes	365
Ascorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac Myocytes	365
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.	365
Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure	365
Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.	365
Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention	365
Survival of medically treated patients in the coronary artery surgery study (CASS) registry.	365
Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute my	365
Noncompaction of the Ventricular Myocardium	364
Precursors of sudden coronary death. Factors related to the incidence of sudden death.	364
Relation of pulmonary vein to mitral flow velocities by transesophageal Doppler echocardiography. Effect of different loading conditions.	364
Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease	364
Predicting Survival in Heart Failure Case and Control Subjects by Use of Fully Automated Methods for Deriving Nonlinear and Conventional Indices of Heart Rate Dynamics	364
Diverse mechanisms of unexpected cardiac arrest in advanced heart failure.	363
Altered myocardial force-frequency relation in human heart failure.	363
Effect of Diagnostic Criteria on the Prevalence of Peripheral Arterial Disease	363
Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function	363
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association	363
The Cardiovascular Aspects of Marfan's Syndrome: A Heritable Disorder of Connective Tissue	362
Passive smoking and heart disease. Epidemiology, physiology, and biochemistry.	362
Acute vascular effects of estrogen in postmenopausal women.	362
Spectral characteristics of heart rate variability before and during postural tilt. Relations to aging and risk of syncope.	362
Characterization of Different Subsets of Atrial Fibrillation in General Practice in France	362
The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European So	362
RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium	362
Non–Insulin-Dependent Diabetes Mellitus and Fasting Glucose and Insulin Concentrations Are Associated With Arterial Stiffness Indexes	362
Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With Chronic Stable Angina	362
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty	362
Ultrafast Computed Tomography as a Diagnostic Modality in the Detection of Coronary Artery Disease	362
Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.	361
Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic Exercise	361
Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores	361
Dobutamine Echocardiography in Myocardial Hibernation	361
Sodium Channel Block With Mexiletine Is Effective in Reducing Dispersion of Repolarization and Preventing Torsade de Pointes in LQT2 and LQT3 Models of the Long-QT Syndrome	361
Thiazolidinediones, Metformin, and Outcomes in Older Patients With Diabetes and Heart Failure	361
Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States	361
Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease	361
Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels	361
Carotid Plaque Echolucency Increases the Risk of Stroke in Carotid Stenting	361
Natural History of Venous Thromboembolism	360
The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart.	360
Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound.	360
Immunosuppressive Therapy for Active Lymphocytic Myocarditis	360
Doppler Estimation of Left Ventricular Filling Pressures in Patients With Hypertrophic Cardiomyopathy	360
Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects.	360
Entrainment and interruption of atrial flutter with atrial pacing: studies in man following open heart surgery.	360
The Role of Premature Beats in the Initiation and the Termination of Supraventricular Tachycardia in the Wolff-Parkinson-White Syndrome	360
Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice	360
Characterization of Complicated Carotid Plaque With Magnetic Resonance Direct Thrombus Imaging in Patients With Cerebral Ischemia	360
Triple control of relaxation: implications in cardiac disease.	359
Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction	359
Discharge Education Improves Clinical Outcomes in Patients With Chronic Heart Failure	359
Effects of Interrupting Precordial Compressions on the Calculated Probability of Defibrillation Success During Out-of-Hospital Cardiac Arrest	359
Predictive Value of Electron Beam Computed Tomography of the Coronary Arteries	359
Predictors of Subacute Stent Thrombosis	359
Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years	359
Optimal Noninvasive Assessment of Left Ventricular Filling Pressures	359
Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol	359
Hemodynamically significant primary anomalies of the coronary arteries. Angiographic aspects.	358
Tumor Necrosis Factor-α Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway	358
Disturbed Connexin43 Gap Junction Distribution Correlates With the Location of Reentrant Circuits in the Epicardial Border Zone of Healing Canine Infarcts That Cause Ventricular Tachycardia	358
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.	358
Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships.	358
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.	357
Survival, Integration, and Differentiation of Cardiomyocyte Grafts	357
Transfer of CD4 ⁺ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice	357
Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery Disease	357
Endothelial Dysfunction and Cardiovascular Risk Prediction in Peripheral Arterial Disease	357
Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial	357
Neovascular Expression of E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Human Atherosclerosis and Their Relation to Intimal Leukocyte Content	357
Systolic Improvement and Mechanical Resynchronization Does Not Require Electrical Synchrony in the Dilated Failing Heart With Left Bundle-Branch Block	357
Risk Factors for Early or Delayed Stroke After Cardiac Surgery	356
Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish	356
Adverse Outcomes of Interrupted Precordial Compression During Automated Defibrillation	356
Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.	356
Myocardial imaging with thallium-201 at rest and during exercise. Comparison with coronary arteriography and resting and stress electrocardiography.	356
Reperfusion injury and its pharmacologic modification.	355
Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and its Local Effects on Tissue	355
Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes	355
Contribution of Muscle Afferents to the Hemodynamic, Autonomic, and Ventilatory Responses to Exercise in Patients With Chronic Heart Failure	355
The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung,	355
Consensus Conference Report	355
Estimation of Left Ventricular Volume by One-Plane Cineangiography	354
Use of endovascular stents in congenital heart disease.	354
Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia	354
Guide to Anticoagulant Therapy: Heparin	354
Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture.	354
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice	354
Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure	354
Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin	354
Antianginal and Antiischemic Effects of Ivabradine, an I _f Inhibitor, in Stable Angina	354
Regular Aerobic Exercise Augments Endothelium-Dependent Vascular Relaxation in Normotensive As Well As Hypertensive Subjects	354
Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms.	354
A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.	354
Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?	353
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity.	353
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.	353
Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury	353
Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function	353
Incremental Prognostic Value of Post-Stress Left Ventricular Ejection Fraction and Volume by Gated Myocardial Perfusion Single Photon Emission Computed Tomography	353
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.	352
Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells	352
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.	352
Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation.	352
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina	352
The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human Forearm	351
Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization.	351
Mitochondrial Integrity and Function in Atherogenesis	351
Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts	351
NHLBI funding policies. Enhancing stability, predictability, and cost control.	350
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins	350
X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.	350
Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions	350
Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance	350
Angiotensin II Type 1 Receptor Blockers	349
Electrocardiographic Findings in 122,043 Individuals	349
Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease.	349
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.	349
Periodontal Microbiota and Carotid Intima-Media Thickness	349
17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease	349
Acute Intramural Hematoma of the Aorta	349
Nonvalvular Cardiovascular Device–Related Infections	349
Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia	349
Electrical alternans and cardiac electrical instability.	348
Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease	348
Clinical Significance of Abnormal Electrocardiographic Patterns in Trained Athletes	348
In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty.	348
Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy	348
Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function.	348
Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy.	347
Longitudinal Myocardial Function Assessed by Tissue Velocity, Strain, and Strain Rate Tissue Doppler Echocardiography in Patients With AL (Primary) Cardiac Amyloidosis	347
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.	347
Inhibition of p38 Mitogen-Activated Protein Kinase Decreases Cardiomyocyte Apoptosis and Improves Cardiac Function After Myocardial Ischemia and Reperfusion	347
Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery	347
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure	346
Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction	346
Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression	346
High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men	346
Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction.	346
SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia	346
Cellular Basis for the ECG Features of the LQT1 Form of the Long-QT Syndrome	346
Influence of Diabetes Mellitus on Early and Late Outcome After Percutaneous Transluminal Coronary Angioplasty	346
Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.	346
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.	346
Magnitude and Time Course of Microvascular Obstruction and Tissue Injury After Acute Myocardial Infarction	345
Primary Prevention of Coronary Heart Disease: Guidance From Framingham	345
Lower Serum Sodium Is Associated With Increased Short-Term Mortality in Hospitalized Patients With Worsening Heart Failure	345
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus	345
Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography.	345
Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis	345
Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk.	345
Role of Autonomic Nervous System in the Pathogenesis of Prinzmetal's Variant Form of Angina	345
Echocardiographic Destruction of Albumin Microbubbles Directs Gene Delivery to the Myocardium	345
Inhibitory Effects of Antioxidants on Neonatal Rat Cardiac Myocyte Hypertrophy Induced by Tumor Necrosis Factor-α and Angiotensin II	345
Estrogen Increases Bone Marrow–Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation	345
Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarc	345
Efficacy of Quinidine in High-Risk Patients With Brugada Syndrome	344
Chagas' Disease	344
Effect of acute coronary artery occlusion on local myocardial extracellular K+ activity in swine.	344
Transcatheter closure of ventricular septal defects.	344
Influence of the Menstrual Cycle on Sympathetic Activity, Baroreflex Sensitivity, and Vascular Transduction in Young Women	344
A Walnut Diet Improves Endothelial Function in Hypercholesterolemic Subjects	344
Sex-associated differences in left ventricular function in aortic stenosis of the elderly.	344
Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status	344
Validation of Myocardial Acceleration During Isovolumic Contraction as a Novel Noninvasive Index of Right Ventricular Contractility	344
Continuous local electrical activity. A mechanism of recurrent ventricular tachycardia.	343
Long-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart Defects	343
Estimation of mean left atrial pressure from transesophageal pulsed Doppler echocardiography of pulmonary venous flow.	343
Effect of Annular Shape on Leaflet Curvature in Reducing Mitral Leaflet Stress	343
Low Circulating Folate and Vitamin B ₆ Concentrations	343
Beneficial Cardiovascular Pleiotropic Effects of Statins	342
Adaptation and Maladaptation of the Heart in Diabetes: Part II	342
Arrhythmogenic Marker for the Sudden Unexplained Death Syndrome in Thai Men	342
Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.	342
Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction	342
Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease	342
Autonomic Neural Control of Dynamic Cerebral Autoregulation in Humans	341
Configuration of Unipolar Atrial Electrograms During Electrically Induced Atrial Fibrillation in Humans	341
Intramural Hemorrhage of the Thoracic Aorta	341
Impaired Heart Rate Response to Graded Exercise	341
Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death.	341
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography.	341
Mobilization of CD34/CXCR4 ⁺ , CD34/CD117 ⁺ , c-met ⁺ Stem Cells, and Mononuclear Cells Express	341
Effect of Endothelial Shear Stress on the Progression of Coronary Artery Disease, Vascular Remodeling, and In-Stent Restenosis in Humans	341
Long-term Effects of Varying Intensities and Formats of Physical Activity on Participation Rates, Fitness, and Lipoproteins in Men and Women Aged 50 to 65 Years	340
Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes	340
Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease	340
Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage.	339
Health Status Predicts Long-Term Outcome in Outpatients With Coronary Disease	339
Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions	339
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.	339
VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial	339
Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS).	339
Inflammation as a Cardiovascular Risk Factor	338
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.	338
Elevations of Cardiac Troponin I Associated With Myocarditis	338
Wolff-Parkinson-White syndrome. The problem, evaluation, and surgical correction.	338
Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina Pectoris	338
Prospective Study of Shift Work and Risk of Coronary Heart Disease in Women	338
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, doubl	338
Cholesterol-Lowering Therapy in Women and Elderly Patients With Myocardial Infarction or Angina Pectoris	338
Electrical Remodeling in Atrial Fibrillation	337
Fish Intake and Risk of Incident Atrial Fibrillation	337
Elevated Levels of C-Reactive Protein at Discharge in Patients With Unstable Angina Predict Recurrent Instability	337
Obesity	336
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.	336
Plasma endothelin in chronic heart failure.	336
Chondrogenic and Adipogenic Potential of Microvascular Pericytes	336
Metabolic Syndrome	335
Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis.	335
Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures.	335
Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.	335
Unhealthy Effects of Atmospheric Temperature and Pressure on the Occurrence of Myocardial Infarction and Coronary Deaths	335
Observer agreement in evaluating coronary angiograms.	334
The Metabolic Syndrome	334
The coronary circulation in human septic shock.	334
Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.	334
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.	334
Sympathetic Activity in Obese Subjects With and Without Obstructive Sleep Apnea	334
Chronic Infections and the Risk of Carotid Atherosclerosis	334
Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery	334
Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs.	334
Prospective Assessment of Late Conduction Recurrence Across Radiofrequency Lesions Producing Electrical Disconnection at the Pulmonary Vein Ostium in Patients With Atrial Fibrillation	334
Restoration of Contractile Function in Isolated Cardiomyocytes From Failing Human Hearts by Gene Transfer of SERCA2a	334
Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/Reperfusion	334
Ticlopidine and Clopidogrel	333
Sensitivity and Specificity of Echocardiographic Diagnosis of Pericardial Effusion	333
Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension	333
Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo	333
Inhibition of Intimal Thickening After Balloon Angioplasty in Porcine Coronary Arteries by Targeting Regulators of the Cell Cycle	333
Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury	333
Effect of Glycoprotein IIb/IIIa Receptor Blockade on Recovery of Coronary Flow and Left Ventricular Function After the Placement of Coronary-Artery Stents in Acute Myocardial Infarction	333
Correlation of the Antemortem Coronary Arteriogram and the Postmortem Specimen	332
The long QT syndrome: a prospective international study.	332
Cigarette Smoking, Cardiovascular Disease, and Stroke	332
Adventitial Myofibroblasts Contribute to Neointimal Formation in Injured Porcine Coronary Arteries	332
The ability of several short-term measures of RR variability to predict mortality after myocardial infarction.	332
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy	332
Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement.	332
Serum Soluble Heat Shock Protein 60 Is Elevated in Subjects With Atherosclerosis in a General Population	332
Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening.	332
Relationship Between Regional Cardiac Hyperinnervation and Ventricular Arrhythmia	332
Noninvasive Evaluation of Intrarenal Oxygenation With BOLD MRI	331
Elastase-induced experimental aneurysms in rats.	331
Sex Difference in Risk of Torsade de Pointes With d,l- Sotalol	331
Mitral Annular Calcification Predicts Cardiovascular Morbidity and Mortality	331
Role of Right Atrial Endocardial Structures as Barriers to Conduction During Human Type I Atrial Flutter	331
Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction	331
Studies on Starling's Law of the Heart	330
Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.	330
Prognostic Significance of Ventricular Ectopic Beats with Respect to Sudden Death in the Late Postinfarction Period	330
Active Serum Vitamin D Levels Are Inversely Correlated With Coronary Calcification	330
Radiation Dose in Computed Tomography of the Heart	329
Spatiotemporal Periodicity During Atrial Fibrillation in the Isolated Sheep Heart	329
Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease	329
Nocturnal Continuous Positive Airway Pressure Decreases Daytime Sympathetic Traffic in Obstructive Sleep Apnea	329
Simvastatin Reduces Graft Vessel Disease and Mortality After Heart Transplantation	329
Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells	329
Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms.	329
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Interv	329
Lipid Lowering by Diet Reduces Matrix Metalloproteinase Activity and Increases Collagen Content of Rabbit Atheroma	329
Kuopio Atherosclerosis Prevention Study (KAPS)	329
Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of th	329
Natural history and classification of occlusive thromboaortopathy (Takayasu's disease).	328
Epinephrine Increases the Severity of Postresuscitation Myocardial Dysfunction	328
Regression of Carotid Atherosclerosis by Control of Postprandial Hyperglycemia in Type 2 Diabetes Mellitus	328
Unfavorable Effects of Resistance Training on Central Arterial Compliance	328
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score	328
Transdifferentiation of Human Peripheral Blood CD34 ⁺ -Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo	328
Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial Dysfunction	328
Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes	328
Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction	328
Very Long-Term Results (More Than 20 Years) of Valve Repair With Carpentier’s Techniques in Nonrheumatic Mitral Valve Insufficiency	328
Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothe	328
Age- and Sex-Related Differences in Clinical Manifestations in Patients With Congenital Long-QT Syndrome	328
Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus.	327
Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.	327
Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.	327
N-13 ammonia as an indicator of myocardial blood flow.	327
Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans	327
Exercise Anaerobic Threshold and Ventilatory Efficiency Identify Heart Failure Patients for High Risk of Early Death	327
Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With P2Y ₁₂ Gene Sequence Variations in Healthy Sub	327
Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerat	327
Assignment of the Vascular Endothelial Growth Factor Gene to Human Chromosome 6p21.3	326
Infiltrates of Activated Mast Cells at the Site of Coronary Atheromatous Erosion or Rupture in Myocardial Infarction	326
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.	326
Vasopressin V ₂ -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure	326
Simvastatin Versus Ezetimibe	326
Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study	326
Cardiovascular Death and Left Ventricular Remodeling Two Years After Myocardial Infarction	326
Hemodilution Is Common in Patients With Advanced Heart Failure	325
Leftward septal displacement during right ventricular loading in man.	325
Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice	325
Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.	325
Gender-Related Differences in Acute Aortic Dissection	325
Mechanisms of blood flow during cardiopulmonary resuscitation.	324
Mitral valve prolapse in one hundred presumably healthy young females.	324
Lead, Cadmium, Smoking, and Increased Risk of Peripheral Arterial Disease	324
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart	324
Increased Collagen Type I Synthesis in Patients With Heart Failure of Hypertensive Origin	324
Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction	324
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure	324
Diabetes and Vascular Disease	323
Treating Electrical Storm	323
Regional Heterogeneity of Human Myocardial Infarcts Demonstrated by Contrast-Enhanced MRI	323
High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure	323
Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis	323
Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation	323
Sphygmomanometrically Determined Pulse Pressure Is a Powerful Independent Predictor of Recurrent Events After Myocardial Infarction in Patients With Impaired Left Ventricular Function	323
Improved Coronary Artery Definition With T2-Weighted, Free-Breathing, Three-Dimensional Coronary MRA	322
Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease	322
Low-T3 Syndrome	322
Expression of Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 in Human Atherosclerotic Lesions	322
Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography.	322
Orthostatic Hypotension Predicts Mortality in Elderly Men	321
Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men	321
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage	321
The Oslo Diet-Heart Study	320
Clinical pharmacology of platelet cyclooxygenase inhibition.	320
Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy	320
Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults	320
Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment	320
Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke	320
Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy	320
Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome	320
Evidence for Association and Genetic Linkage of the Angiotensin-Converting Enzyme Locus With Hypertension and Blood Pressure in Men but Not Women in the Framingham Heart Study	320
Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial Reperfusion	320
Angiogenesis	319
Supravalvular Aortic Stenosis in Association with Mental Retardation and a Certain Facial Appearance	319
Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.	319
Recurrent sustained ventricular tachycardia. 2. Endocardial mapping.	319
Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein	319
Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main	319
Predictive Value of 16-Slice Multidetector Spiral Computed Tomography to Detect Significant Obstructive Coronary Artery Disease in Patients at High Risk for Coronary Artery Disease	319
Intermittent Claudication	318
The Effects of Cycle Length on Cardiac Refractory Periods in Man	318
Assessment of Fetal Compromise by Doppler Ultrasound Investigation of the Fetal Circulation	318
Value of Programmed Ventricular Stimulation After Tetralogy of Fallot Repair	318
Impact of Pulmonary Valve Replacement on Arrhythmia Propensity Late After Repair of Tetralogy of Fallot	318
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction	318
Endothelium-Dependent Hyperpolarization	317
An improved basis for enzymatic estimation of infarct size.	317
Recommendations for Human Blood Pressure Determination by Sphygmomanometers	317
Roles of Infectious Agents in Atherosclerosis and Restenosis	317
Matrix Metalloproteinase-2 Contributes to Ischemia-Reperfusion Injury in the Heart	317
The Relationship of Alterations in Systolic Time Intervals to Ejection Fraction in Patients with Cardiac Disease	317
Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow.	317
Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy	317
Natriuretic peptide system in human heart failure.	317
The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population.	317
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.	317
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.	317
Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus	317
Multivariate Analysis of Risk Factors for Coronary Heart Disease	316
Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study	316
Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease.	316
Effects of Diet and Exercise on Obesity-Related Vascular Dysfunction in Children	316
Clinical and Echocardiographic Characteristics of Papillary Fibroelastomas	316
Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation	316
Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass	316
Effects of Atrial Dilatation on Refractory Period and Vulnerability to Atrial Fibrillation in the Isolated Langendorff-Perfused Rabbit Heart	315
Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial Infarction	315
Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil.	315
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.	315
Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes	315
Potentiated Angiogenic Effect of Scatter Factor/Hepatocyte Growth Factor via Induction of Vascular Endothelial Growth Factor	315
Increased Restenosis in Diabetes Mellitus After Coronary Interventions Is Due to Exaggerated Intimal Hyperplasia	315
Mitral Ratio of Peak Early to Late Diastolic Filling Velocity as a Predictor of Mortality in Middle-Aged and Elderly Adults	315
Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death.	314
Activation of Monocyte/Macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40	314
Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events	314
Exercise as Cardiovascular Therapy	313
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups.	313
Vessel Size and Long-Term Outcome After Coronary Stent Placement	313
Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.	313
Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques	313
Preinfarctional (Unstable) Angina—A Prospective Study— Ten Year Follow-Up	313
Elevated Circulating Level of Ghrelin in Cachexia Associated With Chronic Heart Failure	312
Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.	312
Regional Myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine.	312
Noninvasive Coronary Angiography by Retrospectively ECG-Gated Multislice Spiral CT	312
Select Flavonoids and Whole Juice From Purple Grapes Inhibit Platelet Function and Enhance Nitric Oxide Release	312
Physiological Basis of Myocardial Contrast Enhancement in Fast Magnetic Resonance Images of 2-Day-Old Reperfused Canine Infarcts	312
Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic Lesions	312
Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study.	311
Physical Activity Prevents Age-Related Impairment in Nitric Oxide Availability in Elderly Athletes	311
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.	311
Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.	311
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.	311
Association Between Thrombolytic Treatment and the Prognosis of Hemodynamically Stable Patients With Major Pulmonary Embolism	311
A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure	311
Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation	310
Extracellular Potassium Modulation of Drug Block of I _Kr	310
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy	310
Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging	310
Coronary Angioplasty in Diabetic Patients	310
Left ventricular performance in normal subjects: a comparison of the responses to exercise in the upright and supine positions.	310
Low Incidence of Myocardial Recovery After Left Ventricular Assist Device Implantation in Patients With Chronic Heart Failure	310
Oxidative Stress Mediates Tumor Necrosis Factor-α–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes	310
Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial Infarction	310
Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study.	310
CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors	310
Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary H	310
Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association	310
Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee.	309
Influence of Pulmonary Capillary Wedge Pressure on Central Apnea in Heart Failure	309
Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance	309
Noninvasive Assessment of Significant Left Anterior Descending Coronary Artery Stenosis by Coronary Flow Velocity Reserve With Transthoracic Color Doppler Echocardiography	309
Asymmetrical Dimethylarginine	309
Obesity and Heart Disease	309
Clinical Spectrum of the Sick Sinus Syndrome	309
Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation	309
Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy.	308
Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery	308
Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.	308
Vascular Endothelial Dysfunction and Mortality Risk in Patients With Chronic Heart Failure	308
Natural History of Asymptomatic Mitral Valve Prolapse in the Community	308
Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial Infarction	308
Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with sev	308
Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk Patients	308
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase	308
Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women	308
The Mitral Apparatus	307
Survival in medically treated coronary artery disease.	307
Pulmonary Embolism	307
Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis.	307
Insulin-Resistant Prediabetic Subjects Have More Atherogenic Risk Factors Than Insulin-Sensitive Prediabetic Subjects	307
Infection With Chlamydia pneumoniae Accelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model	307
Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome	307
The thyroid and the heart.	306
Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings.	306
Perspectives on systolic hypertension. The Framingham study.	306
Predictive implications of stress testing. Follow-up of 2700 subjects after maximum treadmill stress testing.	306
Augmentation of Postnatal Neovascularization With Autologous Bone Marrow Transplantation	306
Prevention Conference V	306
Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis	306
Constrictive Pericarditis in 26 Patients With Histologically Normal Pericardial Thickness	306
Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy	306
Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy	306
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.	306
RR Variability in Healthy, Middle-Aged Persons Compared With Patients With Chronic Coronary Heart Disease or Recent Acute Myocardial Infarction	306
Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.	306
Chronic major-vessel thromboembolic pulmonary hypertension.	305
Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction	305
Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans	305
Cardiac Allograft Vasculopathy	304
Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction	304
Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia	304
Improvement of Left Ventricular Function After Cardiac Resynchronization Therapy Is Predicted by Tissue Doppler Imaging Echocardiography	304
Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease	304
Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure	304
Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.	304
Time Dependence of Platelet Inhibition After a 600-mg Loading Dose of Clopidogrel in a Large, Unselected Cohort of Candidates for Percutaneous Coronary Intervention	304
Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity.	303
Nitric Oxide Attenuates the Release of Endothelium-Derived Hyperpolarizing Factor	303
Independent Prognostic Value of Cardiac Troponin T in Patients With Confirmed Pulmonary Embolism	303
Hyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans	303
Identification of 92-kD Gelatinase in Human Coronary Atherosclerotic Lesions	303
Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?	303
Changes in Atrial Fibrillation Cycle Length and Inducibility During Catheter Ablation and Their Relation to Outcome	303
Cardiac Interbeat Interval Dynamics From Childhood to Senescence	303
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparatio	303
High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells	303
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention	303
Recent progress in understanding apolipoprotein B.	302
Characteristics and Distribution of M Cells in Arterially Perfused Canine Left Ventricular Wedge Preparations	302
Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries.	302
Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography.	302
Intravenous short-term infusion of streptokinase in acute myocardial infarction.	302
Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS).	302
Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary Embolism	302
Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.	302
Influence of age and hemodynamics on myocardial blood flow and flow reserve.	302
Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential.	302
Identification of a Potential Role for the Adventitia in Vascular Lesion Formation After Balloon Overstretch Injury of Porcine Coronary Arteries	302
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Two-Year Follow-up	302
Elevated Levels of 8-iso-Prostaglandin F _2α in Pericardial Fluid of Patients With Heart Failure	302
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study	302
Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery	302
Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients	302
Echocardiographic Doppler evaluation of left ventricular diastolic function. Physics and physiology.	301
The effects of acute and chronic cocaine use on the heart.	301
Mortality and Morbidity of Aortic Regurgitation in Clinical Practice	301
Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy	301
Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.	301
Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method.	301
Quantitative Relation Between Myocardial Viability and Improvement in Heart Failure Symptoms After Revascularization in Patients With Ischemic Cardiomyopathy	301
Changes in Intra-Abdominal Visceral Fat and Serum Leptin Levels in Patients With Obstructive Sleep Apnea Syndrome Following Nasal Continuous Positive Airway Pressure Therapy	301
Long-term Cigarette Smoking Impairs Endothelium-Dependent Coronary Arterial Vasodilator Function	300
The Conducting Tissues in Congenitally Corrected Transposition	300
Molecular and cellular mechanism of endothelin regulation. Implications for vascular function.	300
Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein	300
Intra-Arrest Cooling Improves Outcomes in a Murine Cardiac Arrest Model	300
Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities.	300
Correlations Between Fractional Flow Reserve and Intravascular Ultrasound in Patients With an Ambiguous Left Main Coronary Artery Stenosis	300
Desmin Mutation Responsible for Idiopathic Dilated Cardiomyopathy	300
Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women	300
Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction	300
High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study	300
Expression of Inducible Nitric Oxide Synthase in Human Heart Failure	300
Molecular biology of the natriuretic peptides and their receptors.	299
Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.	299
Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction.	299
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.	299
Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in Mice	299
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.	299
Simultaneous Coronary Pressure and Flow Velocity Measurements in Humans	299
Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation	299
Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis	299
Infection and Atherosclerosis	298
Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.	298
Cardiac Sympathetic Nerve Function in Congestive Heart Failure	298
Methylenetetrahydrofolate Reductase Polymorphism, Plasma Folate, Homocysteine, and Risk of Myocardial Infarction in US Physicians	298
Estrogen Promotes Angiogenic Activity in Human Umbilical Vein Endothelial Cells In Vitro and in a Murine Model	298
The value of lesion cross-sectional area determined by quantitative coronary angiography in assessing the physiologic significance of proximal left anterior descending coronary arterial stenoses.	298
Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter	298
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary	298
The Multilevel Compliance Challenge: Recommendations for a Call to Action	297
Inhibition of P-Glycoprotein–Mediated Drug Transport	297
PTX3, A Prototypical Long Pentraxin, Is an Early Indicator of Acute Myocardial Infarction in Humans	297
Protective effects of adenosine in myocardial ischemia.	296
Electrocardiographic quantitation of ventricular repolarization.	296
Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus.	296
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease	296
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.	296
Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.	296
Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets	296
Increased Protein Kinase C Activity and Expression of Ca ²⁺ -Sensitive Isoforms in the Failing Human Heart	296
Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease	296
Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations.	295
Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.	295
Neointimal Tissue Response at Sites of Coronary Stenting in Humans	295
Temporal Trends in Coronary Heart Disease Mortality and Sudden Cardiac Death From 1950 to 1999	295
Free-Floating Thrombi in the Right Heart	295
Gamma-globulin treatment of acute myocarditis in the pediatric population.	295
Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.	295
G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor	295
Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions	295
Guidelines for Carotid Endarterectomy	295
Myocardial protection with preconditioning.	294
Human vascular smooth muscle cells contain functional estrogen receptor.	294
Hirudin in Acute Myocardial Infarction	294
Evaluation of Sino-atrial Node Function in Man by Overdrive Suppression	294
Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.	294
Women’s Early Warning Symptoms of Acute Myocardial Infarction	294
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism.	294
Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension	294
Administration of Wine and Grape Juice Inhibits In Vivo Platelet Activity and Thrombosis in Stenosed Canine Coronary Arteries	294
Delivery of Colloidal Particles and Red Blood Cells to Tissue Through Microvessel Ruptures Created by Targeted Microbubble Destruction With Ultrasound	294
Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism	294
Strain-Rate Imaging During Dobutamine Stress Echocardiography Provides Objective Evidence of Inducible Ischemia	294
Metabolic Modulation of Acute Myocardial Infarction	294
Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury	294
Surgical Management of Aortic Dissection During a 30-Year Period	294
Dysfunctional Voltage-Gated K ⁺ Channels in Pulmonary Artery Smooth Muscle Cells of Patients With Primary Pulmonary Hypertension	294
Spectrum of ST-T–Wave Patterns and Repolarization Parameters in Congenital Long-QT Syndrome	294
Endothelium-derived relaxing factor and coronary vasospasm.	293
Vasodilator Therapy for Primary Pulmonary Hypertension in Children	293
Anemia and Its Relationship to Clinical Outcome in Heart Failure	293
Long-term prognosis for patients with variant angina and influential factors.	293
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways	293
Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure.	293
Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing Heart	293
Increased Short-Term Variability of Repolarization Predicts d -Sotalol–Induced Torsades de Pointes in Dogs	293
Cardiac Risk of Noncardiac Surgery	293
Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction	293
A New Electrocardiographic Pattern Observed in Cerebrovascular Accidents	292
Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease	292
Inhaled nitric oxide in congenital heart disease.	292
Treatment of hypertension with nifedipine, a calcium antagonistic agent.	292
In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men.	292
Antisense to LOX-1 Inhibits Oxidized LDL–Mediated Upregulation of Monocyte Chemoattractant Protein-1 and Monocyte Adhesion to Human Coronary Artery Endothelial Cells	292
Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.	292
Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.	292
Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations	292
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.	292
Particulate Air Pollution and Risk of ST-Segment Depression During Repeated Submaximal Exercise Tests Among Subjects With Coronary Heart Disease	292
Tracking Women’s Awareness of Heart Disease	291
Cytokine Gene Expression After Myocardial Infarction in Rat Hearts	291
Left Ventricular Geometry and Severe Left Ventricular Hypertrophy in Children and Adolescents With Essential Hypertension	291
Long-term l -Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans	291
Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation	291
Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS).	291
A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application	291
CD34 ⁺ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure	291
Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women	291
Role of Neutrophils in Myocardial Ischemia and Reperfusion	290
Ultrasound Localization of Left Ventricular Outflow Obstruction in Hypertrophic Obstructive Cardiomyopathy	290
Mechanisms of Discordant Alternans and Induction of Reentry in Simulated Cardiac Tissue	290
Triggering of Myocardial Infarction by Cocaine	290
Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.	290
A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989.	290
Observations on mechanisms of ventricular tachycardia in man.	289
Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus	289
Prospective Study of Sudden Cardiac Death Among Women in the United States	289
Cardiac Benefits of Fish Consumption May Depend on the Type of Fish Meal Consumed	289
Blood Pressure Response During Treadmill Testing as a Risk Factor for New-Onset Hypertension	289
Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart Failure	289
Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography. Implications for prognosis and therapy. The European Cooperative Study Group on Echocardiogra	289
The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques	289
Detection and estimation of the degree of mitral regurgitation by range-gated pulsed doppler echocardiography.	288
Demonstration of Rapid Onset Vascular Endothelial Dysfunction After Hyperhomocysteinemia	288
Reversal of Chronic Ventricular Dilation in Patients With End-Stage Cardiomyopathy by Prolonged Mechanical Unloading	288
Blood Pressure Reactivity to Psychological Stress Predicts Hypertension in the CARDIA Study	288
Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women	288
Selection and Treatment of Candidates for Heart Transplantation	288
Epidemic Obesity and the Metabolic Syndrome	287
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome	287
Clinical Outcomes After Ablation and Pacing Therapy for Atrial Fibrillation	287
Lung Function and Exercise Gas Exchange in Chronic Heart Failure	287
Blood platelet count and function are related to total and cardiovascular death in apparently healthy men.	287
Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries.	287
Sex-Related Differences in Autonomic Modulation of Heart Rate in Middle-aged Subjects	287
Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade	287
Endothelial Dysfunction Is Detectable in Young Normotensive First-Degree Relatives of Subjects With Type 2 Diabetes in Association With Insulin Resistance	287
Rapid Ventricular Induction of Brain Natriuretic Peptide Gene Expression in Experimental Acute Myocardial Infarction	287
C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites	287
Weight Gain in the First Week of Life and Overweight in Adulthood	287
Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study	287
Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction	286
Left Atrial Relaxation and Left Ventricular Systolic Function Determine Left Atrial Reservoir Function	286
Effect of Risk Factors on the Mechanism of Acute Thrombosis and Sudden Coronary Death in Women	286
Impaired Microvascular Function in Obesity	286
Ionic and Cellular Basis for the Predominance of the Brugada Syndrome Phenotype in Males	286
Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol	286
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.	286
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure	286
Upper-Extremity Deep Vein Thrombosis	285
Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis	285
Lyon Diet Heart Study	285
Anatomy of the Normal Left Atrial Appendage	285
Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice	285
Myocyte Recovery After Mechanical Circulatory Support in Humans With End-Stage Heart Failure	284
Evaluation and Clinical Implications of Aortic Valve Calcification Measured by Electron-Beam Computed Tomography	284
Balloon Dilation of Severe Aortic Stenosis in the Fetus	284
Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women	284
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease	284
Pathways and Functional Significance of the Coronary Collateral Circulation	283
Coming of Age of C-Reactive Protein	283
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.	283
Regional Differences in Current Density and Rate-Dependent Properties of the Transient Outward Current in Subepicardial and Subendocardial Myocytes of Human Left Ventricle	283
Role of Oxidant Stress in Endothelial Dysfunction Produced by Experimental Hyperhomocyst(e)inemia in Humans	283
Successful Surgical Interruption of the Bundle of Kent in a Patient with Wolff-Parkinson-White Syndrome	283
Right Ventricular Diastolic Function 15 to 35 Years After Repair of Tetralogy of Fallot	283
Contribution of Tonic Chemoreflex Activation to Sympathetic Activity and Blood Pressure in Patients With Obstructive Sleep Apnea	283
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.	283
Prevention of Bacterial Endocarditis	283
Magnetic Resonance Imaging Analysis of Right Ventricular Pressure-Volume Loops	283
Dietary Guidelines for Healthy American Adults	283
Quantitative Magnetic Resonance Imaging Analysis of Neovasculature Volume in Carotid Atherosclerotic Plaque	282
Maximal Coronary Flow Reserve and Metabolic Coronary Vasodilation in Patients With Diabetes Mellitus	282
Four-Year Follow-up of Palmaz-Schatz Stent Revascularization as Treatment for Atherosclerotic Renal Artery Stenosis	282
Sudden cardiac death in heart failure. The role of abnormal repolarization.	282
Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease	282
Rising Tide of Cardiovascular Disease in American Indians	282
Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin	282
Red Wine Polyphenols Enhance Endothelial Nitric Oxide Synthase Expression and Subsequent Nitric Oxide Release From Endothelial Cells	281
Glucose for the Heart	281
Secondary Pulmonary Hypertension in Chronic Heart Failure	281
Measurement of regional myocardial blood flow with multiple colored microspheres.	281
Endothelial Cells Promote Cardiac Myocyte Survival and Spatial Reorganization	281
Relationship Between Circadian Blood Pressure Patterns and Progression of Early Carotid Atherosclerosis	281
Tracking of blood lipids and blood pressures in school age children: the Muscatine study.	281
Fundamentals of Reperfusion Injury for the Clinical Cardiologist	281
The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality.	281
Testosterone Relaxes Rabbit Coronary Arteries and Aorta	280
In Vivo Imaging of Proteolytic Activity in Atherosclerosis	280
Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man.	280
Early Predictors of In-Hospital Death in Infective Endocarditis	280
Characterization of Reentrant Circuit in Macroreentrant Right Atrial Tachycardia After Surgical Repair of Congenital Heart Disease	280
Antioxidants and atherosclerosis. A current assessment.	279
Cardiac electrophysiology of adenosine. Basic and clinical concepts.	279
Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning	279
Characterization of Endocardial Electrophysiological Substrate in Patients With Nonischemic Cardiomyopathy and Monomorphic Ventricular Tachycardia	279
Balloon-expandable intracoronary stents in the adult dog.	279
Titin Isoform Switch in Ischemic Human Heart Disease	279
Discrepancies Between Cineangiographic and Postmortem Findings in Patients with Coronary Artery Disease and Recent Myocardial Revascularization	279
Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice	279
Myocardial Fibrosis and Stiffness With Hypertrophy and Heart Failure in the Spontaneously Hypertensive Rat	279
Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group.	279
Sudden unexpected death in patients with congestive heart failure: a second frontier.	278
Electrocardiographic Recognition of the Epicardial Origin of Ventricular Tachycardias	278
Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias.	278
Expression of recombinant genes in myocardium in vivo after direct injection of DNA.	278
Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location.	278
The Antioxidant Acetylcysteine Reduces Cardiovascular Events in Patients With End-Stage Renal Failure	278
Characterization of Plaque Components With Intravascular Ultrasound Elastography in Human Femoral and Coronary Arteries In Vitro	278
Effect of Continuous Positive Airway Pressure on Intrathoracic and Left Ventricular Transmural Pressures in Patients With Congestive Heart Failure	278
Bone Marrow–Derived Cardiomyocytes Are Present in Adult Human Heart	278
Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion	278
Myocardial Perfusion Patterns Related to Thrombolysis in Myocardial Infarction Perfusion Grades After Coronary Angioplasty in Patients With Acute Anterior Wall Myocardial Infarction	278
Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease. Comparison with exercise electrocardiography.	278
Geometric Differences of the Mitral Apparatus Between Ischemic and Dilated Cardiomyopathy With Significant Mitral Regurgitation	278
Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock	278
Assessment of diastolic function: suggested methods and future considerations.	277
Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function.	277
Vascular Anomalies in Alagille Syndrome	277
Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.	277
Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required.	277
Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.	277
Obesity and cardiac function.	276
Side effects of long-term amiodarone therapy.	276
Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs	276
Acute myocarditis. Rapid diagnosis by PCR in children.	276
Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans.	276
Fractional Flow Reserve in Patients With Prior Myocardial Infarction	276
Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction.	276
Soluble CD40L	276
Prospective Study of Atherosclerotic Disease Progression in the Renal Artery	276
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.	276
Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade	276
Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.	276
Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II–Infused Rats	276
Molecular Basis of Transient Outward Potassium Current Downregulation in Human Heart Failure	276
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infar	276
Magnetic Resonance Imaging to Assess the Hemodynamic Effects of Pulmonary Valve Replacement in Adults Late After Repair of Tetralogy of Fallot	276
Atrial Septal Aneurysm in Adult Patients	276
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.	276
Dose Response of Almonds on Coronary Heart Disease Risk Factors: Blood Lipids, Oxidized Low-Density Lipoproteins, Lipoprotein(a), Homocysteine, and Pulmonary Nitric Oxide	276
Preventing Cancer, Cardiovascular Disease, and Diabetes	276
Antioxidant Vitamin Supplements and Cardiovascular Disease	275
Inhibition of NF-κB Activation by Pyrrolidine Dithiocarbamate Prevents In Vivo Expression of Proinflammatory Genes	275
Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries.	275
Osteopontin Is Expressed in Human Aortic Valvular Lesions	275
Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture.	275
Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.	275
Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease	275
Inflammatory Cytokines Impair Endothelium-Dependent Dilatation in Human Veins In Vivo	274
Treatment of Aortic Disease in Patients With Marfan Syndrome	274
Anomalous aortic origin of coronary arteries.	274
Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism	274
Percutaneous balloon valvotomy for patients with severe mitral stenosis.	274
Death of Smooth Muscle Cells and Expression of Mediators of Apoptosis by T Lymphocytes in Human Abdominal Aortic Aneurysms	274
Ischemic Preconditioning at a Distance	274
Electrically Unexcitable Scar Mapping Based on Pacing Threshold for Identification of the Reentry Circuit Isthmus	274
Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.	274
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.	274
Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf	274
Roles of P2-purinoceptors in the cardiovascular system.	273
Safety of Statins	273
Beneficial Effects of Intracoronary Adenosine as an Adjunct to Primary Angioplasty in Acute Myocardial Infarction	273
Prodromal Angina Limits Infarct Size	273
Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation	273
Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart Failure	273
Effect of Epicardial or Biventricular Pacing to Prolong QT Interval and Increase Transmural Dispersion of Repolarization	273
Chronic Venous Insufficiency	272
Mitral valve prolapse.	272
Relation Between Endothelial Cell Apoptosis and Blood Flow Direction in Human Atherosclerotic Plaques	272
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease	272
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts.	272
Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.	272
Decreased magnitude of heart rate spectral components in coronary artery disease. Its relation to angiographic severity.	272
Prospective Study of Markers of Hemostatic Function With Risk of Ischemic Stroke	272
Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors	272
Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation.	271
Androgen Receptors Mediate Hypertrophy in Cardiac Myocytes	271
Trans-fatty acids intake and risk of myocardial infarction.	271
Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition	271
Progress Study of 590 Consecutive Nonsurgical Cases of Coronary Disease Followed 5-9 Years	271
Insulin and Risk of Cardiovascular Disease	271
New-Onset Atrial Fibrillation	271
Functional Recovery of Stroke Rats Induced by Granulocyte Colony-Stimulating Factor–Stimulated Stem Cells	271
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.	271
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.	271
Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression	271
Guidelines for the Evaluation and Management of Heart Failure	271
Transient Mitochondrial Permeability Transition Pore Opening Mediates Preconditioning-Induced Protection	270
Transmitral pressure-flow velocity relation. Importance of regional pressure gradients in the left ventricle during diastole.	270
Balloon dilation angioplasty of aortic coarctations in infants and children.	270
Hyperlipidemia and Coronary Disease	270
The effect of coronary angioplasty on coronary flow reserve.	270
Arterial Neovascularization and Inflammation in Vulnerable Patients	270
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice	270
Intake of Potassium, Magnesium, Calcium, and Fiber and Risk of Stroke Among US Men	270
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.	270
Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.	270
Simvastatin Lowers C-Reactive Protein Within 14 Days	270
Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis	270
Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in Humans	270
Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure	270
Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction	270
Cholesterol Reduction Yields Clinical Benefit	269
Randomized Assessment of Syncope Trial	269
Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor	269
Quantification of regional myocardial blood flow in vivo with H215O.	269
Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.	269
Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease	269
Hepatic Venous Blood and the Development of Pulmonary Arteriovenous Malformations in Congenital Heart Disease	269
Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram.	269
Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus	269
Relationship Between TIMI Frame Count and Clinical Outcomes After Thrombolytic Administration	269
Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography.	269
Team Management of Patients With Heart Failure	269
Renin-Angiotensin System Gene Polymorphisms and Atrial Fibrillation	269
Early and Delayed Consequences of β ₂ -Adrenergic Receptor Overexpression in Mouse Hearts	269
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiova	269
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.	268
Is Slower Early Growth Beneficial for Long-Term Cardiovascular Health?	268
Association Between Local Pulse Pressure, Mean Blood Pressure, and Large-Artery Remodeling	268
Multicenter Validation of a Risk Index for Mortality, Intensive Care Unit Stay, and Overall Hospital Length of Stay After Cardiac Surgery	268
Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy	268
Transplacental Fetal Treatment Improves the Outcome of Prenatally Diagnosed Complete Atrioventricular Block Without Structural Heart Disease	268
Influence of Leptin on Arterial Distensibility	268
Initial Experience With Remote Catheter Ablation Using a Novel Magnetic Navigation System	268
Extracorporeal Cardiac Shock Wave Therapy Markedly Ameliorates Ischemia-Induced Myocardial Dysfunction in Pigs in Vivo	268
In Vivo Quantitative Tissue Characterization of Human Coronary Arterial Plaques by Use of Integrated Backscatter Intravascular Ultrasound and Comparison With Angioscopic Findings	268
Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile.	267
Pathophysiology of Cardiogenic Shock	267
Intracoronary ultrasound observations during stent implantation.	267
Multilineage Potential of Cells From the Artery Wall	267
Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat.	267
Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.	267
Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries.	267
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans	267
Nitric Oxide Activity Is Deficient in Spasm Arteries of Patients With Coronary Spastic Angina	267
Oral D-4F Causes Formation of Pre-β High-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Nu	267
Determinants of ventricular function in pressure-overload hypertrophy in man.	266
Survival after Resuscitation from Out-of-Hospital Ventricular Fibrillation	266
P-Wave Analysis in Valvular Heart Disease	266
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.	266
Diuretics and Risk of Arrhythmic Death in Patients With Left Ventricular Dysfunction	266
Personality, Disease Severity, and the Risk of Long-term Cardiac Events in Patients With a Decreased Ejection Fraction After Myocardial Infarction	266
Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to α _v -Integrins	266
Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias.	266
Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes	266
Vascular Endothelial Growth Factor/Vascular Permeability Factor Augments Nitric Oxide Release From Quiescent Rabbit and Human Vascular Endothelium	266
Impact of Preoperative Symptoms on Survival After Surgical Correction of Organic Mitral Regurgitation	266
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients.	266
Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial Fibrillation	266
Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality	266
Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy	266
Physical Activity and Exercise Recommendations for Stroke Survivors	266
Sex Hormone–Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nati	266
Pulmonary Vein Stenosis After Radiofrequency Ablation of Atrial Fibrillation	266
Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease	265
Mapping and Ablation of Left Atrial Flutters	265
Arrhythmogenic Substrate of the Pulmonary Veins Assessed by High-Resolution Optical Mapping	265
Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury	265
Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization	265
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.	265
The long QT syndrome in children. An international study of 287 patients.	265
Determinants and Prognostic Implications of Persistent ST-Segment Elevation After Primary Angioplasty for Acute Myocardial Infarction	265
A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice.	265
Direct Intramuscular Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor Augments Collateral Development and Tissue Perfusion	265
Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells	265
Prevention of Iatrogenic Atrial Tachycardia After Ablation of Atrial Fibrillation	265
Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury	265
Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance	265
Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients	265
Cell-Membrane Ultrastructure	264
Vitamin C Improves Endothelial Function of Conduit Arteries in Patients With Chronic Heart Failure	264
Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease.	264
Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique.	264
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease	264
Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention	264
Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death	263
Prognosis in coronary artery disease. Angiographic, hemodynamic, and clinical factors.	263
Ultrasound-Targeted Microbubble Destruction Can Repeatedly Direct Highly Specific Plasmid Expression to the Heart	263
Inadequate Response to Treatment in Coronary Heart Disease	263
Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome.	263
Noninvasive quantification of left ventricular rotational deformation in normal humans using magnetic resonance imaging myocardial tagging.	263
Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension	263
Blood Lipids and Human Atherosclerosis	262
Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia	262
Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches.	262
Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction.	262
Apoptosis and Related Proteins in Different Stages of Human Atherosclerotic Plaques	262
Innate Immune Recognition of Invasive Bacteria Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice	262
Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes	262
Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation	262
Endovascular Low-Dose Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in Swine	262
Role of neural crest in congenital heart disease.	261
Anomalies of the Coronary Arteries and their Clinical Significance	261
Oxidized Lipoproteins Degrade the Endothelial Surface Layer	261
Sequence of events in angina at rest: primary reduction in coronary flow.	261
Coronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions	261
Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors.	261
Intravenous nitroglycerin in acute myocardial infarction.	261
Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques.	261
Association of Body Fat Distribution and Cardiovascular Risk Factors in Children and Adolescents	261
Sex Hormones Prolong the QT Interval and Downregulate Potassium Channel Expression in the Rabbit Heart	261
Perturbation of the T-Cell Repertoire in Patients With Unstable Angina	261
Right Ventricular Enlargement on Chest Computed Tomography	261
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women	261
A Meta-analysis of the Association of the Deletion Allele of the Angiotensin-Converting Enzyme Gene With Myocardial Infarction	261
High Prevalence of Peripheral Arterial Disease in Persons With Renal Insufficiency	261
Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure	261
25-Hydroxyvitamin D ₃ -1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds	261
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting	261
Oral hydralazine therapy for chronic refractory heart failure.	260
Arrhythmogenic Right Ventricular Cardiomyopathy and Fatty Replacement of the Right Ventricular Myocardium	260
Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling	260
Patent Foramen Ovale Is an Important Predictor of Adverse Outcome in Patients With Major Pulmonary Embolism	260
M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.	260
High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.	260
Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity	260
Angiographic Assessment of Collateral Connections in Comparison With Invasively Determined Collateral Function in Chronic Coronary Occlusions	260
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes	260
Intramural Hematoma of the Aorta	260
Assessment of QT Interval and QT Dispersion for Prediction of All-Cause and Cardiovascular Mortality in American Indians	260
Primary Prevention of Ischemic Stroke	260
Electrical Stability of Acutely Ischemic Myocardium	259
Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.	259
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome.	259
Endothelial Function Predicts Future Development of Coronary Artery Disease	259
Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure.	259
Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response.	259
Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Vascular Reactivity of the Forearm Microcirculation in Hyperlipidemic, Overweight Men	259
Major Racial Differences in Coronary Constrictor Response Between Japanese and Caucasians With Recent Myocardial Infarction	259
Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans.	259
Electrical Storm Presages Nonsudden Death	259
Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease	259
Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia.	258
Left-to-Right Gradient of Atrial Frequencies During Acute Atrial Fibrillation in the Isolated Sheep Heart	258
Idiopathic Ventricular Fibrillation Induced With Vagal Activity in Patients Without Obvious Heart Disease	258
The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting.	258
Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar Apparatus	258
Detecting Acute Coronary Syndrome in the Emergency Department With Cardiac Magnetic Resonance Imaging	258
Cardiovascular Status of Carriers of the Apolipoprotein A-I _Milano Mutant	258
Platelets, endothelium, and vasospasm.	258
Circulating Cardiac Troponin I in Severe Congestive Heart Failure	258
Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care.	258
Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).	258
Meeting Highlights	258
Cardiac Atrophy After Bed-Rest Deconditioning	258
Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia	258
Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial Infarction	258
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors	257
Reconstitution of Excitable Cell Membrane Structure in Vitro	257
The Junction Between the Left Atrium and the Pulmonary Veins	257
Treatment of infective endocarditis: a 10-year comparative analysis.	257
Emotional and Physical Precipitants of Ventricular Arrhythmia	257
Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes	257
Reduced Endothelial Nitric Oxide Synthase Expression and Production in Human Atherosclerosis	257
Interleukin-6 ( IL-6 ) and the Prognosis of Abdominal Aortic Aneurysms	257
Absence of Low-Frequency Variability of Sympathetic Nerve Activity in Severe Heart Failure	257
Catheter Ablation of Cardiac Autonomic Nerves for Prevention of Vagal Atrial Fibrillation	257
Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.	257
Long-Term Ascorbic Acid Administration Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease	257
Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes.	257
Relationship Between Na ⁺ -Ca ²⁺ –Exchanger Protein Levels and Diastolic Function of Failing Human Myocardium	257
Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels.	257
31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.	257
Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease	257
AT ₁ Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase	257
Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries	257
Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction	257
Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke	257
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring	257
A Classification of Unstable Angina Revisited	256
“Brugada” Syndrome	256
Antecedents of Cardiovascular Disease in Six Solomon Islands Societies	256
The Elusive Pathophysiology of Neurally Mediated Syncope	256
Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men.	256
Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation	256
Aldosterone Production Is Activated in Failing Ventricle in Humans	256
Endothelin-1 Increases Vascular Superoxide via Endothelin _A –NADPH Oxidase Pathway in Low-Renin Hypertension	256
Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Apparently Uncomplicated Type 2 Diabetic Patients	256
Influence of Lipid-Lowering Therapy on the Progression of Coronary Artery Calcification	256
Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction.	256
Hyperhomocysteinemia and Low Pyridoxal Phosphate	256
Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe	256
Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy	256
Use of Biplane Cinefluorography for Measurement of Ventricular Volume	255
Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease	255
Regression of Cellular Hypertrophy After Left Ventricular Assist Device Support	255
Ventricular premature complexes and sudden death after myocardial infarction.	255
Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction	255
The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micro	255
Adenoviral Gene Transfer of Activated Phosphatidylinositol 3′-Kinase and Akt Inhibits Apoptosis of Hypoxic Cardiomyocytes In Vitro	255
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats	255
Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury	255
Takayasu's Arteritis	255
Catheter modification of the atrioventricular junction with radiofrequency energy for control of atrioventricular nodal reentry tachycardia.	255
Estrogen Modulates AT ₁ Receptor Gene Expression In Vitro and In Vivo	255
Common Estrogen Receptor Polymorphism Augments Effects of Hormone Replacement Therapy on E-Selectin but Not C-Reactive Protein	255
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association	255
Rate Dependence and Regulation of Action Potential and Calcium Transient in a Canine Cardiac Ventricular Cell Model	254
Body Iron Stores and the Risk of Carotid Atherosclerosis	254
Statin-Sensitive Dysregulated AT1 Receptor Function and Density in Hypercholesterolemic Men	254
Integrated Mechanism for Functional Mitral Regurgitation	254
Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation	254
Oscillatory Patterns in Sympathetic Neural Discharge and Cardiovascular Variables During Orthostatic Stimulus	254
Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia	254
Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits	254
Carotid Plaques Increase the Risk of Stroke and Subtypes of Cerebral Infarction in Asymptomatic Elderly	254
Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro.	254
Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles	254
Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-α in Pacing-Induced Heart Failure	254
Right ventricular tachycardia: clinical and electrophysiologic characteristics.	253
Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists	253
Visualization of Ventricular Thrombi With Contrast-Enhanced Magnetic Resonance Imaging in Patients With Ischemic Heart Disease	253
Postmenopausal Hormone Therapy and Risk of Stroke	253
Dual-Chamber Pacing in the Treatment of Neurally Mediated Tilt-Positive Cardioinhibitory Syncope	253
Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic ^99m Tc Sestamibi Imaging Predicts Subsequent Mortality	253
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects.	253
Comparison of Coronary Plaque Rupture Between Stable Angina and Acute Myocardial Infarction	253
Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Soprav	253
ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: Executive Summary and Recommendations	253
Cigarette smoking is a major risk factor for coronary spasm.	252
Isolated Ambulatory Hypertension Predicts Cardiovascular Morbidity in Elderly Men	252
Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects.	252
The Hemodynamic and Metabolic Interrelationships in the Activity of Epinephrine, Norepinephrine and the Thyroid Hormones	252
The Anatomic Basis of Connections Between the Coronary Sinus Musculature and the Left Atrium in Humans	252
Single-Beat Estimation of End-Systolic Pressure-Volume Relation in Humans	252
Improved Outcome After Coronary Bypass Surgery in Patients With Ischemic Cardiomyopathy and Residual Myocardial Viability	252
Hydrodynamic compression of the right atrium: a new echocardiographic sign of cardiac tamponade.	252
Characterizing Vulnerable Plaque Features With Intravascular Elastography	252
Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In Vivo	252
Effects of I _Kr and I _Ks Heterogeneity on Action Potential Duration and Its Rate Dependence	252
Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction	252
Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging.	252
Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction	252
Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass Surgery	252
Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de	252
Migration of smooth muscle and endothelial cells. Critical events in restenosis.	251
Congenital heart block in newborns of mothers with connective tissue disease.	251
Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation.	251
Small Heat Shock Proteins and Protection Against Ischemic Injury in Cardiac Myocytes	251
Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein	251
Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged Men	251
Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans.	251
Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-β–Independent Mechanism	251
Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated Cardiomyopathy	251
Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit.	251
Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction.	251
Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement.	251
Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated With Calcium Release Channel (Ryanodine Receptor) Leak	251
Combined Accelerated Tissue-Plasminogen Activator and Platelet Glycoprotein IIb/IIIa Integrin Receptor Blockade With Integrilin in Acute Myocardial Infarction	251
Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease.	250
Pathophysiologic Observations in Prehospital Ventricular Fibrillation and Sudden Cardiac Death	250
Re-entrant ventricular arrhythmias in the late myocardial infarction period. 2. Patterns of initiation and termination of re-entry.	250
Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice	250
Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography.	250
Quantitative analysis of the high-frequency components of the terminal portion of the body surface QRS in normal subjects and in patients with ventricular tachycardia.	250
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension	250
Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients	250
Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.	250
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis	249
Cardiac Disease in Young Trained Athletes	249
Presence of Left-to-Right Atrial Frequency Gradient in Paroxysmal but Not Persistent Atrial Fibrillation in Humans	249
A New Method for Radionuclide Imaging of Acute Myocardial Infarction in Humans	249
Atrial Fibrillation Is Associated With Increased Spontaneous Calcium Release From the Sarcoplasmic Reticulum in Human Atrial Myocytes	249
Power Law Behavior of RR-Interval Variability in Healthy Middle-Aged Persons, Patients With Recent Acute Myocardial Infarction, and Patients With Heart Transplants	249
Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation.	249
Gene Transfer of Stromal Cell–Derived Factor-1α Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase–Related Pathway	249
ACC/AHA Guidelines for Coronary Angiography: Executive Summary and Recommendations	249
Esophageal echocardiography.	248
Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry.	248
Cellular mechanisms of myocardial infarct expansion.	248
A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead.	248
Coronary Endothelial Dysfunction in Humans Is Associated With Myocardial Perfusion Defects	248
The relationship of mitral annular shape to the diagnosis of mitral valve prolapse.	248
Detection of left ventricular thrombus by two-dimensional echocardiography: sensitivity, specificity, and causes of uncertainty.	248
Impact of Low Birth Weight and Cardiovascular Risk Factors on Endothelial Function in Early Adult Life	248
Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis	248
Midwall Left Ventricular Mechanics	248
Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report.	248
Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.	248
Activation and Entrainment Mapping Defines the Tricuspid Annulus as the Anterior Barrier in Typical Atrial Flutter	248
Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia	248
Carotid Intima-Media Thickness Is Only Weakly Correlated With the Extent and Severity of Coronary Artery Disease	248
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.	248
Platelet/Endothelial Biomarkers in Depressed Patients Treated With the Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events	248
Increased Neutrophil-Platelet Adhesion in Patients With Unstable Angina	247
Compound Mutations	247
Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans	247
Statin Prevents Tissue Factor Expression in Human Endothelial Cells	247
Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions	247
Dissociation between left ventricular untwisting and filling. Accentuation by catecholamines.	247
Increased Reactive Oxygen Species in Rostral Ventrolateral Medulla Contribute to Neural Mechanisms of Hypertension in Stroke-Prone Spontaneously Hypertensive Rats	247
Asynchronous Electrical Activation Induces Asymmetrical Hypertrophy of the Left Ventricular Wall	247
C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction	247
Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease.	247
Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia Among US Adults	247
Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease	247
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers	247
Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction	247
Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthe	247
A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting	247
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis	247
Monounsaturated Fatty Acids and Risk of Cardiovascular Disease	246
Reductions in Systemic and Skeletal Muscle Blood Flow and Oxygen Delivery Limit Maximal Aerobic Capacity in Humans	246
Impairment of Ventilatory Efficiency in Heart Failure	246
Transthoracic Echocardiography in Models of Cardiac Disease in the Mouse	246
Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.	246
Electrical Conduction in Canine Pulmonary Veins	246
Relation Among Stenosis Severity, Myocardial Blood Flow, and Flow Reserve in Patients With Coronary Artery Disease	246
Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial	246
A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of ch	246
Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin	246
Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age)	246
FTO-Dependent N ⁶ -Methyladenosine Regulates Cardiac Function During Remodeling and Repair	246
Natural history of aortoarteritis (Takayasu's disease).	245
Primary Pulmonary Hypertension	245
Metastatic Cancer to the Heart	245
International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable Angina	245
Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.	245
Elevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure	245
Comparison of Dobutamine Stress Magnetic Resonance, Adenosine Stress Magnetic Resonance, and Adenosine Stress Magnetic Resonance Perfusion	245
Severity of Coronary Artery Calcification by Electron Beam Computed Tomography Predicts Silent Myocardial Ischemia	245
Elastin Degradation and Calcification in an Abdominal Aorta Injury Model	245
Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.	245
Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve	245
Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia.	244
The Complications of Coronary Arteriography	244
From 'Emax' to pressure-volume relations: a broader view.	244
C-Reactive Protein	244
Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy	244
Regional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects	244
Reinduction of Atrial Fibrillation Immediately After Termination of the Arrhythmia Is Mediated by Late Phase 3 Early Afterdepolarization–Induced Triggered Activity	244
Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease.	244
Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: a prospective study.	244
Right Ventricular Volume Determinations in Children	244
Management of Vasovagal Syncope	244
Intimal Tear Without Hematoma	244
Rate Dependence of [Na ⁺ ] _i and Contractility in Nonfailing and Failing Human Myocardium	244
Tissue Expression and Immunolocalization of Tumor Necrosis Factor-α in Postinfarction Dysfunctional Myocardium	244
Expression of bcl-2 Protein, an Inhibitor of Apoptosis, and Bax, an Accelerator of Apoptosis, in Ventricular Myocytes of Human Hearts With Myocardial Infarction	244
Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion.	244
Cardiac-Specific Overexpression of GLUT1 Prevents the Development of Heart Failure Attributable to Pressure Overload in Mice	244
Endothelial Dysfunction in Chronic Myocardial Infarction Despite Increased Vascular Endothelial Nitric Oxide Synthase and Soluble Guanylate Cyclase Expression	244
Interleukin-18 and the Risk of Coronary Heart Disease in European Men	244
Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi.	244
Ablation of ‘Incisional’ Reentrant Atrial Tachycardia Complicating Surgery for Congenital Heart Disease	244
Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis	244
Impact of Regular Physical Activity on the NAD(P)H Oxidase and Angiotensin Receptor System in Patients With Coronary Artery Disease	244
Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.	244
Genetic and Environmental Contributions to Cardiovascular Risk Factors in Mexican Americans	244
Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human Heart	243
Seeding of intravascular stents with genetically engineered endothelial cells.	243
Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients.	243
Phobic Anxiety and Risk of Coronary Heart Disease and Sudden Cardiac Death Among Women	243
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.	243
Alterations in the Local Myocardial Motion Pattern in Patients Suffering From Pressure Overload Due to Aortic Stenosis	243
Acute Anti-Ischemic Effect of Testosterone in Men With Coronary Artery Disease	243
Late Coronary Occlusion After Intracoronary Brachytherapy	243
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure	243
Low-Output, Low-Gradient Aortic Stenosis in Patients With Depressed Left Ventricular Systolic Function	243
Predictors of Systolic Augmentation From Left Ventricular Preexcitation in Patients With Dilated Cardiomyopathy and Intraventricular Conduction Delay	243
Acute Pulmonary Embolism: Part I	242
Molecular biology of the renin-angiotensin system.	242
Silent ischemia during daily life is an independent predictor of mortality in stable angina.	242
Effect of Coronary Artery Disease and Acute Myocardial Infarction on Left Ventricular Compliance in Man	242
Survival After Coronary Revascularization in the Elderly	242
Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice	242
Physiology and Pathophysiology of Vascular Signaling Controlled by Cyclic Guanosine 3′,5′-Cyclic Monophosphate–Dependent Protein Kinase	242
Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction	242
Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy	242
Rheumatic Fever and Rheumatic Heart Disease	241
HDL Cholesterol and Protective Factors in Atherosclerosis	241
A Tale of Two Diseases	241
Race-Specific Differences in Endothelial Function	241
The anatomical substrates of wolff-parkinson-white syndrome. A clinicopathologic correlation in seven patients.	241
A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing.	241
Adverse Neonatal and Cardiac Outcomes Are More Common in Pregnant Women With Cardiac Disease	241
Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure	241
Circumstances of Death and Gross and Microscopic Observations in a Series of 200 Cases of Sudden Death Associated With Arrhythmogenic Right Ventricular Cardiomyopathy and/or Dysplasia	241
Lipoprotein-Associated Phospholipase A ₂ Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the Gen	241
A new method for quantification of regurgitant flow rate using color Doppler flow imaging of the flow convergence region proximal to a discrete orifice. An in vitro study.	241
Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic Cardiomyopathy	241
Peripartum Cardiomyopathy	240
Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias.	240
Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.	240
Insulin as a Vascular and Sympathoexcitatory Hormone	240
Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure.	240
Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery	240
Major Vascular Anomalies in Turner Syndrome	240
Exercise echocardiography versus 201Tl single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients.	240
Relationship Between Neointimal Thickness and Shear Stress After Wallstent Implantation in Human Coronary Arteries	240
Relation of Weight and Rate of Increase in Weight During Childhood and Adolescence to Body Size, Blood Pressure, Fasting Insulin, and Lipids in Young Adults	240
Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure	240
Application of a new phased-array ultrasound imaging catheter in the assessment of vascular dimensions. In vivo comparison to cineangiography.	240
Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature	240
Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-κB Activation and Protects Against Hypovolemic Hemorrhagic Shock	240
Role of the Tricuspid Annulus and the Eustachian Valve/Ridge on Atrial Flutter	240
Novel Inflammatory Markers of Coronary Risk	239
Abdominal Aortic Aneurysm: A Study of One Hundred and Two Cases	239
Albumin Microbubble Echo-Contrast Material as an Enhancer for Ultrasound Accelerated Thrombolysis	239
Summary estimates of cholesterol used to predict coronary heart disease.	239
Electrocardiographic Findings Among the Adult Population of a Total Natural Community, Tecumseh, Michigan	239
Role of Mahaim fibers in cardiac arrhythmias in man.	239
Measurement of Arterial Wall Thickness as a Surrogate Marker for Atherosclerosis	239
Body Weight Reduction, Sympathetic Nerve Traffic, and Arterial Baroreflex in Obese Normotensive Humans	239
Dilated Cardiomyopathy Is Associated With Significant Changes in Collagen Type I/III ratio	239
Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation	239
Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty.	239
Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up	239
Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells	239
A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.	239
Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease	239
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.	239
Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS)	239
New Frontiers in Cardiology	238
Electrocardiographic Changes Simulating Myocardial Ischemia and Infarction Associated with Spontaneous Intracranial Hemorrhage	238
Exacerbation of vasotonic angina pectoris by propranolol.	238
Effects of Experimental Heart Failure on Atrial Cellular and Ionic Electrophysiology	238
Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases	238
Mean Velocity of Fiber Shortening	238
Mediastinitis After Coronary Artery Bypass Graft Surgery	238
Antibiotic Prophylaxis for Permanent Pacemaker Implantation	238
Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion.	238
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.	238
Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood.	238
Oxidized Low-Density Lipoprotein Induces Apoptosis of Human Endothelial Cells by Activation of CPP32-Like Proteases	238
β-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure	238
Fast Measurement of Left Ventricular Mass With Real-Time Three-Dimensional Echocardiography	238
Carcinoid Heart Disease	238
Coronary Calcium Does Not Accurately Predict Near-Term Future Coronary Events in High-Risk Adults	238
Endovascular β-Radiation to Reduce Restenosis After Coronary Balloon Angioplasty	238
Common Carotid Intima-Media Thickness and Arterial Stiffness	238
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertroph	238
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure	238
Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction	238
Clinical trials of restenosis after coronary angioplasty.	237
Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.	237
Activation of Mitochondrial ATP-Dependent Potassium Channels by Nitric Oxide	237
Longitudinal dissociation in the His bundle. Bundle branch block due to asynchronous conduction within the His bundle in man.	237
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs	237
Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events	237
Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.	237
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms.	237
Intracellular Na ⁺ Concentration Is Elevated in Heart Failure But Na/K Pump Function Is Unchanged	237
Mechanisms of Organized Left Atrial Tachycardias Occurring After Pulmonary Vein Isolation	237
Is Worrying Bad for Your Heart?	237
Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study.	237
Modulating Angiogenesis	237
Antiremodeling Effect of Long-Term Exercise Training in Patients With Stable Chronic Heart Failure	237
Vascular Effects of Acute Hyperglycemia in Humans Are Reversed by l -Arginine	237
Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment	237
Bench to Bedside	236
Cardiovascular disease in women.	236
Hyperhomocysteinemia After an Oral Methionine Load Acutely Impairs Endothelial Function in Healthy Adults	236
HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.	236
Left Ventricular Stress and Compliance in Man	236
Role of the Pulmonary Circulation in the Distribution of Human Fetal Cardiac Output During the Second Half of Pregnancy	236
Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox.	236
Deletion of p66 ^shc Gene Protects Against Age-Related Endothelial Dysfunction	236
Influence of Direct Myocardial Revascularization on Left Ventricular Asynergy and Function in Patients with Coronary Heart Disease	236
Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits	236
Principles for National and Regional Guidelines on Cardiovascular Disease Prevention	236
Unchanged Protein Levels of SERCA II and Phospholamban but Reduced Ca ²⁺ Uptake and Ca ²⁺ -ATPase Activity of Cardiac Sarcoplasmic	236
Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activato	236
The nitrovasodilators. New ideas about old drugs.	235
Determination of Left Ventricular Volumes by Ultrasound	235
Alcohol Consumption and Plasma Concentration of C-Reactive Protein	235
The Study of Left Ventricular Function in Man by Increasing Resistance to Ventricular Ejection with Angiotensin	235
The Effect of Clinical Pharmacy Services on Patients with Essential Hypertension	235
Changes in Diastolic Stiffness and Tone of the Left Ventricle During Angina Pectoris	235
Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms. Effects of interventions that alter repolarization time.	235
World Heart Day 2002	235
Heat-shock protein induction in rat hearts. A direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection.	235
Determinants of blood flow to vital organs during cardiopulmonary resuscitation in dogs.	235
Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking	235
Magnetic Resonance Angiography of Anomalous Coronary Arteries	235
Alteration in Left Ventricular Diastolic Filling and Accumulation of Myocardial Collagen at Insulin-Resistant Prediabetic Stage of a Type II Diabetic Rat Model	235
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.	235
Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect.	235
Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight Heparin	235
Attenuated Progression of Coronary Artery Disease After 6 Years of Multifactorial Risk Intervention	235
Severe Aortic Stenosis With Low Transvalvular Gradient and Severe Left Ventricular Dysfunction	235
Determinants of Elevated Pulse Pressure in Middle-Aged and Older Subjects With Uncomplicated Systolic Hypertension	235
Angiogenesis Is Induced in a Rabbit Model of Hindlimb Ischemia by Naked DNA Encoding an HIF-1α/VP16 Hybrid Transcription Factor	235
Computed Tomographic Analysis of the Anatomy of the Left Atrium and the Esophagus	235
ACC/AHA/ACP–ASIM Guidelines for the Management of Patients With Chronic Stable Angina: Executive Summary and Recommendations	235
The Discovery of Dicumarol and Its Sequels	234
Cardiac Resynchronization Therapy for Heart Failure	234
Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up.	234
Pulmonary venous flow pattern--its relationship to cardiac dynamics. A pulsed Doppler echocardiographic study.	234
Sudden Coronary Death	234
Hyperinsulinemia Predicts Coronary Heart Disease Risk in Healthy Middle-aged Men	234
Tricuspid Valve Tethering Predicts Residual Tricuspid Regurgitation After Tricuspid Annuloplasty	234
Detection of Coronary Artery Disease With Myocardial Contrast Echocardiography	234
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.	234
Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.	234
Differential Effects of β-Blockers in Patients With Heart Failure	234
Intake of Dietary Fiber and Risk of Coronary Heart Disease in a Cohort of Finnish Men	234
Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications	234
Predictors of survival in neonates with critical aortic stenosis.	233
Sustained bundle branch reentry as a mechanism of clinical tachycardia.	233
Survival in primary pulmonary hypertension. Validation of a prognostic equation.	233
KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome	233
Prognostic Importance of Emotional Support for Elderly Patients Hospitalized With Heart Failure	233
Cell-Derived Microparticles Generated in Patients During Cardiopulmonary Bypass Are Highly Procoagulant	233
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.	233
Randomized Comparison of Angioplasty of Complex Coronary Lesions at a Single Center	233
An MRI Study of Neurological Injury Before and After Congenital Heart Surgery	233
Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel	233
Syncope Evaluation in the Emergency Department Study (SEEDS)	233
ACC/AHA Guidelines for Exercise Testing: Executive Summary	233
Obesity, Metabolic Syndrome, and Coronary Atherosclerosis	232
Reduction of Blood Cholesterol in Man	232
Natural History and Prognosis of Atrial Septal Defect	232
A Study of Ventricular Arrhythmias Associated with Acute Myocardial Infarction in the Canine Heart	232
Left Ventricular Pressure-Volume Alterations and Regional Disorders of Contraction During Myocardial Ischemia Induced by Atrial Pacing	232
Efferent Vagal Innervation of the Canine Atria and Sinus and Atrioventricular Nodes	232
Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium	232
Noninvasive Coronary Vessel Wall and Plaque Imaging With Magnetic Resonance Imaging	232
Activation of the Unfolded Protein Response Occurs at All Stages of Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice	232
Implantation and intermediate-term follow-up of stents in congenital heart disease.	232
Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes	232
Upregulation of β ₃ -Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium	232
Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries	232
Effectiveness of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin in Preventing Stent Thrombosis After Coronary Stent Implantation	232
Restoration of Endothelial Function by Increasing High-Density Lipoprotein in Subjects With Isolated Low High-Density Lipoprotein	232
Platelet GP IIIa Pl ^A Polymorphisms Display Different Sensitivities to Agonists	232
C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly	232
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.	232
Soy Protein and Cardiovascular Disease	231
The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man.	231
Transient transmural reduction of myocardial blood flow demonstrated by thallium-201 scintigraphy, as a cause of variant angina.	231
Mechanism of abnormal septal motion in patients with right ventricular volume overload: a cross-sectional echocardiographic study.	231
Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion.	231
C(−260)→T Polymorphism in the Promoter of the CD14 Monocyte Receptor Gene as a Risk Factor for Myocardial Infarction	231
Effects of Carvedilol on Left Ventricular Remodeling After Acute Myocardial Infarction	231
The physiology of external cardiac massage: high-impulse cardiopulmonary resuscitation.	231
Cardiac Troponin I Predicts Short-Term Mortality in Vascular Surgery Patients	231
Supplementation With Conjugated Linoleic Acid Causes Isomer-Dependent Oxidative Stress and Elevated C-Reactive Protein	231
Toll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction	231
Beyond Restenosis	231
Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia	231
Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients.	231
Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects	231
Long-Term Heart Rate Reduction Induced by the Selective I _f Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardi	231
Sudden coronary death in the United States: 1980-1985.	230
Cardiac Output and Central Distribution of Blood Flow in the Human Fetus	230
Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease	230
Effect of Pulse Pressure and Mean Arterial Pressure Modification on Renal Hemodynamics and Electrolyte and Water Excretion	230
Body fat and sympathetic nerve activity in healthy subjects.	230
Morphology of the Human Mitral Valve	230
Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload.	230
First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo	230
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.	230
Mechanisms responsible for sympathetic activation by cigarette smoking in humans.	230
Determination of Left Ventricular Chamber Stiffness From the Time for Deceleration of Early Left Ventricular Filling	230
Body Weight, Cardiovascular Risk Factors, and Coronary Mortality	230
Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism	230
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.	230
Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated Platelets	230
Salt Induces Myocardial and Renal Fibrosis in Normotensive and Hypertensive Rats	230
5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia	230
Studies of blood pressures in children, ages 5-14 years, in a total biracial community: the Bogalusa Heart Study.	230
Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.	230
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.	230
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Corona	230
TAXUS III Trial	230
Association of Angiotensin-Converting Enzyme Gene I/D Polymorphism With Change in Left Ventricular Mass in Response to Physical Training	230
Venous Thromboembolism and Cancer: Risks and Outcomes	229
The clinical significance of diurnal blood pressure variations. Dippers and nondippers.	229
Arterial Remodeling	229
Effects of Continuous Positive Airway Pressure on Sleep Apnea and Ventricular Irritability in Patients With Heart Failure	229
Functional Mechanisms Underlying Tachycardia-Induced Sustained Atrial Fibrillation in a Chronic Dog Model	229
Use of an Extended Monitoring Strategy in Patients With Problematic Syncope	229
Opening and Closing Characteristics of the Aortic Valve After Different Types of Valve-Preserving Surgery	229
Tumor Necrosis Factor-α Provokes a Hypertrophic Growth Response in Adult Cardiac Myocytes	229
Nitroglycerin to Unmask Reversible Asynergy Correlation with Post Coronary Bypass Ventriculography	229
Vitamin C Improves Endothelium-Dependent Vasodilation in Forearm Resistance Vessels of Humans With Hypercholesterolemia	229
Heart Rate Variability During Specific Sleep Stages	229
Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias.	229
Association of a T29→C Polymorphism of the Transforming Growth Factor-β1 Gene With Genetic Susceptibility to Myocardial Infarction in Japanese	229
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy	229
Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells	229
Serial Assessment of the Cardiovascular System in Normal Pregnancy	229
Comparison of Low-Dose Dobutamine–Gradient-Echo Magnetic Resonance Imaging and Positron Emission Tomography With [ ¹⁸ F]Fluorodeoxyglucose in Patients With Chronic C	229
Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions	229
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017	229
Pathophysiological dilemma of syndrome X.	228
Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.	228
Simvastatin Preserves the Ischemic-Reperfused Myocardium in Normocholesterolemic Rat Hearts	228
Quantitative Doppler assessment of valvular regurgitation.	228
α-Tocopherol Inhibits Aggregation of Human Platelets by a Protein Kinase C–Dependent Mechanism	228
Ventricular Fibrillation	228
Assessment of Aortic Valve Stenosis Severity	228
Transient Myocardial Contrast After Initial Exposure to Diagnostic Ultrasound Pressures With Minute Doses of Intravenously Injected Microbubbles	228
Prognostic Influence of Elevated Values of Cardiac Troponin I in Patients With Unstable Angina	228
Natural History of Ischemic Heart Disease in Relation to Arteriographic Findings	228
Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia	228
Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997	228
Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth	228
Three-Dimensional Black-Blood Cardiac Magnetic Resonance Coronary Vessel Wall Imaging Detects Positive Arterial Remodeling in Patients With Nonsignificant Coronary Artery Disease	228
Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation.	228
Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIB	228
Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis	228
Vasodilator Therapy for Heart Failure	227
Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.	227
Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement	227
The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.	227
The role of an accessory atrioventricular pathway in reciprocal tachycardia. Observations in patients with and without the Wolff-Parkinson-White syndrome.	227
Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest.	227
Smoking, Serum Lipids, Blood Pressure, and Sex Differences in Myocardial Infarction	227
Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave.	227
Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes	227
Predictors of Stroke Complicating Carotid Artery Stenting	227
Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease	227
Role of Endogenous Endothelin in Chronic Heart Failure	227
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left	227
Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart Failure	227
Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension	226
HERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine	226
Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy.	226
New Insights Into the Progression of Aortic Stenosis	226
Abnormal Aortic Valve Development in Mice Lacking Endothelial Nitric Oxide Synthase	226
Cellular electrophysiological effects of hyperthermia on isolated guinea pig papillary muscle. Implications for catheter ablation.	226
Exercise-Induced Increase in Baroreflex Sensitivity Predicts Improved Prognosis After Myocardial Infarction	226
Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy	226
Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart Disease	226
Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase Pathways	226
Inhibition of Angiogenesis by Thrombospondin-1 Is Mediated by 2 Independent Regions Within the Type 1 Repeats	226
Mental Stress Induces Prolonged Endothelial Dysfunction via Endothelin-A Receptors	226
The Pressor Response to Water Drinking in Humans	226
Basic Fibroblast Growth Factor Upregulates the Expression of Vascular Endothelial Growth Factor in Vascular Smooth Muscle Cells	226
Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Disease Severity	226
Three-Year Clinical and Angiographic Follow-Up After Intracoronary Radiation	226
Double-Outlet Right Ventricle and Overriding Tricuspid Valve Reflect Disturbances of Looping, Myocardialization, Endocardial Cushion Differentiation, and Apoptosis in TGF-β ₂	226
TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction	226
Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on	226
Platelet Function Testing in Cardiovascular Diseases	225
Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium.	225
Double-umbrella closure of atrial defects. Initial clinical applications.	225
Effect of Nitroglycerin on the Coronary Circulation in Patients with Coronary Artery Disease or Increased Left Ventricular Work	225
Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events	225
Randomized Comparison of Coronary Stenting With Balloon Angioplasty in Selected Patients With Acute Myocardial Infarction	225
Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.	225
Cross-sectional echocardiography. I. Analysis of mathematic models for quantifying mass of the left ventricle in dogs.	225
Practical Value of Cardiac Magnetic Resonance Imaging for Clinical Quantification of Aortic Valve Stenosis	225
Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up.	225
Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy	225
Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death	225
Macrophages, Smooth Muscle Cells, and Tissue Factor in Unstable Angina	225
Ascorbate Restores Endothelium-Dependent Vasodilation Impaired by Acute Hyperglycemia in Humans	224
Determination of right atrial and right ventricular size by two-dimensional echocardiography.	224
Novel, Ultraslow Inactivating Sodium Current in Human Ventricular Cardiomyocytes	224
Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation.	224
Central Sleep Apnea in Left Ventricular Dysfunction	224
Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells	224
The relationship between pericardial pressure and right atrial pressure: an intraoperative study.	224
Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.	224
Cardiac Hypertrophy Is Not a Required Compensatory Response to Short-Term Pressure Overload	224
Noninvasive Quantification of Left-to-Right Shunt in Pediatric Patients	224
Modulation of Anthracycline-Induced Myofibrillar Disarray in Rat Ventricular Myocytes by Neuregulin-1β and Anti-erbB2	224
Molecular Imaging of Cardiac Cell Transplantation in Living Animals Using Optical Bioluminescence and Positron Emission Tomography	224
In Vivo Magnetic Resonance Evaluation of Atherosclerotic Plaques in the Human Thoracic Aorta	224
Drug-Eluting Stents in Preclinical Studies	224
Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests.	224
High Glucose–Induced Apoptosis in Human Endothelial Cells Is Mediated by Sequential Activations of c-Jun NH ₂ -Terminal Kinase and Caspase-3	224
A new technique for assessing right ventricular ejection fraction using rapid multiple-gated equilibrium cardiac blood pool scintigraphy. Description, validation and findings in chronic coronary arter	224
Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril	224
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.	224
Age-Dependent Associations Between Sleep-Disordered Breathing and Hypertension	224
Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Facto	224
Guidelines for Carotid Endarterectomy	224
Indirect Systolic Pressures and Pulse Waves in Arterial Occlusive Disease of the Lower Extremities	224
Family history of heart attack as an independent predictor of death due to cardiovascular disease.	224
Emergency stenting for acute occlusion after coronary balloon angioplasty.	224
Cardiac tamponade in medical patients.	223
In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease	223
Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?	223
A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease.	223
Progressive Aortic Root Dilatation in Adults Late After Repair of Tetralogy of Fallot	223
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease	223
Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction	223
Epicardial Mapping of Chronic Atrial Fibrillation in Patients	223
Coronary Thermodilution to Assess Flow Reserve	223
Vasopressin Improves Vital Organ Blood Flow During Closed-Chest Cardiopulmonary Resuscitation in Pigs	223
Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men	223
Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis i	223
Alterations in Intracellular Calcium Handling Associated With the Inverse Force-Frequency Relation in Human Dilated Cardiomyopathy	223
Guide to Preventive Cardiology for Women	223
Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry.	223
Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium	223
Slow Conduction and Enhanced Anisotropy Increase the Propensity for Ventricular Tachyarrhythmias in Adult Mice With Induced Deletion of Connexin43	223
Long-term Angiographic and Clinical Outcome After Percutaneous Transluminal Coronary Angioplasty and Intracoronary Radiation Therapy in Humans	223
Electrical Remodeling due to Atrial Fibrillation in Chronically Instrumented Conscious Goats	223
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thromboly	223
Digitalis	222
Angiotensin II–Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice	222
Prognostic Importance of Exercise-Induced Changes in Mitral Regurgitation in Patients With Chronic Ischemic Left Ventricular Dysfunction	222
Effect of Aldosterone Antagonism on Myocardial Dysfunction in Hypertensive Patients With Diastolic Heart Failure	222
Fast-Fourier transform analysis of signal-averaged electrocardiograms for identification of patients prone to sustained ventricular tachycardia.	222
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.	222
QTc Dispersion Predicts Cardiac Mortality in the Elderly	222
Vascular Structural and Functional Changes in Type 2 Diabetes Mellitus	222
Arrhythmias and Conduction Defects as Presenting Symptoms of Fatty Acid Oxidation Disorders in Children	222
Ischemic Preconditioning Prevents Endothelial Injury and Systemic Neutrophil Activation During Ischemia-Reperfusion in Humans In Vivo	222
Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol?	222
Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice	222
Diabetes and Cardiovascular Disease Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association	222
Utility of Fast Cine Magnetic Resonance Imaging and Display for the Detection of Myocardial Ischemia in Patients Not Well Suited for Second Harmonic Stress Echocardiography	222
Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis	222
Identification of functional angiotensin II receptors on rat cardiac fibroblasts.	221
Diastolic collapse of the right ventricle with cardiac tamponade: an echocardiographic study.	221
Successful Catheter Ablation of Electrical Storm After Myocardial Infarction	221
Induction of Cyclooxygenase-2 and Activation of Nuclear Factor-κB in Myocardium of Patients With Congestive Heart Failure	221
Assessment of Mitral Regurgitation Severity by Doppler Color Flow Mapping of the Vena Contracta	221
Effects of Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Left Ventricular Afterload in Patients With Heart Failure	221
Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction.	221
Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications.	221
Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis	221
Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice	221
Clinical Presentation, Investigation, and Management of Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation	221
Hemodynamic and Renal Excretory Effects of Human Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure	221
Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries	221
Determinants of Echocardiographic Aortic Root Size	220
Home-Based Intervention in Congestive Heart Failure	220
Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study.	220
Color Doppler evaluation of valvular regurgitation in normal subjects.	220
Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy.	220
Cross-sectional echocardiography in acute myocardial infarction: detection and localization of regional left ventricular asynergy.	220
Heat shock protein induction in rat hearts. A role for improved myocardial salvage after ischemia and reperfusion?	220
Coronary Restenosis After Sirolimus-Eluting Stent Implantation	220
The Sick Sinus Syndrome	219
A view of vascular stents.	219
Role of Bradykinin in Mediating Vascular Effects of Angiotensin-Converting Enzyme Inhibitors in Humans	219
Cell Cycle Progression	219
Respiratory Sinus Arrhythmia	219
Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy	219
Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure.	219
Cerebral versus systemic hemodynamics during graded orthostatic stress in humans.	219
Does PTCA in Acute Myocardial Infarction Affect Mortality and Reinfarction Rates?	219
Impaired Endothelium-Dependent Vasodilation of Coronary Resistance Vessels Is Associated With Exercise-Induced Myocardial Ischemia	219
Transcatheter Implantation of a Bovine Valve in Pulmonary Position	219
Fibrin D-Dimer and Coronary Heart Disease	219
Apoptosis of Endothelial Cells Precedes Myocyte Cell Apoptosis in Ischemia/Reperfusion Injury	219
Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects.	219
Identification of Anomalous Coronary Arteries and Their Anatomic Course by Magnetic Resonance Coronary Angiography	219
Prospective Study of Oral Contraceptives and Hypertension Among Women in the United States	219
Human Connective Tissue Growth Factor Is Expressed in Advanced Atherosclerotic Lesions	219
Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout Mice	219
Fish Oil–Derived Fatty Acids, Docosahexaenoic Acid and Docosapentaenoic Acid, and the Risk of Acute Coronary Events	219
Atherosclerotic Vascular Disease Conference	219
Transthoracic Cardioversion of Atrial Fibrillation	219
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)	219
Percutaneous Transcatheter Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism	219
Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine Concentrations	219
Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older. A report from the Coronary Artery Surgery Study.	219
Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome	219
Is the Association Between Parity and Coronary Heart Disease Due to Biological Effects of Pregnancy or Adverse Lifestyle Risk Factors Associated With Child-Rearing?	219
Small LDL, Atherogenic Dyslipidemia, and the Metabolic Syndrome	218
Acute Coronary Syndromes	218
Flow-dependent coronary artery dilatation in humans.	218
Posterior Extensions of the Human Compact Atrioventricular Node	218
New Noninvasive Method for Coronary Flow Reserve Assessment	218
Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia.	218
Myocardial Ultrastructure in Idiopathic Hypertrophic Subaortic Stenosis	218
Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.	218
Echocardiographic and Electrocardiographic Diagnoses of Left Ventricular Hypertrophy Predict Mortality Independently of Each Other in a Population of Elderly Men	218
Effect of baffle fenestration on outcome of the modified Fontan operation.	218
Termination of Left Superior Vena Cava in Left Atrium, Atrial Septal Defect, and Absence of Coronary Sinus	218
Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis, and long-term clinical follow-up.	218
Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis	218
Stroke Volume and Cardiac Output in Normotensive Children and Adults	218
Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.	218
Significance of Myocytes With Positive DNA In Situ Nick End-Labeling (TUNEL) in Hearts With Dilated Cardiomyopathy	218
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lova	218
Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent	218
In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent	218
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myoc	218
Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy.	217
Cardiac tamponade: hemodynamic observations in man.	217
True and false left ventricular aneurysms. Propensity for the altter to rupture.	217
Prosthetic valve endocarditis.	217
Myocardial Necrosis from Direct Current Countershock	217
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.	217
Association Between Myocardial Infarction and the Mast Cells in the Adventitia of the Infarct-Related Coronary Artery	217
Vein of Marshall Cannulation for the Analysis of Electrical Activity in Patients With Focal Atrial Fibrillation	217
Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease.	217
Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction.	217
Role of gp91 ^phox (Nox2)-Containing NAD(P)H Oxidase in Angiogenesis in Response to Hindlimb Ischemia	217
Hibernating Myocardium	217
Contribution of Inadequate Arterial Remodeling to the Development of Focal Coronary Artery Stenoses	217
Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis.	217
Effect of Glucose-Insulin-Potassium Infusion on Myocardial Infarction following Experimental Coronary Artery Occlusion	217
Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients	217
Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction.	217
Effect of Intracoronary Recombinant Human Vascular Endothelial Growth Factor on Myocardial Perfusion	217
Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment–Elevation Myocardial Infarction	217
Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis	217
Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron	217
Cell Swelling	216
Cytosolic Heat Shock Protein 60, Apoptosis, and Myocardial Injury	216
Doppler Tissue Imaging Quantitates Regional Wall Motion During Myocardial Ischemia and Reperfusion	216
Chaos and the Transition to Ventricular Fibrillation	216
High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection	216
Cardiac Myocytes Produce Interleukin-6 in Culture and in Viable Border Zone of Reperfused Infarctions	216
Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial.	216
Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: retrospective study of patients with typical anterior and posterior infarcts.	216
Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation	216
Aortic Valve Replacement for Aortic Stenosis With Severe Left Ventricular Dysfunction	216
Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive Patients	216
Late Gadolinium Enhancement Cardiovascular Magnetic Resonance of the Systemic Right Ventricle in Adults With Previous Atrial Redirection Surgery for Transposition of the Great Arteries	216
Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension	216
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction	216
A clinical study of left ventricular relaxation.	215
Influence of heart rate and inhibition of autonomic tone on the QT interval.	215
Multifactorial Inheritance Hypothesis for the Etiology of Congenital Heart Diseases	215
A Hemodynamic Study of Left Ventricular Aneurysm	215
Arteriosclerosis Obliterans: Review of 520 Cases with Special Reference to Pathogenic and Prognostic Factors	215
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat.	215
Left Ventricular Systolic Performance, Function, and Contractility in Patients With Diastolic Heart Failure	215
Exercise standards. A statement for health professionals from the American Heart Association.	215
Vitamin E Reduces the Uptake of Oxidized LDL by Inhibiting CD36 Scavenger Receptor Expression in Cultured Aortic Smooth Muscle Cells	215
Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death.	215
TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways	215
Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.	215
The linearity of the end-systolic pressure-volume relationship in man and its sensitivity for assessment of left ventricular function.	215
Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.	215
Intracoronary β-Radiation Therapy Inhibits Recurrence of In-Stent Restenosis	215
Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients.	215
Electrophysiological and Electroanatomic Characterization of the Atria in Sinus Node Disease	215
Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF ₁₆₅ Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia	215
Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart Disease	215
Use of Emergency Medical Services in Acute Myocardial Infarction and Subsequent Quality of Care	215
Randomized, Single-Blind, Placebo-Controlled Pilot Study of Catheter-Based Myocardial Gene Transfer for Therapeutic Angiogenesis Using Left Ventricular Electromechanical Mapping in Patients With Chron	215
Recommended Guidelines for Reviewing, Reporting, and Conducting Research on In-Hospital Resuscitation: The In-Hospital ‘Utstein Style’	215
Exercise and Cardiovascular Health	214
The extraction of thallium-201 by the myocardium.	214
Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy	214
Patient-Specific Dose and Radiation Risk Estimation in Pediatric Cardiac Catheterization	214
The Syndrome of Short P-R Interval Normal QRS Complex and Paroxysmal Rapid Heart Action	214
Ranolazine Stimulates Glucose Oxidation in Normoxic, Ischemic, and Reperfused Ischemic Rat Hearts	214
Assessment of Left Ventricular Filling Pressures by Doppler in the Presence of Atrial Fibrillation	214
Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.	214
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.	214
Effect of Atrial Fibrillation on Atrial Refractoriness in Humans	214
Tripling Survival From Sudden Cardiac Arrest Via Early Defibrillation Without Traditional Education in Cardiopulmonary Resuscitation	214
Testosterone Induces Dilation of Canine Coronary Conductance and Resistance Arteries In Vivo	214
Demonstration of a widely distributed atrial pacemaker complex in the human heart.	214
Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity	214
Simultaneous Endocardial Mapping in the Human Left Ventricle Using a Noncontact Catheter	214
Infections, Inflammation, and the Risk of Coronary Heart Disease	214
Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current.	214
Coronary Stenting After Rotational Atherectomy in Calcified and Complex Lesions	214
Complete Repair of Transposition of the Great Arteries with Pulmonary Stenosis	214
Quantitative Assessment of Alterations in Regional Left Ventricular Contractility With Color-Coded Tissue Doppler Echocardiography	214
Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma	214
Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse Outcomes	214
Antioxidative Effects of Exercise Training in Patients With Chronic Heart Failure	214
Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging.	214
Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease	214
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease	214
Cellular and Ionic Basis for T-Wave Alternans Under Long-QT Conditions	213
Effects of pacing on triggered activity induced by early afterdepolarizations.	213
Significance of the Diagnostic Q Wave of Myocardial Infarction	213
The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group.	213
Atrial Amyloidosis	213
Cigarette Smoking Increases Sympathetic Outflow in Humans	213
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.	213
Mechanism of Recurrent Ischemic Mitral Regurgitation After Annuloplasty	213
Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells	213
Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment.	213
Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification	213
Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease	213
Multicenter, Randomized, Controlled Trial of 150-J Biphasic Shocks Compared With 200- to 360-J Monophasic Shocks in the Resuscitation of Out-of-Hospital Cardiac Arrest Victims	213
Prognostic Impact of Plasma N-Terminal Pro–Brain Natriuretic Peptide in Severe Chronic Congestive Heart Failure	213
Intracoronary Stent Implantation Without Ultrasound Guidance and With Replacement of Conventional Anticoagulation by Antiplatelet Therapy	213
The Salt-Secreting Gland of Marine Birds	212
Diuretics Shift Circadian Rhythm of Blood Pressure From Nondipper to Dipper in Essential Hypertension	212
The effects of daily exercise on susceptibility to sudden cardiac death.	212
Simvastatin Induces Heme Oxygenase-1	212
Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs.	212
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy	212
Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.	212
Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog.	212
Clinical Progression of Incidental, Asymptomatic Lesions Discovered During Culprit Vessel Coronary Intervention	212
Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry.	212
Fish and Long-Chain ω-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women	212
Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease.	212
Chlamydia pneumoniae (TWAR) in Atherosclerosis of the Carotid Artery	212
Coronary Pressure Measurement to Assess the Hemodynamic Significance of Serial Stenoses Within One Coronary Artery	212
Urinary 8-iso-Prostaglandin F _2α as a Risk Marker in Patients With Coronary Heart Disease	212
Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group.	212
Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks	212
Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986	212
Relation of Electrolyte Disturbances to Cardiac Arrhythmias	211
Relationship of Heart Rate Variability to Parasympathetic Effect	211
Histological Correlates of Carotid Plaque Surface Morphology on Lumen Contrast Imaging	211
Marfan Syndrome	211
Essential Role of Endothelial Notch1 in Angiogenesis	211
Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation.	211
Two-dimensional echocardiographic recognition of myocardial injury in man: comparison with postmortem studies.	211
Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction	211
Diagnosis of thoracic aortic dissection. Magnetic resonance imaging versus transesophageal echocardiography.	211
Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping.	211
Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus	211
Prediction of Improvement of Regional Left Ventricular Function After Surgical Revascularization	211
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction	211
Adventitial Remodeling After Coronary Arterial Injury	210
Morphology of the Human Mitral Valve	210
Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999	210
Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model.	210
Radiofrequency Catheter Ablation of Type 1 Atrial Flutter	210
Physical Activity in Relation to Cardiovascular Disease and Total Mortality Among Men With Type 2 Diabetes	210
Novel, Magnetically Guided Catheter for Endocardial Mapping and Radiofrequency Catheter Ablation	210
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension	210
Limb Blood Flow and Vascular Conductance Are Reduced With Age in Healthy Humans	210
Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in Humans	210
Analysis of Cardiovascular Phenotype and Genotype-Phenotype Correlation in Individuals With a JAG1 Mutation and/or Alagille Syndrome	210
Impaired Endothelium-Dependent Vasodilation in Patients With Essential Hypertension	210
Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery.	210
Risk and Predictors for Pregnancy-Related Complications in Women With Heart Disease	210
Subtype Specific Regulation of Human Vascular α ₁ -Adrenergic Receptors by Vessel Bed and Age	210
Prediction of the normal blood volume. Relation of blood volume to body habitus.	210
Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary Embolism	210
Inhaled Nitric Oxide	209
The Paradox of Beta-Adrenergic Blockade in Hypertension	209
Aortic Dissection: New Frontiers in Diagnosis and Management	209
Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy	209
Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics.	209
Prognosis of Surgically Corrected Coarctation of the Aorta	209
Noninvasive Ultrasound Imaging of Inflammation Using Microbubbles Targeted to Activated Leukocytes	209
Identification of Authentic Estrogen Receptor in Cultured Endothelial Cells	209
Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.	209
Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery	209
Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels	209
Acute Myocardial Infarction Complicated by Atrial Fibrillation in the Elderly	209
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.	209
L-Type Ca ²⁺ Current Downregulation in Chronic Human Atrial Fibrillation Is Associated With Increased Activity of Protein Phosphatases	209
Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States	209
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention	209
Role of I _Kur in Controlling Action Potential Shape and Contractility in the Human Atrium	209
Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension	209
Plaque Instability Frequently Occurs Days or Weeks Before Occlusive Coronary Thrombosis	209
Core Components of Cardiac Rehabilitation/Secondary Prevention Programs	209
Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery Is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BK _Ca	209
Terminology of congenital heart disease. Glossary and commentary.	208
The Changes in the Circulation After Birth	208
Influence of Age on the Hemodynamic Response to Exercise	208
Chlamydia Pneumoniae , Cytomegalovirus, and Herpes Simplex Virus in Atherosclerosis of the Carotid Artery	208
Magnetic Resonance Imaging Determination of Cardiac Prognosis	208
Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.	208
Human Pulmonary Circulation Is an Important Site for Both Clearance and Production of Endothelin-1	208
Aspirin as a Therapeutic Agent in Cardiovascular Disease	208
Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.	208
Avoiding Papillary Muscle Infarction With Myocardial Contrast Echocardiographic Guidance of Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy	208
Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy.	208
Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension	208
Left ventricular pressure-volume and Frank-Starling relations in endurance athletes. Implications for orthostatic tolerance and exercise performance.	208
Trends for coronary heart disease and stroke and their risk factors in Japan.	208
Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.	208
Morning increase in platelet aggregability. Association with assumption of the upright posture.	208
Right ventricular and right atrial collapse in patients with cardiac tamponade--a combined echocardiographic and hemodynamic study.	208
Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy.	208
Unusual Properties of Accessory Pathways	207
Blood Capillaries of the Heart and Other Organs	207
Structural Basis for Heart Failure	207
The Relationship of the Degree of Coronary Atherosclerosis with Age, in Men	207
Prosthetic Valve Endocarditis	207
Impaired Endothelial Function and Increased Carotid Stiffness in 9-Year-Old Children With Low Birthweight	207
Thromboembolic Complications After Fontan Operations	207
Exercise cross-sectional echocardiography in ischemic heart disease.	207
Measurement of Atherosclerotic Carotid Plaque Size In Vivo Using High Resolution Magnetic Resonance Imaging	207
Weekly variation of acute myocardial infarction. Increased Monday risk in the working population.	207
Clinical Trials for Claudication	207
Importance of left atrial function in patients with myocardial infarction.	207
Flow-Mediated Dilation in 9- to 11-Year-Old Children	207
Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure.	207
Possible Inhibition of Focal Cerebral Ischemia by Angiotensin II Type 2 Receptor Stimulation	207
Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow.	207
Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction?	207
Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiologic studies.	207
Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic--histologic correlative analysis in 28 patients.	207
Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness	207
Cognitive Development After the Fontan Operation	207
Pioglitazone, a Peroxisome Proliferator–Activated Receptor-γ Agonist, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction	207
Electroanatomic Substrate and Outcome of Catheter Ablative Therapy for Ventricular Tachycardia in Setting of Right Ventricular Cardiomyopathy	207
Structural Alterations in Subcutaneous Small Arteries of Normotensive and Hypertensive Patients With Non–Insulin-Dependent Diabetes Mellitus	207
Inhibition of δ-Protein Kinase C Protects Against Reperfusion Injury of the Ischemic Heart In Vivo	207
Intravascular Ultrasound Guidance Improves Angiographic and Clinical Outcome of Stent Implantation for Long Coronary Artery Stenoses	207
Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvas	207
Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients	207
Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the Ame	207
In Vivo Gene Transfer of the O ₂ -Sensitive Potassium Channel Kv1.5 Reduces Pulmonary Hypertension and Restores Hypoxic Pulmonary Vasoconstriction in Chronically Hyp	207
Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease	207
Dickinson W. Richards Lecture: Circulatory adjustments to hypoxia.	206
Echocardiographic Features of Atrial Septal Defect	206
Correlation between echocardiographically demonstrated segmental dyskinesis and regional myocardial perfusion.	206
Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement.	206
Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta.	206
Oral Sulfonylurea Hypoglycemic Agents Prevent Ischemic Preconditioning in Human Myocardium	206
Temporal Trends in Sudden Cardiac Arrest	206
Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis	206
Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging	206
Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock.	206
Electrophysiological Effects of Catheter Ablation of Inferior Vena Cava–Tricuspid Annulus Isthmus in Common Atrial Flutter	206
Angiotensin II Increases Tissue Endothelin and Induces Vascular Hypertrophy	206
Value of Myoglobin, Troponin T, and CK-MB _mass in Ruling Out an Acute Myocardial Infarction in the Emergency Room	206
Ultrasound Imaging of Acute Cardiac Transplant Rejection With Microbubbles Targeted to Intercellular Adhesion Molecule-1	206
Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies.	206
The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema	206
Thermal Heterogeneity Within Human Atherosclerotic Coronary Arteries Detected In Vivo	206
Intracoronary Low-Dose β-Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in the Swine Restenosis Model	206
Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction	206
Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for Chlamydia pneumoniae Infection	206
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial	206
Alpha-adrenergic mechanisms in myocardial ischemia.	205
Morphology of the Human Tricuspid Valve	205
Diesel Exhaust Particles in Lung Acutely Enhance Experimental Peripheral Thrombosis	205
Immediate diagnosis of acute myocardial infarction by two-dimensional echocardiography.	205
Graded Exercise Stress Tests in Angiographically Documented Coronary Artery Disease	205
A Randomized Comparison of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin After the Placement of Coronary-Artery Stents	205
Prerequisite for Cardiac Aldosterone Action	205
A simple ultrasound approach for detection of recurrent proximal-vein thrombosis.	205
Insulin Stimulates Both Endothelin and Nitric Oxide Activity in the Human Forearm	205
Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates.	205
Association Between Intima-Media Thickness and Wall Shear Stress in Common Carotid Arteries in Healthy Male Subjects	205
Excessive Tumor Necrosis Factor Activation After Infarction Contributes to Susceptibility of Myocardial Rupture and Left Ventricular Dysfunction	205
Electroanatomic Left Ventricular Mapping in the Porcine Model of Healed Anterior Myocardial Infarction	205
Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice	205
Association of Coronary Heart Disease Risk Factors With Microscopic Qualities of Coronary Atherosclerosis in Youth	205
Improved Exercise Tolerance and Quality of Life With Cardiac Rehabilitation of Older Patients After Myocardial Infarction	205
Catheter Ablation of Paroxysmal Atrial Fibrillation Using a 3D Mapping System	205
Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience.	205
“Apoptotic” Myocytes in Infarct Area in Rabbit Hearts May Be Oncotic Myocytes With DNA Fragmentation	205
Chronobiological Patterns of Acute Aortic Dissection	205
Symposium on Research on Acute Myocardial Infarction	204
Tissue Cations and Water in Arterial Hypertension	204
Compensatory changes of the distal coronary vascular bed during progressive coronary constriction.	204
An Acute Effect of Cigarette Smoking on Platelet Function	204
Testosterone Increases Human Platelet Thromboxane A ₂ Receptor Density and Aggregation Responses	204
Electrical Stimulation Versus Coronary Artery Bypass Surgery in Severe Angina Pectoris	204
Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.	204
Lack of Benefit for Intravenous Thrombolysis in Patients With Myocardial Infarction Who Are Older Than 75 Years	204
A Critical Appraisal of the Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy	204
C-Reactive Protein as a Predictor of Infarct Expansion and Cardiac Rupture After a First Q-Wave Acute Myocardial Infarction	204
Clinical and Hemodynamic Results of Intraaortic Balloon Pumping and Surgery for Cardiogenic Shock	204
Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins.	204
Prognostic value of exercise testing, coronary angiography and left ventriculography 6--8 weeks after myocardial infarction.	204
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation	204
Angiogenesis by Implantation of Peripheral Blood Mononuclear Cells and Platelets Into Ischemic Limbs	203
A forty-year review of bacterial endocarditis in infancy and childhood.	203
Short-term Economic and Health Benefits of Smoking Cessation	203
Late potentials detected after myocardial infarction: natural history and prognostic significance.	203
Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.	203
Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model.	203
High-Energy Defibrillation Increases the Severity of Postresuscitation Myocardial Dysfunction	203
Endothelial Progenitor Cells	203
Defective l -Arginine–Nitric Oxide Pathway in Offspring of Essential Hypertensive Patients	203
The noninvasive diagnosis of right ventricular infarction.	203
Characterization of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes.	203
Effects of Changing Heart Rate in Man by Electrical Stimulation of the Right Atrium	203
Significance of regional wall thickening abnormalities relative to transmural myocardial perfusion in anesthetized dogs.	203
The incidence and natural history of pericardial effusion after cardiac surgery--an echocardiographic study.	203
Distinct Renal Injury in Early Atherosclerosis and Renovascular Disease	203
Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.	203
Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of thallium-201.	203
Vascular complications after balloon and new device angioplasty.	203
Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease	203
Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II	203
Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance.	203
Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features	203
Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion.	203
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.	203
Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass	203
Automatic External Defibrillators for Public Access Defibrillation: Recommendations for Specifying and Reporting Arrhythmia Analysis Algorithm Performance, Incorporating New Waveforms, and Enhancing S	203
Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia	203
Are aortic aneurysms caused by atherosclerosis?	202
A clinical and follow-up study of right and left bundle branch block.	202
E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.	202
Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men	202
Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure	202
Conformational Rearrangement in C-Reactive Protein Is Required for Proinflammatory Actions on Human Endothelial Cells	202
Association of Coronary Disease With Segment-Specific Intimal-Medial Thickening of the Extracranial Carotid Artery	202
Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance.	202
Implantable transvenous cardioverter-defibrillators.	202
Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.	202
Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes	202
Parallel cardiac and vascular adaptation in hypertension.	202
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.	202
Ambient Pollution and Blood Pressure in Cardiac Rehabilitation Patients	202
Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary Syndrome	202
Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy	202
LDL-Apheresis Atherosclerosis Regression Study (LAARS)	202
Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction	202
Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease. Effects of arousal and upright posture.	202
Randomized, Double-Blind Comparison of Intravenous Amiodarone and Bretylium in the Treatment of Patients With Recurrent, Hemodynamically Destabilizing Ventricular Tachycardia or Fibrillation	202
Myocarditis in the Setting of Cancer Therapeutics	202
Respiratory muscle function and dyspnea in patients with chronic congestive heart failure.	201
Relative Intensity of Physical Activity and Risk of Coronary Heart Disease	201
A new method for measurement of sinoatrial conduction time.	201
gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension	201
Symptomatic Valvular Myxomatous Transformation (The Floppy Valve Syndrome)	201
Relation Between Myocardial Fractional Flow Reserve Calculated From Coronary Pressure Measurements and Exercise-Induced Myocardial Ischemia	201
Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery.	201
Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and β-Carotene	201
Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs.	201
Predictors of New-Onset Diastolic and Systolic Hypertension	201
Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries	201
Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis.	201
8-Epi PGF _2α Generation During Coronary Reperfusion	201
Cerebral Venous Thrombosis in Children	201
Investigation Into the Sources of Superoxide in Human Blood Vessels	201
Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty. A prospective randomized study.	201
Matrix Metalloproteinase Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in a Rat Model of Progressive Heart Failure	201
Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty	201
Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomize	201
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo	201
Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia	201
Pathologic Changes in Aortic-Coronary Arterial Saphenous Vein Grafts	200
Biostatistics: how to detect, correct and prevent errors in the medical literature.	200
Silent Myocardial Ischemia	200
The Clinical Pharmacology of Lidocaine as an Antiarrhythymic Drug	200
Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias.	200
Peripheral Adiposity Exhibits an Independent Dominant Antiatherogenic Effect in Elderly Women	200
Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion.	200
Importance of Refractoriness Heterogeneity in the Enhanced Vulnerability to Atrial Fibrillation Induction Caused by Tachycardia-Induced Atrial Electrical Remodeling	200
Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice	200
Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications.	200
Characterization of Left Atrial Activation in the Intact Human Heart	200
Cardiac Involvement in Mitochondrial Diseases	200
Induction of Interleukin-6 Synthesis in the Myocardium	200
Regional Alterations in Protein Expression in the Dyssynchronous Failing Heart	200
Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function	200
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve.	200
Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle Cells	200
Tachycardia-Related Channel in the Scar Tissue in Patients With Sustained Monomorphic Ventricular Tachycardias	200
Prevention of Accelerated Atherosclerosis by Angiotensin-Converting Enzyme Inhibition in Diabetic Apolipoprotein E–Deficient Mice	200
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.	200
Genetic Polymorphism of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) as a Risk Factor for Coronary Artery Disease	200
Increased Cardiomyocyte Apoptosis and Changes in Proapoptotic and Antiapoptotic Genes bax and bcl -2 During Left Ventricular Adaptations t	200
Fundamental Relations Between Short-term RR Interval and Arterial Pressure Oscillations in Humans	199
Characterization of Right Ventricular Diastolic Performance After Complete Repair of Tetralogy of Fallot	199
Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation.	199
Congenital Cardiac Disease Associated with Polysplenia	199
Predisposition to Atherosclerosis by Infections	199
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion.	199
Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in Humans	199
Parvovirus B19 Infection Mimicking Acute Myocardial Infarction	199
HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis	199
Systemic Lupus Erythematosus	199
Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human Atherosclerosis	199
Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.	199
Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus	199
Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men.	199
Genetically Defined Therapy of Inherited Long-QT Syndrome	199
Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E–Knockout Mice	199
Diabetes Mellitus: A Major Risk Factor for Cardiovascular Disease	199
Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease.	199
Bedside Multimarker Testing for Risk Stratification in Chest Pain Units	199
Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart	198
Hypercholesterolemia Stimulates Angiotensin Peptide Synthesis and Contributes to Atherosclerosis Through the AT _1A Receptor	198
Levels of Soluble Cell Adhesion Molecules in Patients With Dyslipidemia	198
Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease	198
Assessment of QT Dispersion for Prediction of Mortality or Arrhythmic Events After Myocardial Infarction	198
Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography.	198
Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing.	198
Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival.	198
Biological Gradient Between Long-Term Arsenic Exposure and Carotid Atherosclerosis	198
Assessment of Atrioventricular Junction Ablation and VVIR Pacemaker Versus Pharmacological Treatment in Patients With Heart Failure and Chronic Atrial Fibrillation	198
Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development	198
Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina	198
Phase 2 Early Afterdepolarization as a Trigger of Polymorphic Ventricular Tachycardia in Acquired Long-QT Syndrome	198
Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.	198
Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.	198
Endothelial Cytotoxicity Mediated by Serum Antibodies to Heat Shock Proteins of Escherichia coli and Chlamydia pneumoniae	198
Mutations in the Human Muscle LIM Protein Gene in Families With Hypertrophic Cardiomyopathy	198
Dissecting aortic aneurysm associated with congenital bicuspid aortic valve.	198
Cardiovascular Outcome in White-Coat Versus Sustained Mild Hypertension	198
Mechanisms Underlying Aortic Dilatation in Congenital Aortic Valve Malformation	198
Pathogenesis of persistent truncus arteriosus and dextroposed aorta in the chick embryo after neural crest ablation.	198
Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results.	198
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs	198
Atherogenic Lipoprotein Particles in Atherosclerosis	197
Upper-Extremity Deep Vein Thrombosis	197
A Hemodynamic Technic for the Detection of Hypertrophic Subaortic Stenosis	197
Factors contributing to altered left ventricular diastolic properties during angina pectoris.	197
Aspirin Inhibits Nuclear Factor–κB Mobilization and Monocyte Adhesion in Stimulated Human Endothelial Cells	197
Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits.	197
Evaluation of left ventricular size and function by echocardiography. Results in normal children.	197
Accelerated Onset and Increased Incidence of Ventricular Arrhythmias Induced by Ischemia in Cx43-Deficient Mice	197
Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis.	197
Acute Hemodynamic Improvement by Thermal Vasodilation in Congestive Heart Failure	197
Angiotensin II Has Multiple Profibrotic Effects in Human Cardiac Fibroblasts	197
The relationships between alcoholic beverage use and other traits to blood pressure: a new Kaiser Permanente study.	197
Gene Expression of Antioxidative Enzymes in the Human Heart	197
Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression	197
Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers	197
Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy	197
Temporal response of left ventricular performance to mitral valve surgery.	197
Association of Virulent Helicobacter pylori Strains With Ischemic Heart Disease	197
Resumption of Electrical Conduction in Previously Isolated Pulmonary Veins	197
Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes	197
Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice	197
Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid Arthritis	197
Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome	197
Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations.	197
Relationship of Cardiovascular Risk Factors to Echocardiographic Left Ventricular Mass in Healthy Young Black and White Adult Men and Women	197
Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses.	197
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALK	197
Reduction of Serum Cholesterol and Hypercholesterolemic Atherosclerosis in Rabbits by Secoisolariciresinol Diglucoside Isolated From Flaxseed	196
Hypoxic Stress Induces Cardiac Myocyte–Derived Interleukin-6	196
Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina.	196
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.	196
Evidence for Altered Balance Between Matrix Metalloproteinases and Their Inhibitors in Human Aortic Diseases	196
Quantitative left ventricular wall motion analysis: a comparison of area, chord and radial methods.	196
Differential Effect of Hydrogen Peroxide and Superoxide Anion on Apoptosis and Proliferation of Vascular Smooth Muscle Cells	196
Coronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years	196
Relation of Mean Right Atrial Pressure to Echocardiographic and Doppler Parameters of Right Atrial and Right Ventricular Function	196
Sex Differences in Mortality After Myocardial Infarction	196
Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction	196
Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis	196
No-Reflow Phenomenon and Lesion Morphology in Patients With Acute Myocardial Infarction	196
Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes	196
Endothelial Nitric Oxide Production and Insulin Sensitivity	196
Impact of impinging wall jet on color Doppler quantification of mitral regurgitation.	196
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.	196
A prospective study of nutritional factors and hypertension among US women.	196
Use of a Prognostic Treadmill Score in Identifying Diagnostic Coronary Disease Subgroups	196
Microvascular Obstruction and Left Ventricular Remodeling Early After Acute Myocardial Infarction	196
Congenital Aortic Stenosis	196
Combined and Individual Mitochondrial HSP60 and HSP10 Expression in Cardiac Myocytes Protects Mitochondrial Function and Prevents Apoptotic Cell Deaths Induced by Simulated Ischemia-Reoxygenation	196
Probing the Contribution of I _Ks to Canine Ventricular Repolarization	196
The N ⁶ -Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy	196
Recommendations for standardization and specifications in automated electrocardiography: bandwidth and digital signal processing. A report for health professionals by an ad hoc writing group of the Co	196
Cation Transport and Structure of the Red-Cell Plasma Membrane	195
Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic.	195
Conduction Disturbances and Increased Atrial Vulnerability in Connexin40-Deficient Mice Analyzed by Transesophageal Stimulation	195
Sodium Restriction Shifts Circadian Rhythm of Blood Pressure From Nondipper to Dipper in Essential Hypertension	195
Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations.	195
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.	195
Effect of Renal Artery Stenting on Renal Function and Size in Patients with Atherosclerotic Renovascular Disease	195
Identification of patients with ventricular tachycardia after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring, and cardiac catheterization.	195
Nonstationary Vortexlike Reentrant Activity as a Mechanism of Polymorphic Ventricular Tachycardia in the Isolated Rabbit Heart	195
Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection	195
Short-Term Oral Endothelin-Receptor Antagonist Therapy in Conventionally Treated Patients With Symptomatic Severe Chronic Heart Failure	195
Noninducibility of Atrial Fibrillation as an End Point of Left Atrial Circumferential Ablation for Paroxysmal Atrial Fibrillation	195
Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population	195
Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young,	195
The Mechanism of Supraventricular Tachycardia	194
Acute Pulmonary Embolectomy	194
Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region	194
Status of the adult and adolescent after repair of tetralogy of Fallot.	194
The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.	194
Transcatheter occlusion of patent ductus arteriosus with Gianturco coils.	194
Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.	194
Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure	194
Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.	194
Radiofrequency Catheter Ablation of Atrial Flutter	194
Estradiol Therapy Combined With Progesterone and Endothelium-Dependent Vasodilation in Postmenopausal Women	194
Coronary Artery Pattern and Outcome of Arterial Switch Operation for Transposition of the Great Arteries	194
Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance.	194
Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E–Knockout Mouse	194
Detection of Adenoviral Genome in the Myocardium of Adult Patients With Idiopathic Left Ventricular Dysfunction	194
Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease.	194
Population Versus Clinical View of Case Fatality From Acute Coronary Heart Disease	194
Infections, Immunity, and Atherosclerosis	194
Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia	194
Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure	194
Para-Hisian Pacing	194
Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a)	194
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group.	194
Natural History of Mitral Stenosis: A Review	193
Right Aortic Arch	193
Prognostic significance of progression of coronary atherosclerosis.	193
The Cardiomyopathy of Progressive Muscular Dystrophy	193
Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man	193
Incomplete mitral leaflet closure in patients with papillary muscle dysfunction.	193
Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.	193
Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium.	193
Endothelial Dysfunction Late After Kawasaki Disease	193
Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation.	193
Body surface detection of delayed depolarizations in patients with recurrent ventricular tachycardia and left ventricular aneurysm.	193
Continuous Probabilistic Prediction of Angiographically Significant Coronary Artery Disease Using Electron Beam Tomography	193
The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria.	193
Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.	193
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure	193
The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity.	193
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.	193
Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol	193
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease	193
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients	193
ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:Executive Summary	193
Perceived Mental Stress and Mortality From Cardiovascular Disease Among Japanese Men and Women	192
Evidence-Based Analysis of Amiodarone Efficacy and Safety	192
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.	192
Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture.	192
Digoxin Metabolism in the Elderly	192
Electrical Impedance Plethysmography	192
Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomic validation.	192
Role of nitric oxide in reactive hyperemia in human forearm vessels.	192
Amlodipine Releases Nitric Oxide From Canine Coronary Microvessels	192
Occurrence of oxidative stress during reperfusion of the human heart.	192
Type II Diabetes Abrogates Sex Differences in Endothelial Function in Premenopausal Women	192
Creatine Kinase System in Failing and Nonfailing Human Myocardium	192
Sex Differences in the Prognosis of Congestive Heart Failure	192
Losartan in Heart Failure	192
The Dye Dilution Method for Describing the Central Circulation	192
Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man.	192
Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo 1. Correlation with monophasic action potentials and contraction.	192
Vagal and Sympathetic Mechanisms in Patients With Orthostatic Vasovagal Syncope	192
Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease	192
A Randomized Comparison of Combined Ticlopidine and Aspirin Therapy Versus Aspirin Therapy Alone After Successful Intravascular Ultrasound–Guided Stent Implantation	192
Atherosclerotic Plaque Burden and CK-MB Enzyme Elevation After Coronary Interventions	192
TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.	192
Segmental Ostial Ablation to Isolate the Pulmonary Veins During Atrial Fibrillation	192
Remnant Lipoprotein Particles Induce Apoptosis in Endothelial Cells by NAD(P)H Oxidase–Mediated Production of Superoxide and Cytokines via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Activ	192
The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up.	192
Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention	192
Clinical pharmacology of propranolol.	191
Jones Criteria (Revised) for Guidance in the Diagnosis of Rheumatic Fever	191
Sudden death recorded during Holter monitoring.	191
Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus	191
Balloon dilation angioplasty of hypoplastic and stenotic pulmonary arteries.	191
Ankylosing Spondylitis and Aortic Regurgitation	191
Genetic--epidemiologic study of early-onset ischemic heart disease.	191
Lipoprotein predictors of the severity of coronary artery disease in men and women.	191
Propranolol in the Treatment of Acute Myocardial Infarction	191
Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.	191
The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions.	191
Effect of Diet and Exercise Intervention on Blood Pressure, Insulin, Oxidative Stress, and Nitric Oxide Availability	191
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.	191
Atrial Arrhythmias in Adults After Repair of Tetralogy of Fallot	191
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.	191
Diagnostic Marker Cooperative Study for the Diagnosis of Myocardial Infarction	191
Dual Inhibition of β-Adrenergic and Angiotensin II Receptors by a Single Antagonist	191
Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis.	191
Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy.	191
Measurement of absolute left ventricular volume from gated blood pool studies.	191
Chronic changes in skeletal muscle histology and function in peripheral arterial disease.	191
Assessment of Functional Capacity in Clinical and Research Applications	191
ACCF/AHA/HRS/SCAI Clinical Competence Statement on Physician Knowledge to Optimize Patient Safety and Image Quality in Fluoroscopically Guided Invasive Cardiovascular Procedures	191
Tetrahydrobiopterin and Dysfunction of Endothelial Nitric Oxide Synthase in Coronary Arteries	190
Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.	190
Transseptal Left Heart Catheterization	190
Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts.	190
Evaluation of tricuspid regurgitation by pulsed Doppler and two-dimensional echocardiography.	190
Nerve Growth Factor Promotes Angiogenesis and Arteriogenesis in Ischemic Hindlimbs	190
Vascular Superoxide Production and Vasomotor Function in Hypertension Induced by Deoxycorticosterone Acetate–Salt	190
Demonstration of Re-entry within the His-Purkinje System in Man	190
The Variable Spectrum of Echocardiographic Manifestations of the Mitral Valve Prolapse Syndrome	190
Estrogen-Receptor–Mediated Inhibition of Human Endothelial Cell Apoptosis	190
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.	190
Abnormalities of the Extracellular Degradation of Collagen Type I in Essential Hypertension	190
The Cost-effectiveness of Automatic Implantable Cardiac Defibrillators:	190
Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism	190
Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.	190
Increased Formation of Distinct F ₂ Isoprostanes in Hypercholesterolemia	190
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults.	190
Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial	190
Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual Recovery From GP IIb/IIIa Receptor Blockade	190
Immunolocalization of β ₂ -Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques	190
Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.	190
Identification of Atherosclerotic Plaque Components With Intravascular Ultrasound Elastography In Vivo	190
Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2	190
The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study.	190
Prognostic Value of Anxiety and Depression in Patients With Chronic Heart Failure	190
Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis	190
Intravascular Ultrasound Assessment of Ulcerated Ruptured Plaques	190
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention	190
Nitric Oxide and Angiogenesis	189
The mural left anterior descending coronary artery, strenuous exercise and sudden death.	189
Platelet Function in Acute Myocardial Infarction Treated With Direct Angioplasty	189
Sudden death prevention in patients with advanced ventricular dysfunction.	189
Mechanisms of Digitalis Toxicity	189
Effect of strenuous exercise on platelet activation state and reactivity.	189
Protective Role of Uncoupling Protein 2 in Atherosclerosis	189
Low Pro-Brain Natriuretic Peptide Levels Predict Benign Clinical Outcome in Acute Pulmonary Embolism	189
Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography.	189
1,25-Dihydroxyvitamin D ₃ Increases In Vitro Vascular Calcification by Modulating Secretion of Endogenous Parathyroid Hormone–Related Peptide	189
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.	189
Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.	189
Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study.	189
Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and Rabbits	189
Autoantibodies Activating Human β ₁ -Adrenergic Receptors Are Associated With Reduced Cardiac Function in Chronic Heart Failure	189
Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in a working population.	189
Impaired Arteriogenic Response to Acute Hindlimb Ischemia in CD4-Knockout Mice	189
Sino-MONICA Project	189
Endothelial Progenitor Cells Are Rapidly Recruited to Myocardium and Mediate Protective Effect of Ischemic Preconditioning via “Imported” Nitric Oxide Synthase Activity	189
High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction	189
Thrombin Stimulates Human Endothelial Arginase Enzymatic Activity via RhoA/ROCK Pathway	189
FKBP12.6-Mediated Stabilization of Calcium-Release Channel (Ryanodine Receptor) as a Novel Therapeutic Strategy Against Heart Failure	189
Endogenous Endothelin-1 Participates in the Maintenance of Cardiac Function in Rats With Congestive Heart Failure	189
Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.	189
Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic Cardiomyopathy	189
Long-Term Consumption of Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Mortality in US Adults	189
Inhibition of Restenosis With β-Emitting Radiotherapy	189
Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice	189
Elevated Blood Pressure Linked to Primary Hyperaldosteronism and Impaired Vasodilation in BK Channel–Deficient Mice	189
Hemodynamic and Hypotensive Effects of Long-term Therapy with Chlorothiazide	188
Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart Disease	188
Probucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor Effect	188
Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention.	188
Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.	188
Percutaneous transluminal balloon valvuloplasty for pulmonary valve stenosis.	188
Insulin-Like Growth Factor-1 as a Vascular Protective Factor	188
Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers.	188
The Fourth Walter Wile Hamburger Memorial Lecture, Institute of Medicine of Chicago	188
Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.	188
Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study.	188
N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes	188
Conversion From Vagal to Sympathetic Predominance With Strenuous Training in High-Performance World Class Athletes	188
Further Observations on Ventricular Tachycardia As Studied by Electrical Stimulation of the Heart	188
High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.	188
Family History as a Risk Factor for Primary Cardiac Arrest	188
Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.	188
Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.	188
Arrhythmogenic Right Ventricular Cardiomyopathy Causing Sudden Cardiac Death in Boxer Dogs	188
A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.	188
Radial Artery Bypass Grafts Have an Increased Occurrence of Angiographically Severe Stenosis and Occlusion Compared With Left Internal Mammary Arteries and Saphenous Vein Grafts	188
Comparison of Five Antihypertensive Monotherapies and Placebo for Change in Left Ventricular Mass in Patients Receiving Nutritional-Hygienic Therapy in the Treatment of Mild Hypertension Study (TOMHS)	188
Targeting of Apoptotic Macrophages and Experimental Atheroma With Radiolabeled Annexin V	188
Sustained Hemodynamic Effects of Intravenous Levosimendan	187
A Prospective Study of Anger and Coronary Heart Disease	187
Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.	187
Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans.	187
Histopathology of In-Stent Restenosis in Patients With Peripheral Artery Disease	187
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia.	187
Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet.	187
Changes in conduction velocity during acute ischemia in ventricular myocardium of the isolated porcine heart.	187
The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.	187
Impaired Cerebral Autoregulation in Patients With Malignant Hypertension	187
Influence of the Novel Inotropic Agent Levosimendan on Isometric Tension and Calcium Cycling in Failing Human Myocardium	187
Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.	187
Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.	187
Clinical Potential of Intravascular Ultrasound for Physiological Assessment of Coronary Stenosis	187
Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.	187
Inhibition of Clinical Benefits of Aspirin on First Myocardial Infarction by Nonsteroidal Antiinflammatory Drugs	187
Distinct Subcellular Localization of Different Sodium Channel α and β Subunits in Single Ventricular Myocytes From Mouse Heart	187
Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells	187
Cohort Study of Cytomegalovirus Infection as a Risk Factor for Carotid Intimal-Medial Thickening, a Measure of Subclinical Atherosclerosis	187
Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Oral l -Arginine in Patients With Heart Failure	187
Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers.	187
Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes	187
Prognostic Value of Intracoronary Flow Velocity and Diameter Stenosis in Assessing the Short- and Long-term Outcomes of Coronary Balloon Angioplasty	187
Intimal hyperplasia, vascular modeling, and the restenosis problem.	186
P-Selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates	186
Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.	186
Anatomical configuration of the His bundle and bundle branches in the human heart.	186
Mechanism of ischemic mitral regurgitation. An experimental evaluation.	186
Epicardial and endocardial activation during sustained ventricular tachycardia in man.	186
Complication rate of coronary arteriography. A review of 5250 cases studied by a percutaneous femoral technique.	186
Heart Failure With a Normal Ejection Fraction	186
Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension.	186
Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events.	186
Left Heart Volume Estimation in Infancy and Childhood	186
Left ventricular volumes by gated equilibrium radionuclide angiography: a new method.	186
Myocardial infarction in the conscious dog: three-dimensional mapping of infarct, collateral flow and region at risk.	186
Early Morning Attenuation of Endothelial Function in Healthy Humans	186
Long-term results of catheter ablation of idiopathic right ventricular tachycardia.	186
Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis	186
Predictors of Improved Renal Function After Percutaneous Stent-Supported Angioplasty of Severe Atherosclerotic Ostial Renal Artery Stenosis	186
Exercise Stress Test Amplifies Genotype-Phenotype Correlation in the LQT1 and LQT2 Forms of the Long-QT Syndrome	186
Fast Determination of Regional Myocardial Strain Fields From Tagged Cardiac Images Using Harmonic Phase MRI	186
Comparison of Surgical and Medical Group Survival in Patients With Left Main Coronary Artery Disease	186
Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis. A prospective, randomized trial.	186
Verapamil Reduces Tachycardia-Induced Electrical Remodeling of the Atria	186
Augmented Peripheral Chemosensitivity as a Potential Input to Baroreflex Impairment and Autonomic Imbalance in Chronic Heart Failure	186
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.	186
Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women	186
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis	186
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association	186
Intracellular calcium homeostasis in cardiac myocytes.	185
Dynamic mechanisms in human coronary stenosis.	185
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure	185
Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury	185
Large conduit arteries in hypertension: role of the vascular renin-angiotensin system.	185
Vulnerable Plaque	185
Cardiac Conduction in Patients with Symptomatic Sinus Node Disease	185
Radiofrequency Catheter Ablation of Ventricular Tachycardia After Myocardial Infarction	185
Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.	185
Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.	185
Nitric Oxide	185
Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo.	185
Atrial Fibrillation After Coronary Artery Bypass Surgery	185
Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.	185
The tricuspid valve annulus: study of size and motion in normal subjects and in patients with tricuspid regurgitation.	185
Long-Term Serotonin Administration Induces Heart Valve Disease in Rats	185
Rapid Platelet-Function Assay	185
Regulation of Angiotensin II Receptor Subtypes During Atrial Fibrillation in Humans	185
Regional differences in function within noninfarcted myocardium during left ventricular remodeling.	185
Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques	185
Percutaneous Balloon Versus Surgical Closed and Open Mitral Commissurotomy	185
Safety and Tolerability of Pravastatin in Long-Term Clinical Trials	185
Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.	185
Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease.	185
Serial Echocardiographic-Doppler Assessment of Left Ventricular Geometry and Function in Rats With Pressure-Overload Hypertrophy	185
Optimizing the Percutaneous Interventional Outcomes for Patients With Diabetes Mellitus	185
Influence of myocardial ischemia and infarction on autonomic innervation of heart.	184
Increased embolic risk in patients with left ventricular thrombi.	184
Public Locations of Cardiac Arrest	184
Increased endothelin in experimental heart failure.	184
Catheter ablation of the atrioventricular junction: a report of the percutaneous mapping and ablation registry.	184
Sensitivity of end-systolic pressure-dimension and pressure-volume relations to the inotropic state in humans.	184
Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback.	184
Interarterial Coronary Anastomoses in the Human Heart, with Particular Reference to Anemia and Relative Cardiac Anoxia	184
Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics.	184
Lung Function and Cardiovascular Risk	184
Postsystolic Shortening in Ischemic Myocardium	184
Time course of regression of left ventricular hypertrophy after aortic valve replacement.	184
Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction	184
Impaired Renal Clearance Explains Elevated Troponin T Fragments in Hemodialysis Patients	184
Epicardial Stenosis Severity Does Not Affect Minimal Microcirculatory Resistance	184
Pressure-Derived Fractional Flow Reserve to Assess Serial Epicardial Stenoses	184
Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension	184
Age-related changes in beta-adrenergic neuroeffector systems in the human heart.	184
5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic	184
First Human Experience With Pulmonary Vein Isolation Using a Through-the-Balloon Circumferential Ultrasound Ablation System for Recurrent Atrial Fibrillation	184
Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men	184
ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary	184
Coronary bypass surgery for chronic angina--1981. A perspective.	183
New Perspectives on Atherogenesis	183
Main left coronary artery disease. Clinical experience from 1964-1974.	183
Physical Activity and Mortality in Older Men With Diagnosed Coronary Heart Disease	183
Radiation exposure during radiofrequency catheter ablation of accessory atrioventricular connections.	183
High Homocysteine Levels Are Independently Related to Isolated Systolic Hypertension in Older Adults	183
Risk Stratification After Acute Myocardial Infarction by Heart Rate Turbulence	183
Blade Balloon Atrial Septostomy in Patients With Severe Primary Pulmonary Hypertension	183
Sequential Alterations in Myocardial Lactate Metabolism, S-T Segments, and Left Ventricular Function During Angina Induced by Atrial Pacing	183
Cross-sectional echocardiography. II. Analysis of mathematic models for quantifying volume of the formalin-fixed left ventricle.	183
Activation of Blood Coagulation After Cardiac Arrest Is Not Balanced Adequately by Activation of Endogenous Fibrinolysis	183
Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow.	183
Alimentary Lipemia, Postprandial Triglyceride-Rich Lipoproteins, and Common Carotid Intima-Media Thickness in Healthy, Middle-Aged Men	183
Hemodynamic, Renal, and Hormonal Effects of Adrenomedullin Infusion in Patients With Congestive Heart Failure	183
One-Year Coronary Bypass Graft Patency	183
Stroke After Thrombolysis	183
Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells	183
Role of Variability in Microvascular Resistance on Fractional Flow Reserve and Coronary Blood Flow Velocity Reserve in Intermediate Coronary Lesions	183
Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary Intervention	183
Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy	182
Cardiovascular Actions of Sodium Nitroprusside in Animals and Hypertensive Patients	182
Early Detection of Fabry Cardiomyopathy by Tissue Doppler Imaging	182
Heparin kinetics in venous thrombosis and pulmonary embolism.	182
Mitral anulus motion. Relation to pulmonary venous and transmitral flows in normal subjects and in patients with dilated cardiomyopathy.	182
A comparison of real-time, two dimensional echocardiography and cineangiography in detecting left ventricular asynergy.	182
Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice	182
Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure.	182
Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings.	182
Nonsurgical Septal Reduction for Hypertrophic Obstructive Cardiomyopathy	182
Multiple-Lead Exercise Electrocardiography	182
Angiogenesis and Vasculogenesis Are Impaired in the Precocious-Aging klotho Mouse	182
Gadolinium-Enhanced 3-Dimensional Magnetic Resonance Angiography of Pulmonary Blood Supply in Patients With Complex Pulmonary Stenosis or Atresia	182
Frequency of Atrial Septal Aneurysms in Patients With Cerebral Ischemic Events	182
Reduction in Cardiovascular Events During Pravastatin Therapy	182
Oral Glycoprotein IIb/IIIa Inhibition With Orbofiban in Patients With Unstable Coronary Syndromes (OPUS-TIMI 16) Trial	182
Identification by a Differential Proteomic Approach of Heat Shock Protein 27 as a Potential Marker of Atherosclerosis	182
Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary Stent	182
Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women	182
Natriuretic Peptide Testing in Heart Failure	182
Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia.	181
Right and Left Myocardial Antioxidant Responses During Heart Failure Subsequent to Myocardial Infarction	181
Control of radiofrequency lesion size by power regulation.	181
Use of Sublingual Nitroglycerin in Congestive Failure following Acute Myocardial Infarction	181
Methods of measurement of myocardial blood flow in patients: a critical review.	181
Regional Left Ventricular Performance in the Year following Myocardial Infarction	181
Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.	181
Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current.	181
Dietary iron intake and risk of coronary disease among men.	181
α-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans	181
Survival After Coronary Revascularization Among Patients With Kidney Disease	181
Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina Pectoris	181
Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension	181
Expression and Function of a Biological Pacemaker in Canine Heart	181
Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise.	181
Cystatin C	181
Early Potent Antithrombotic Effect With Combined Aspirin and a Loading Dose of Clopidogrel on Experimental Arterial Thrombogenesis in Humans	181
Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction	181
Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms.	181
Simultaneous Transmission/Emission Myocardial Perfusion Tomography	181
Guidelines for the Reporting of Renal Artery Revascularization in Clinical Trials	181
Differential Cardiac Effects of Growth Hormone and Insulin-like Growth Factor1 in the Rat	181
The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction.	181
Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring Study	181
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Pr	181
An Airline Cardiac Arrest Program	180
Inflammation, Metalloproteinases, and Increased Proteolysis	180
Free radicals and myocardial injury: pharmacologic implications.	180
Fat-suppressed breath-hold magnetic resonance coronary angiography.	180
Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts.	180
Atrial Ischemia Promotes Atrial Fibrillation in Dogs	180
Fibrinopeptide A and platelet factor levels in unstable angina pectoris.	180
Analysis of Left Ventricular Wall Motion by Reflected Ultrasound	180
Vascular Smooth Muscle Cell Heme Oxygenases Generate Guanylyl Cyclase–Stimulatory Carbon Monoxide	180
Digitalis-associated cardiac mortality after myocardial infarction.	180
Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension	180
Association Between Body Iron Stores and the Risk of Acute Myocardial Infarction in Men	180
Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability.	180
Respiratory Muscle Dysfunction in Congestive Heart Failure	180
Aortic root dilatation and mitral valve prolapse in Marfan's syndrome: an ECHOCARDIOgraphic study.	180
Renin-Aldosterone Paradox and Perturbed Blood Volume Regulation Underlying Postural Tachycardia Syndrome	180
Simvastatin Initiated Early After Heart Transplantation	180
Endothelin ET _A and ET _B Receptors Cause Vasoconstriction of Human Resistance and Capacitance Vessels In Vivo	180
Development of Heart Failure and Congenital Septal Defects in Mice Lacking Endothelial Nitric Oxide Synthase	180
Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction	180
Overnight Shift From Obstructive to Central Apneas in Patients With Heart Failure	180
Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women	180
Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods.	180
Effect of Single-Drug Therapy on Reduction of Left Ventricular Mass in Mild to Moderate Hypertension	180
Predictive Value of D-Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia	180
Treatment of In-Stent Restenosis With Excimer Laser Coronary Angioplasty	180
Assessment of Left Ventricular Torsional Deformation by Doppler Tissue Imaging	180
Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.	180
Inferior myocardial infarction. High-risk subgroups.	179
Testing Endothelial Vasomotor Function	179
Increasing Burden of Cardiovascular Disease	179
Circadian variation of blood pressure in autonomic failure.	179
Evidence for the Rapid Onset of Apoptosis in Medial Smooth Muscle Cells After Balloon Injury	179
Mechanism of Repetitive Monomorphic Ventricular Tachycardia	179
Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction	179
Quantitative detection of regional left ventricular contraction abnormalities by two-dimensional echocardiography. I. Analysis of methods.	179
Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia	179
Noninvasive Imaging of Inflammation by Ultrasound Detection of Phagocytosed Microbubbles	179
β-Adrenergic Blockade in Developing Heart Failure	179
Prevalence of Fabry Disease in Female Patients With Late-Onset Hypertrophic Cardiomyopathy	179
Transcatheter closure of atrial septal defects. Experimental studies.	179
In Vivo Downregulation of T Helper Cell 1 Immune Responses Reduces Atherogenesis in Apolipoprotein E-Knockout Mice	179
Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.	179
Catheter ablation of the atrioventricular junction with radiofrequency energy.	179
Hypoplastic Left Heart Syndrome With Intact or Highly Restrictive Atrial Septum	179
Chronic Hyperglycemia Impairs Endothelial Function and Insulin Sensitivity Via Different Mechanisms in Insulin-Dependent Diabetes Mellitus	179
Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction.	179
Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris.	179
Increased Availability and Open Probability of Single L-Type Calcium Channels From Failing Compared With Nonfailing Human Ventricle	179
Localization of Optimal Ablation Site of Idiopathic Ventricular Tachycardia from Right and Left Ventricular Outflow Tract by Body Surface ECG	179
Impact of Community-Wide Police Car Deployment of Automated External Defibrillators on Survival From Out-of-Hospital Cardiac Arrest	179
Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non–ST-Elevation Acute Coronary Syndromes	179
More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction	179
Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group.	179
Myocardial Infarct Expansion and Matrix Metalloproteinase Inhibition	179
Effect of Lean Body Mass, Fat Mass, Blood Pressure, and Sexual Maturation on Left Ventricular Mass in Children and Adolescents	179
In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions	179
Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exercise.	179
Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia	179
Syphilitic Aortitis	178
Mineralocorticoid Receptor Antagonism in Experimental Atherosclerosis	178
Isolated Congenital Complete Atrioventricular Block in Adult Life	178
Relative lack of coronary blood flow during closed-chest resuscitation in dogs.	178
Complete atrioventricular block in patients with atrioventricular discordance.	178
Ultrasonic duplex scanning for disease of the carotid artery.	178
Endothelial ICAM-1 Expression Associated With Inflammatory Cell Response in Human Ischemic Stroke	178
The Elusive Link Between LQT3 and Brugada Syndrome	178
Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats	178
Remodeling of the Left Ventricle in Primary Aldosteronism Due to Conn’s Adenoma	178
Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death	178
Oral Magnesium Therapy Improves Endothelial Function in Patients With Coronary Artery Disease	178
Predictive Adaptive Responses to Maternal High-Fat Diet Prevent Endothelial Dysfunction but Not Hypertension in Adult Rat Offspring	178
Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs	178
Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart.	178
Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty.	178
Noninvasive Electrocardiographic Imaging	178
Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction	178
Oxidized Low-Density Lipoprotein Regulates Matrix Metalloproteinase-9 and Its Tissue Inhibitor in Human Monocyte-Derived Macrophages	178
Microvascular Function Relates to Insulin Sensitivity and Blood Pressure in Normal Subjects	178
Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.	178
Rebuilding a Damaged Heart	178
Decreased Expression of Tumor Necrosis Factor-α in Failing Human Myocardium After Mechanical Circulatory Support	178
Magnetic Resonance Fluoroscopy Allows Targeted Delivery of Mesenchymal Stem Cells to Infarct Borders in Swine	178
Inhibition of Myosin Phosphatase by Upregulated Rho-Kinase Plays a Key Role for Coronary Artery Spasm in a Porcine Model With Interleukin-1β	178
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation	178
Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial	178
Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical Risk	178
The Safety of Intracoronary Ultrasound	178
Subendocardial resection for ventricular tachycardia: predictors of surgical success.	177
The prognostic spectrum of left main stenosis.	177
Understanding the coronary circulation through studies at the microvascular level.	177
Plasma Total Cysteine as a Risk Factor for Vascular Disease	177
Aortic Plaque Morphology and Vascular Events	177
Ischemic Preconditioning in the Intact Rat Heart Is Mediated by δ ₁ - But Not μ- or κ-Opioid Receptors	177
Angiotensin II Induces LOX-1, the Human Endothelial Receptor for Oxidized Low-Density Lipoprotein	177
Early Contrast-Enhanced MRI Predicts Late Functional Recovery After Reperfused Myocardial Infarction	177
Heterogeneity in the Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Heart Failure	177
Influence of Pregnancy on the Risk for Cardiac Events in Patients With Hereditary Long QT Syndrome	177
Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative angiographic observations.	177
Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive Patients	177
Carotid Artery Plaque Burden, Stiffness, and Mortality Risk in Elderly Men	177
A new method for estimating left ventricular dP/dt by continuous wave Doppler-echocardiography. Validation studies at cardiac catheterization.	177
Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease.	177
Variation of C-Reactive Protein Levels in Adolescents	177
Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery.	177
Prediction of Indications for Valve Replacement Among Asymptomatic or Minimally Symptomatic Patients With Chronic Aortic Regurgitation and Normal Left Ventricular Performance	177
Hemodynamic and Neurohumoral Effects of Selective Endothelin A (ET _A ) Receptor Blockade in Chronic Heart Failure	177
Thrombogenic Factors and Recurrent Coronary Events	177
Cholesterol Production in Obesity	177
Subacute Effusive-Constrictive Pericarditis	177
Identification of Viable Myocardium	177
Vulnerable Atherosclerotic Plaque	177
Defining coronary restenosis. Newer clinical and angiographic paradigms.	177
Pacing-Induced Chronic Atrial Fibrillation Impairs Sinus Node Function in Dogs	177
Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.	176
Natural History of Transposition of the Great Arteries	176
Neutrophil function in ischemic heart disease.	176
The Rate of Change of Left Ventricular Volume in Man	176
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score	176
Fluid Flow Inhibits Endothelial Adhesiveness	176
Nonatheromatous Ischemic Heart Disease following Withdrawal from Chronic Industrial Nitroglycerin Exposure	176
Superiority of Clopidogrel Versus Aspirin in Patients With Prior Cardiac Surgery	176
Which Patients Benefit From Percutaneous Mitral Balloon Valvuloplasty?	176
Anger Proneness Predicts Coronary Heart Disease Risk	176
Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.	176
Microbubble Persistence in the Microcirculation During Ischemia/Reperfusion and Inflammation Is Caused by Integrin- and Complement-Mediated Adherence to Activated Leukocytes	176
Platelet-Derived Growth Factor–Stimulated Superoxide Anion Production Modulates Activation of Transcription Factor NF-κB and Expression of Monocyte Chemoattractant Protein 1 in Human Aortic Smooth Mus	176
Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1–Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation	176
Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice	176
Gender Differences in Survival in Advanced Heart Failure	176
Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol	176
Creatine Kinase-MB Enzyme Elevation Following Successful Saphenous Vein Graft Intervention Is Associated With Late Mortality	176
Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension	176
Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography.	176
Regulation of Bone Morphogenetic Protein-2 Expression in Endothelial Cells	176
Age and Outcome With Contemporary Thrombolytic Therapy	176
Primary Stenting Versus Balloon Angioplasty in Occluded Coronary Arteries	176
Feasibility of Shockwave Coronary Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses	176
Mental Stress–Induced Ischemia and All-Cause Mortality in Patients With Coronary Artery Disease	176
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups	176
Hemodynamic Studies in Patients with Borderline Blood Pressure Elevation	175
Tissue angiotensin system in cardiovascular medicine. A paradigm shift?	175
Vitamin C Improves Endothelial Dysfunction of Epicardial Coronary Arteries in Hypertensive Patients	175
Analysis of 12-Lead T-Wave Morphology for Risk Stratification After Myocardial Infarction	175
Reentrant ventricular arrhythmias in the late myocardial infarction period. 9. Electrophysiologic-anatomic correlation of reentrant circuits.	175
Noninvasive detection of skeletal muscle underperfusion with near-infrared spectroscopy in patients with heart failure.	175
Hormones and the Pathogenesis of Congestive Heart Failure:Vasopressin, Aldosterone, and Angiotensin II	175
Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events.	175
Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina.	175
Polymorphism of the NADH/NADPH Oxidase p22 phox Gene in Patients With Coronary Artery Disease	175
Endocardial activation of left bundle branch block.	175
Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine.	175
Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure.	175
Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy.	175
Cardiovascular Consequences of Sleep-Disordered Breathing: Past, Present and Future	175
Trypanosoma cruzi –Infected Cardiomyocytes Produce Chemokines and Cytokines That Trigger Potent Nitric Oxide–Dependent Trypanocidal Activity	175
Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.	175
Existence of the Frank-Starling Mechanism in the Failing Human Heart	175
Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction	175
Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study	175
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction	175
Effect of Cardiac Contraction on Coronary Blood Flow	174
Cardiac fatigue after prolonged exercise.	174
Myocardial Contractile Response to Nitric Oxide and cGMP	174
Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia	174
The Essential Role of Atrioventricular Conduction Delay in the Initiation of Paroxysmal Supraventricular Tachycardia	174
Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.	174
Short-term effect of dynamic exercise on arterial blood pressure.	174
Bundle-Branch Block in a General Male Population	174
Angiotensin converting enzyme inhibition in patients with congestive heart failure.	174
Clinical Profile and Outcome of Idiopathic Restrictive Cardiomyopathy	174
Heart rate variability during the acute phase of myocardial infarction.	174
Increased Arteriovenous Oxygen Difference After Physical Training in Coronary Heart Disease	174
Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.	174
Prognostic Value of Health Status in Patients With Heart Failure After Acute Myocardial Infarction	174
Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension.	174
Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging.	174
Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients.	174
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade	174
Disparities Between Aortic and Peripheral Pulse Pressures Induced by Upright Exercise and Vasomotor Changes in Man	174
Shed Membrane Particles From T Lymphocytes Impair Endothelial Function and Regulate Endothelial Protein Expression	174
Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model.	174
LOX-1 Mediates Oxidized Low-Density Lipoprotein-Induced Expression of Matrix Metalloproteinases in Human Coronary Artery Endothelial Cells	174
Reduction of enzyme levels by propranolol after acute myocardial infarction.	174
Infarct Size Measured by Single Photon Emission Computed Tomographic Imaging With ^99m Tc-Sestamibi	174
Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias	174
Fasting Glucose Is an Important Independent Risk Factor for 30-Day Mortality in Patients With Acute Myocardial Infarction	174
13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography.	174
Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.	174
Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects	174
Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease	174
Associations of Parental, Birth, and Early Life Characteristics With Systolic Blood Pressure at 5 Years of Age	174
MEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo	174
Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women	174
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses	174
Effect of Ca ²⁺ on GP IIb-IIIa Interactions With Integrilin	174
Correction to: Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association	174
Acute hemodynamic interventions shift the diastolic pressure-volume curve in man.	173
Peripartum myocarditis and cardiomyopathy.	173
Epicardial Excitation of the Ventricles in a Patient with Wolff-Parkinson-White Syndrome (Type B)	173
Interleukin-6 and RANTES in Takayasu Arteritis	173
Angiogenesis Therapy	173
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors.	173
Improved neurologic recovery and survival after early defibrillation.	173
Risk factors for the development of prosthetic valve endocarditis.	173
Effects of Cardiopulmonary Resuscitation on Predictors of Ventricular Fibrillation Defibrillation Success During Out-of-Hospital Cardiac Arrest	173
Genetic Determinants of Hemostasis Phenotypes in Spanish Families	173
Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio.	173
Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.	173
Multivariate prediction of coronary heart disease in the Western Collaborative Group Study compared to the findings of the Framingham study.	173
Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance.	173
Direct In Vivo Evidence Demonstrating Neointimal Migration of Adventitial Fibroblasts After Balloon Injury of Rat Carotid Arteries	173
Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice	173
Tissue Endothelin-1 Immunoreactivity in the Active Coronary Atherosclerotic Plaque	173
Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients.	173
Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene	173
Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation	173
Statins Enhance Migratory Capacity by Upregulation of the Telomere Repeat-Binding Factor TRF2 in Endothelial Progenitor Cells	173
Low Circulating Vitamin B ₆ Is Associated With Elevation of the Inflammation Marker C-Reactive Protein Independently of Plasma Homocysteine Levels	173
Differential Expression of Tissue Factor Protein in Directional Atherectomy Specimens From Patients With Stable and Unstable Coronary Syndromes	173
Analysis of coronary angioplasty practice in the United States with an insurance-claims data base.	173
Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease	173
Defining the Optimal Activated Clotting Time During Percutaneous Coronary Intervention	173
Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)	173
Abnormalities in Beat-to-Beat Dynamics of Heart Rate Before the Spontaneous Onset of Life-Threatening Ventricular Tachyarrhythmias in Patients With Prior Myocardial Infarction	173
Percutaneous Pericardial Instrumentation for Endo-Epicardial Mapping of Previously Failed Ablations	173
Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy.	173
Restenosis Rates in Diabetic Patients	173
Beneficial Effects of Clopidogrel Combined With Aspirin in Reducing Cerebral Emboli in Patients Undergoing Carotid Endarterectomy	173
Circulating Levels of Secretory Type II Phospholipase A ₂ Predict Coronary Events in Patients with Coronary Artery Disease	173
Results and Long-Term Predictors of Adverse Clinical Events After Elective Percutaneous Interventions on Unprotected Left Main Coronary Artery	173
Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy	173
Clinical Profiles and Outcomes of Acute Type B Aortic Dissection in the Current Era: Lessons From the International Registry of Aortic Dissection (IRAD)	173
Stress echocardiography. From pathophysiological toy to diagnostic tool.	172
Update on Statins: 2003	172
Ischemic Preconditioning in Humans	172
Use of Echocardiography in Patients with Prolapsed Mitral Valve	172
Echocardiographic Abnormalities in the Mitral Valve Prolapse Syndrome	172
Noninvasive evaluation of ventricular hypertrophy in professional athletes.	172
Longitudinal Gradients for Endothelium-Dependent and -Independent Vascular Responses in the Coronary Microcirculation	172
Preload Induces Troponin I Degradation Independently of Myocardial Ischemia	172
Bystander cardiopulmonary resuscitation. Is ventilation necessary?	172
Congenital Heart Defects	172
Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs.	172
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies.	172
Stimulation of Fecal Steroid Excretion After Infusion of Recombinant Proapolipoprotein A-I	172
Progressive Tricuspid Valve Disease in Patients With Congenitally Corrected Transposition of the Great Arteries	172
Endurance exercise training augments diastolic filling at rest and during exercise in healthy young and older men.	172
Clinical outcomes after the arterial switch operation for transposition. Patient, support, procedural, and institutional risk factors. Congenital Heart Surgeons Society.	172
Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure	172
Reduction of Infarct Size and Prevention of Cardiac Rupture in Transgenic Mice Overexpressing FrzA	172
The value of catheter mapping during sinus rhythm to localize site of origin of ventricular tachycardia.	172
Effect of Radiofrequency Catheter Ablation on Health-Related Quality of Life and Activities of Daily Living in Patients With Recurrent Arrhythmias	172
Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy	172
CD4+CD28− T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients	172
Delayed Treatment of Traumatic Rupture of the Thoracic Aorta With Endoluminal Covered Stent	172
The mitral valve orifice method for noninvasive two-dimensional echo Doppler determinations of cardiac output.	172
Detection of coronary artery disease with exercise two-dimensional echocardiography. Description of a clinically applicable method and comparison with radionuclide ventriculography.	172
Relations of Left Ventricular Mass to Fat-Free and Adipose Body Mass	172
Autologous Bone-Marrow Mononuclear Cell Implantation Improves Endothelium-Dependent Vasodilation in Patients With Limb Ischemia	172
Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb	172
Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events	172
Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.	172
Long-Term Follow-Up After Percutaneous Transluminal Coronary Angioplasty Was Not Performed Based on Intravascular Ultrasound Findings	172
Value of Serial Troponin T Measures for Early and Late Risk Stratification in Patients With Acute Coronary Syndromes	172
Determinants and prediction of transmural myocardial perfusion.	171
Contemporary Management of Patent Foramen Ovale	171
Future of Biomarkers in Acute Coronary Syndromes	171
Aspirin Improves Endothelial Dysfunction in Atherosclerosis	171
Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularization.	171
Atherosclerosis and the Two Faces of Endothelial Nitric Oxide Synthase	171
The Anatomic Basis for High-Frequency Components in the Electrocardiogram	171
Experimental validation of quantitative coronary arteriography for determining pressure-flow characteristics of coronary stenosis.	171
Electrophysiologic evaluation of sinus node function in patients with sinus node dysfunction.	171
Stem Cell Factor in Mast Cells and Increased Mast Cell Density in Idiopathic and Ischemic Cardiomyopathy	171
Predictors of Atrial Fibrillation After Conventional and Beating Heart Coronary Surgery	171
Evaluation of Regional Differences in Right Ventricular Systolic Function by Acoustic Quantification Echocardiography and Cine Magnetic Resonance Imaging	171
Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy	171
Left Heart Obstructive Lesions and Left Ventricular Growth in the Midtrimester Fetus	171
Vascular Endothelial Growth Factor-A–Induced Chemotaxis of Monocytes Is Attenuated in Patients With Diabetes Mellitus	171
Paradoxical Arterial Wall Shrinkage May Contribute to Luminal Narrowing of Human Atherosclerotic Femoral Arteries	171
p38 Mitogen-Activated Protein Kinase Downregulates Endothelial Progenitor Cells	171
Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death.	171
Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of Gαq Transgenic Mice	171
Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure	171
Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups	171
Acute Coronary Syndromes in the GUSTO-IIb Trial	171
Increased Plasminogen Activator Inhibitor Type 1 in Coronary Artery Atherectomy Specimens From Type 2 Diabetic Compared With Nondiabetic Patients	171
Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.	171
Effects of Long-Term Monotherapy With Eplerenone, a Novel Aldosterone Blocker, on Progression of Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure	171
Coronary Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic Stroke	171
Mouse Model of SCN5A -Linked Hereditary Lenègre’s Disease	171
Racial Variations in Treatment and Outcomes of Black and White Patients With High-Risk Non–ST-Elevation Acute Coronary Syndromes	171
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion	171
Transcatheter treatment of congenital heart disease.	170
Decreased Sarcoplasmic Reticulum Calcium Content Is Responsible for Defective Excitation-Contraction Coupling in Canine Heart Failure	170
Atrial Fibrillation and Ventricular Dysfunction	170
The echocardiographic assessment of pulmonary artery pressure and pulmonary vascular resistance.	170
Noninvasive Quantification of Coronary Blood Flow Reserve in Humans Using Myocardial Contrast Echocardiography	170
Risk stratification with low-level exercise testing 2 weeks after acute myocardial infarction.	170
Arrhythmias in patients with mitral valve prolapse.	170
Basal Pulmonary Vascular Resistance and Nitric Oxide Responsiveness Late After Fontan-Type Operation	170
Echocardiographic measurement of right ventricular volume.	170
Histopathologic validation of angioscopy and intravascular ultrasound.	170
Systolic Time Intervals as Measures of the Contractile State of the Left Ventricular Myocardium in Man	170
Fibrillar collagen and remodeling of dilated canine left ventricle.	170
Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia.	170
Estradiol Accelerates Reendothelialization in Mouse Carotid Artery Through Estrogen Receptor-α but Not Estrogen Receptor-β	170
Importance of the Design of an Exercise Protocol in the Evaluation of Patients with Angina Pectoris	170
Reduction of Stroke Events With Pravastatin	170
Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors.	170
Recommendations for Cardiovascular Screening, Staffing, and Emergency Policies at Health/Fitness Facilities	170
G20210A Mutation in Prothrombin Gene and Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in a Large Cohort of US Men	170
Assessment of Cardiac Contractility	170
Power-Law Relationship of Heart Rate Variability as a Predictor of Mortality in the Elderly	170
Colchicine Treatment for Recurrent Pericarditis	170
Interaction of Coagulation Defects and Cardiovascular Risk Factors	170
Vascular Oxidant Stress Enhances Progression and Angiogenesis of Experimental Atheroma	170
Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.	170
Myocardial First-Pass Perfusion Magnetic Resonance Imaging	170
Care and Outcomes of Patients Newly Hospitalized for Heart Failure in the Community Treated by Cardiologists Compared With Other Specialists	170
Three-dimensional reconstruction of human coronary and peripheral arteries from images recorded during two-dimensional intravascular ultrasound examination.	170
Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.	170
Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.	170
Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion.	170
Left ventricular diastolic performance at rest and during exercise in patients with coronary artery disease. Assessment with first-pass radionuclide angiography.	170
Better Outcome for Women Compared With Men Undergoing Coronary Revascularization	170
Mortality in Patients After a Recent Myocardial Infarction	170
Abciximab Improves Both Epicardial Flow and Myocardial Reperfusion in ST-Elevation Myocardial Infarction	170
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association	170
Relations of Stroke Volume and Cardiac Output to Body Composition	169
Implantation of balloon-expandable intravascular grafts by catheterization in pulmonary arteries and systemic veins.	169
Nonsustained Ventricular Tachycardia in Severe Heart Failure	169
Long-Term Healthcare and Cost Outcomes of Disease Management in a Large, Randomized, Community-Based Population With Heart Failure	169
Noninvasive Assessment of Left Ventricular Force-Frequency Relationships Using Tissue Doppler–Derived Isovolumic Acceleration	169
The Apolipoprotein ε4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction	169
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial	169
Enhanced Ca ²⁺ Release and Na/Ca Exchange Activity in Hypertrophied Canine Ventricular Myocytes	169
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents	169
Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Coronary Stents	169
Contemporary Presentation and Management of Valvular Heart Disease	169
Physiologically Significant Specializations of the Cell Surface	169
Platelet–Monocyte Aggregates	169
Nanotechnology for Molecular Imaging and Targeted Therapy	169
Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction.	169
Adenosine Concentrations in the Interstitium of Resting and Contracting Human Skeletal Muscle	169
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.	169
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.	169
Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland.	169
Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement.	169
Correlation of coronary arteriograms and left ventriculograms with postmortem studies.	169
Glucocorticoid-Induced Granulocytosis	169
Remodeling of Sinus Node Function in Patients With Congestive Heart Failure	169
In vivo validation of a thermodilution method to determine regional left ventricular blood flow in patients with coronary disease.	169
Health-Related Quality of Life Is Better for Cardiac Arrest Survivors Who Received Citizen Cardiopulmonary Resuscitation	169
Effect of Low-Dose Aspirin on Vascular Inflammation, Plaque Stability, and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice	169
Radiation Exposure During Catheter Ablation of Atrial Fibrillation	169
Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women	169
Leptin Induces Hypertrophy via Endothelin-1–Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes	169
The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction.	169
Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography.	169
Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction.	168
Racial Profiling	168
Cyclic changes in arterial pulse during respiratory support.	168
Endothelial Replacement and Angiogenesis in Arteriosclerotic Lesions of Allografts Are Contributed by Circulating Progenitor Cells	168
Cardiac Doppler flow velocities in human fetuses.	168
Elevated endothelin-1 in heart failure and loss of normal response to postural change.	168
Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction.	168
Locus for Atrial Fibrillation Maps to Chromosome 6q14–16	168
Water Drinking Acutely Improves Orthostatic Tolerance in Healthy Subjects	168
Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias.	168
Reversal by Vasopressin of Intractable Hypotension in the Late Phase of Hemorrhagic Shock	168
Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.	168
Cocaine Use and the Likelihood of Nonfatal Myocardial Infarction and Stroke	168
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study	168
Effects of Recombinant Apolipoprotein A-I _Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice	168
Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension	168
Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation	168
Coffee Acutely Increases Sympathetic Nerve Activity and Blood Pressure Independently of Caffeine Content	168
Multivariate Assessment of Lipid Parameters as Predictors of Coronary Heart Disease Among Postmenopausal Women	168
Transient entrainment and interruption of the atrioventricular bypass pathway type of paroxysmal atrial tachycardia. A model for understanding and identifying reentrant arrhythmias.	168
Altered Complexity and Correlation Properties of R-R Interval Dynamics Before the Spontaneous Onset of Paroxysmal Atrial Fibrillation	168
Activated Platelets Induce Monocyte Chemotactic Protein-1 Secretion and Surface Expression of Intercellular Adhesion Molecule-1 on Endothelial Cells	168
Overexpression of the 5-Hydroxytryptamine Transporter Gene	168
Creation of an Atrial Septal Defect In Utero for Fetuses With Hypoplastic Left Heart Syndrome and Intact or Highly Restrictive Atrial Septum	168
β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction	168
Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.	168
Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL)	168
Ischemic, Hemodynamic, and Neurohormonal Responses to Mental and Exercise Stress	168
Trial of Abciximab With and Without Low-Dose Reteplase for Acute Myocardial Infarction	167
Toward a New Frontier in Myocardial Reperfusion Therapy	167
Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.	167
Type A behavior pattern and coronary atherosclerosis.	167
Endothelial Control of Arterial Distensibility Is Impaired in Chronic Heart Failure	167
Correlation between refractory periods and activation-recovery intervals from electrograms: effects of rate and adrenergic interventions.	167
Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries.	167
Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.	167
Pulmonary Autograft Procedure for Aortic Valve Disease	167
Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease.	167
Esophageal pacing: a diagnostic and therapeutic tool.	167
Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction	167
Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction.	167
Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and of 1132 after one year.	167
The Role of Nitric Oxide in Coronary Vascular Effects of Estrogen in Postmenopausal Women	167
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.	167
Nicotine Strongly Activates Dendritic Cell–Mediated Adaptive Immunity	167
Electrical Resynchronization	167
Comparison of Ultrasound and Cineangiographic Measurements of the Mean Rate of Circumferential Fiber Shortening in Man	167
Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease	167
Genetic Deficiency of Inducible Nitric Oxide Synthase Reduces Atherosclerosis and Lowers Plasma Lipid Peroxides in Apolipoprotein E–Knockout Mice	167
Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo	167
Visualization and Temporal/Spatial Characterization of Cardiac Radiofrequency Ablation Lesions Using Magnetic Resonance Imaging	167
Ventilatory and Heart Rate Responses to Exercise	167
Familial Hypertrophic Cardiomyopathy in Maine Coon Cats	167
Prognostic Significance of Heart Rate Variability in Post–Myocardial Infarction Patients in the Fibrinolytic Era	167
Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E–Deficient Mice	167
Characterization of Reentrant Circuits in Left Atrial Macroreentrant Tachycardia	167
Cardiovascular Disease Mortality in Familial Forms of Hypertriglyceridemia: A 20-Year Prospective Study	167
Impaired Collateral Vessel Development Associated With Reduced Expression of Vascular Endothelial Growth Factor in ApoE ^−/− Mice	167
The Ib Phase of Ventricular Arrhythmias in Ischemic In Situ Porcine Heart Is Related to Changes in Cell-to-Cell Electrical Coupling	167
Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease	167
Sustained Hemodynamic Efficacy of Therapy Tailored to Reduce Filling Pressures in Survivors With Advanced Heart Failure	167
Restoration of Diastolic Function in Senescent Rat Hearts Through Adenoviral Gene Transfer of Sarcoplasmic Reticulum Ca ²⁺ -ATPase	167
Probability of Middle-Aged Men Developing Coronary Heart Disease in Five Years	167
Quality of Life, Employment Status, and Anginal Symptoms After Coronary Angioplasty or Bypass Surgery	167
Influence of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor Gene Polymorphisms on Aortic Stiffness in Normotensive and Hypertensive Patients	167
Resuscitation Preferences Among Patients With Severe Congestive Heart Failure	167
Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns	167
Antiarrhythmic Effects of Polyunsaturated Fatty Acids	166
Genesis of Cardiac Arrhythmias	166
Stem Cell-Derived Cardiomyocytes Demonstrate Arrhythmic Potential	166
Anomalies Associated with Coarctation of Aorta Particular Reference to Infancy	166
Effects of diastolic transseptal pressure gradient on ventricular septal position and motion.	166
Preconditioning of Human Myocardium With Adenosine During Coronary Angioplasty	166
Angina Pectoris at Rest with Preservation of Exercise Capacity	166
Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function.	166
Sudden cardiac death. Support for a role of triggering in causation.	166
Cigarette Smoking Acutely Increases Platelet Thrombus Formation in Patients With Coronary Artery Disease Taking Aspirin	166
Echoventriculography -- a simultaneous analysis of two-dimensional echocardiography and cineventriculography.	166
Differential Pacing for Distinguishing Block From Persistent Conduction Through an Ablation Line	166
In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans.	166
Stent and Artery Geometry Determine Intimal Thickening Independent of Arterial Injury	166
Selective Pharmacological Agents Implicate Mitochondrial but Not Sarcolemmal K _ATP Channels in Ischemic Cardioprotection	166
Aberrant coronary artery origin from the aorta. Report of 18 patients, review of literature and delineation of natural history and management.	166
Power spectrum analysis of heart rate variability in human cardiac transplant recipients.	166
Androgen Exposure Increases Human Monocyte Adhesion to Vascular Endothelium and Endothelial Cell Expression of Vascular Cell Adhesion Molecule-1	166
Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits	166
Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis.	166
Insulin Prevents Cardiomyocytes From Oxidative Stress–Induced Apoptosis Through Activation of PI3 Kinase/ Akt	166
Contribution of Collagen, Elastin, and Smooth Muscle to In Vivo Human Brachial Artery Wall Stress and Elastic Modulus	166
Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure	166
Transforming Growth Factor-β Receptor Mutations and Pulmonary Arterial Hypertension in Childhood	166
Characterization of Sodium Channel α- and β-Subunits in Rat and Mouse Cardiac Myocytes	166
Third-Generation β-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux	166
Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene	166
Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients	166
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.	166
Comparison of Surgical and Medical Group Survival in Patients With Left Main Equivalent Coronary Artery Disease	166
Relationship Between Diabetes Mellitus and Long-term Survival After Coronary Bypass and Angioplasty	166
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.	166
Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene	166
TNK-Tissue Plasminogen Activator in Acute Myocardial Infarction	166
The Carotid Sinus	165
Dynamic Responses of the Right Ventricle following Extensive Damage by Cauterization	165
Spiral Computed Tomography for Acute Pulmonary Embolism	165
Development of coronary heart disease in familial hypercholesterolemia.	165
Two-dimensional echocardiographic assessment of mitral stenosis.	165
The first decade of aortocoronary bypass grafting, 1967-1977. A review.	165
Flow-mediated and reflex changes in large peripheral artery tone in humans.	165
Left Ventricular Performance Following Correction of Free Aortic Regurgitation	165
Formation of the Tricuspid Valve in the Human Heart	165
AMP-Activated Protein Kinase Inhibits Angiotensin II–Stimulated Vascular Smooth Muscle Cell Proliferation	165
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.	165
Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation.	165
Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis.	165
Inflammation as a Possible Link Between Coronary and Carotid Plaque Instability	165
Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis.	165
Improved Vascular Endothelial Function After Oral B Vitamins	165
Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.	165
Transvenous Closure of Secundum Atrial Septal Defects	165
Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and α _v β ₃	165
Flow-Induced Dilation of Human Coronary Arterioles	165
Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription	165
Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits	165
Ciprofibrate Therapy Improves Endothelial Function and Reduces Postprandial Lipemia and Oxidative Stress in Type 2 Diabetes Mellitus	165
Early Surgery in Patients With Mitral Regurgitation Due to Flail Leaflets	165
Outcomes and Long-Term Survival for Patients Undergoing Mitral Valve Repair Versus Replacement	165
Membrane Type 1 Matrix Metalloproteinase Expression in Human Atherosclerotic Plaques	165
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.	165
Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts	165
Enhanced Susceptibility for Acquired Torsade de Pointes Arrhythmias in the Dog With Chronic, Complete AV Block Is Related to Cardiac Hypertrophy and Electrical Remodeling	165
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction	165
Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction	165
Fine Structure of the His Bundle	164
Left Axis Deviation	164
Digoxin sensitivity in amyloid cardiomyopathy.	164
Serotonin Is Associated with Coronary Artery Disease and Cardiac Events	164
Survivorship patterns in the posthospital phase of myocardial infarction.	164
Detection of Hypokinesis by a Quantitative Analysis of Left Ventricular Cineangiograms	164
Prognosis in medically-treated coronary artery disease: influence of ejection fraction compared to other parameters.	164
Pressure Gradients without Obstruction	164
Aminorex, Fenfluramine, and Chlorphentermine Are Serotonin Transporter Substrates	164
Amplified Transmural Dispersion of Repolarization as the Basis for Arrhythmogenesis in a Canine Ventricular-Wedge Model of Short-QT Syndrome	164
Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction.	164
Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction.	164
Vascular Extracellular Superoxide Dismutase Activity in Patients With Coronary Artery Disease	164
Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia.	164
Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.	164
Hyperparathyroidism and the Calcium Paradox of Aldosteronism	164
Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression	164
Association Between Enhanced Soluble CD40L and Prothrombotic State in Hypercholesterolemia	164
Early Endothelial Dysfunction Predicts the Development of Transplant Coronary Artery Disease at 1 Year Posttransplant	164
Magnetic Resonance Imaging Assessment of the Severity of Mitral Regurgitation	164
LocaLisa	164
The early recognition of right ventricular infarction: diagnostic accuracy of the electrocardiographic V4R lead.	164
Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: reversal after coronary angioplasty.	164
Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging	164
Reverse Remodeling From Cardiomyoplasty in Human Heart Failure	164
Matrix-Dependent Mechanism of Neutrophil-Mediated Release and Activation of Matrix Metalloproteinase 9 in Myocardial Ischemia/Reperfusion	164
Reactive Oxygen Species Are Involved in Smoking-Induced Dysfunction of Nitric Oxide Biosynthesis and Upregulation of Endothelial Nitric Oxide Synthase	164
Downregulation of Delayed Rectifier K ⁺ Currents in Dogs With Chronic Complete Atrioventricular Block and Acquired Torsades de Pointes	164
Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.	164
Using Peripheral Blood Mononuclear Cells to Determine a Gene Expression Profile of Acute Ischemic Stroke	164
Investigation of Vascular Responses in Endothelial Nitric Oxide Synthase/Cyclooxygenase-1 Double-Knockout Mice	164
Changes in intracardiac blood flow velocities and right and left ventricular stroke volumes with gestational age in the normal human fetus: a prospective Doppler echocardiographic study.	164
Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016	164
Patient Selection for Cardiac Resynchronization Therapy	164
Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association	164
Evaluation of Left Ventricular Function by Echocardiography	163
Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording.	163
Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis.	163
The Electric Field of an Eccentric Dipole in a Homogeneous Spherical Conducting Medium	163
Anaphylactic and Anaphylactoid Reactions Associated With Lepirudin in Patients With Heparin-Induced Thrombocytopenia	163
Pulmonary atresia and intact ventricular septum: a revised classification.	163
The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture.	163
Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis.	163
Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.	163
Effect of Coronary Artery Diameter in Patients Undergoing Coronary Bypass Surgery	163
Natural History of Hypertrophic Cardiomyopathy	163
Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study.	163
Hyperinsulinemia and Autonomic Nervous System Dysfunction in Obesity	163
Clinical features of amiodarone-induced pulmonary toxicity.	163
Subclinical Disease as an Independent Risk Factor for Cardiovascular Disease	163
The effects of graded doses of epinephrine on regional myocardial blood flow during cardiopulmonary resuscitation in swine.	163
Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting.	163
Intravascular ultrasound imaging of coronary arteries. Is three layers the norm?	163
A randomized comparison of external and internal cardioversion of chronic atrial fibrillation.	163
Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure	163
Intraoperative Coronary Collateral Function in Patients With Coronary Occlusive Disease	163
Vascular Effects of Estrogen and Cholesterol-Lowering Therapies in Hypercholesterolemic Postmenopausal Women	163
Diastolic Dysfunction in Hypertensive Heart Disease Is Associated With Altered Myocardial Metabolism	163
Accelerated Restitution of Endothelial Integrity and Endothelium-Dependent Function After phVEGF ₁₆₅ Gene Transfer	163
Increased Bioavailability of Nitric Oxide After Lipid-Lowering Therapy in Hypercholesterolemic Patients	163
Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma	163
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disea	163
The Importance of Identification of the Myocardial-Specific Isoenzyme of Creatine Phosphokinase (MB Form) in the Diagnosis of Acute Myocardial Infarction	163
Inhibitory Role of Plasminogen Activator Inhibitor-1 in Arterial Wound Healing and Neointima Formation	163
Improved Survival With Radial Artery Versus Vein Conduits in Coronary Bypass Surgery With Left Internal Thoracic Artery to Left Anterior Descending Artery Grafting	163
Death Following Creatine Kinase-MB Elevation After Coronary Intervention	163
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver	163
Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction	163
Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy	163
Endothelin Receptor Blockers in Cardiovascular Disease	162
Failure of Intracoronary Nitroglycerin to Alleviate Pacing-Induced Angina	162
A Vascular Abnormality in Hypertension	162
Death and other time-related events after valve replacement.	162
Responses of GLUT4-Deficient Hearts to Ischemia Underscore the Importance of Glycolysis	162
Protective Role of Angiopoietin-1 in Endotoxic Shock	162
Dietary salt intake. A determinant of cardiac involvement in essential hypertension.	162
Activation of gp130 Transduces Hypertrophic Signals via STAT3 in Cardiac Myocytes	162
Relation of Body Weight to Development of Coronary Heart Disease	162
Normalization of Diastolic Dysfunction in Aortic Stenosis Late After Valve Replacement	162
Regional Differences in Electrophysiological Properties of Epicardium, Midmyocardium, and Endocardium	162
Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.	162
The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion.	162
Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy	162
Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.	162
Activation of the Heart by Donor Brain Death Accelerates Acute Rejection After Transplantation	162
Improved efficiency of treadmill exercise testing using a multiple lead ECG system and basic hemodynamic exercise response.	162
Long-Term Results of the Radial Artery Used for Myocardial Revascularization	162
High Pressure Induces Superoxide Production in Isolated Arteries Via Protein Kinase C–Dependent Activation of NAD(P)H Oxidase	162
Prevention of Bioprosthetic Heart Valve Calcification by Ethanol Preincubation	162
Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.	162
Reduced Alveolar–Capillary Membrane Diffusing Capacity in Chronic Heart Failure	162
Assisted Ventilation Does Not Improve Outcome in a Porcine Model of Single-Rescuer Bystander Cardiopulmonary Resuscitation	162
Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation	162
Association of Serum Antibodies to Heat-Shock Protein 65 With Carotid Atherosclerosis	162
Astroglial Protein S-100 Is an Early and Sensitive Marker of Hypoxic Brain Damage and Outcome After Cardiac Arrest in Humans	162
Effect of Body Size, Ponderosity, and Blood Pressure on Left Ventricular Growth in Children and Young Adults in the Bogalusa Heart Study	162
Time to Presentation With Acute Myocardial Infarction in the Elderly	162
Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.	162
Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null Mice	162
Exaggerated Blood Pressure Responses During Mental Stress Are Associated With Enhanced Carotid Atherosclerosis in Middle-Aged Finnish Men	162
Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy	162
In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent	162
Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy	162
Reversal of Reflex-Induced Myocardial Ischemia by Median Nerve Stimulation	161
Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction	161
Persistent Elevation of Plasma Insulin Levels Is Associated With Increased Cardiovascular Risk in Children and Young Adults	161
A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis	161
Ischemia-Induced Coronary Collateral Growth Is Dependent on Vascular Endothelial Growth Factor and Nitric Oxide	161
Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment	161
Computerized image analysis for quantitative measurement of vessel diameter from cineangiograms.	161
Reduction of Serum Cholesterol in Postmenopausal Women With Previous Myocardial Infarction and Cholesterol Malabsorption Induced by Dietary Sitostanol Ester Margarine	161
Coronary Calcium, as Determined by Electron Beam Computed Tomography, and Coronary Disease on Arteriogram	161
Screening of Obstructive Sleep Apnea Syndrome by Heart Rate Variability Analysis	161
Silent Cerebral Infarction in Patients With Nonrheumatic Atrial Fibrillation	161
Quantitation of regional cardiac function by two-dimensional echocardiography. I. Patterns of contraction in the normal left ventricle.	161
Alteration of the left ventricular diastolic pressure-segment length relation produced by the pericardium. Effects of cardiac distension and afterload reduction in conscious dogs.	161
Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease.	161
Effects of Walking on Coronary Heart Disease in Elderly Men	161
Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis	161
Relation of Body Mass Index and Insulin Resistance to Cardiovascular Risk Factors, Inflammatory Factors, and Oxidative Stress During Adolescence	161
A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.	161
Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.	161
Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.	161
Normalization of bundle branch block patterns by distal His bundle pacing. Clinical and experimental evidence of longitudinal dissociation in the pathologic his bundle.	161
Gene for Arrhythmogenic Right Ventricular Cardiomyopathy With Diffuse Nonepidermolytic Palmoplantar Keratoderma and Woolly Hair (Naxos Disease) Maps to 17q21	161
Amiodarone Interaction With β-Blockers	161
Region- and Type-Specific Induction of Matrix Metalloproteinases in Post–Myocardial Infarction Remodeling	161
Sinoatrial Node Dysfunction and Early Unexpected Death of Mice With a Defect of klotho Gene Expression	161
Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease	161
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association	161
Sleep and Ventricular Premature Beats	161
Hemodynamics of Uremic Anemia	161
Determinants of infarct size in reperfusion therapy for acute myocardial infarction.	161
A perspective of coronary disease seen through the arteries of living man.	161
Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates.	161
Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human Hearts	161
Association of Fibrinolytic Parameters With Early Atherosclerosis	161
Association of Type 2 Diabetes With Cyclooxygenase-Mediated Inflammation and Oxidative Stress in an Elderly Population	161
Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling.	161
Critical Assessment of Use of Central Venous Oxygen Saturation as a Mirror of Mixed Venous Oxygen in Severely Ill Cardiac Patients	161
Initial Ventricular Impulse	160
Systemic vascular resistance: an unreliable index of left ventricular afterload.	160
Hydraulic estimation of stenotic orifice area: a correction of the Gorlin formula.	160
Neutrophil Elastase in Human Atherosclerotic Plaques	160
Intraventricular early diastolic filling during acute myocardial ischemia, assessment by multigated color m-mode Doppler echocardiography.	160
The Corrected Orthogonal Electrocardiogram and Vectorcardiogram in 510 Normal Men (Frank Lead System)	160
Left Ventricular Function in Acute Myocardial Infarction Evaluated by Gated Scintiphotography	160
Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity.	160
Impact of a Molecular Approach to Improve the Microbiological Diagnosis of Infective Heart Valve Endocarditis	160
Anomalous Origin of the Left Circumflex Coronary Artery	160
Inflammation in the Prediabetic State Is Related to Increased Insulin Resistance Rather Than Decreased Insulin Secretion	160
Extracellular Matrix Changes in Stented Human Coronary Arteries	160
Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction.	160
Functional Changes in Coronary Microcirculation After Valve Replacement in Patients With Aortic Stenosis	160
Upregulation of Vascular Angiotensin II Receptor Gene Expression by Low-Density Lipoprotein in Vascular Smooth Muscle Cells	160
Usefulness of transesophageal echocardiography in assessment of aortic dissection.	160
Speed of Intracranial Clot Lysis With Intravenous Tissue Plasminogen Activator Therapy	160
Identification of α-Chloro Fatty Aldehydes and Unsaturated Lysophosphatidylcholine Molecular Species in Human Atherosclerotic Lesions	160
Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans	160
Identification of Active Tissue Factor in Human Coronary Atheroma	160
Cryosurgical ablation of the A-V node-His bundle: a new method for producing A-V block.	160
Patients With Depressive Symptoms Have Lower Health Status Benefits After Coronary Artery Bypass Surgery	160
Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis	160
Low Dietary Folate Intake Is Associated With an Excess Incidence of Acute Coronary Events	160
Interindividual Heterogeneity in the Hypoxic Regulation of VEGF	160
Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients With Peripheral Arterial Disease and Type 2 Diabetes	160
Long-Term Follow-Up of Aortic Intramural Hematoma	160
Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat	160
Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits	160
Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.	160
Metoprolol CR/XL in Female Patients With Heart Failure	160
Assessment of Cardiac Function by Three-dimensional Echocardiography Compared With Conventional Noninvasive Methods	160
The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function.	160
l -Arginine Treatment Alters the Kinetics of Nitric Oxide and Superoxide Release and Reduces Ischemia/Reperfusion Injury in Skeletal Muscle	160
Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis	160
Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)	160
Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis	160
Intravascular Ultrasound Analysis of Infarct-Related and Non–Infarct-Related Arteries in Patients Who Presented With an Acute Myocardial Infarction	160
Nebivolol: A Third-Generation β-Blocker That Augments Vascular Nitric Oxide Release	160
Randomized Trial of ⁹⁰ Sr/ ⁹⁰ Y β-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis	160
Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.	159
The Reduction of Infarct Size — An Idea Whose Time (For Testing) Has Come	159
A mathematical model of parasystole and its application to clinical arrhythmias.	159
Ozone Air Pollution Is Associated With Acute Myocardial Infarction	159
Acute Aortic Dissection Related to Crack Cocaine	159
Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring.	159
Serum lipoprotein profile in children from a biracial community: the Bogalusa Heart Study.	159
Assessment of Sinus Node Function in Patients with the Sick Sinus Syndrome	159
The influence of verapamil on serum digoxin concentration.	159
Hemodynamic Spectrum of Myocardial Infarction and Cardiogenic Shock	159
Total, LDL, and HDL Cholesterol Decrease With Age in Older Men and Women	159
Overexpression of Thioredoxin-1 in Transgenic Mice Attenuates Adriamycin-Induced Cardiotoxicity	159
The Antiarrhythmic Properties of Lidocaine and Procaine Amide	159
Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction	159
Exploration of the Precision of Classifying Sudden Cardiac Death	159
Diagnosis and management of right ventricle-dependent coronary circulation in pulmonary atresia with intact ventricular septum.	159
Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.	159
B-Type Natriuretic Peptide and Ischemia in Patients With Stable Coronary Disease	159
Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock.	159
Endothelium-Dependent Dilatation Is Impaired in Young Healthy Subjects With a Family History of Premature Coronary Disease	159
Mitochondrial Ca ²⁺ -Activated K ⁺ Channels in Cardiac Myocytes	159
17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine.	159
Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E–Deficient Mice	159
Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment.	159
Obesity and Risk of Adverse Outcomes Associated With Coronary Artery Bypass Surgery	159
Nitric Oxide Modulates Expression of Cell Cycle Regulatory Proteins	159
Cardiac-Specific Overexpression of Tumor Necrosis Factor-α Causes Oxidative Stress and Contractile Dysfunction in Mouse Diaphragm	159
Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)	159
Heterozygous Cellular Glutathione Peroxidase Deficiency in the Mouse	159
Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction	159
The Hemodynamic Response to Chronic Anemia	158
Prosthetic Valvular Endocarditis	158
Digoxin in the Management of Cardiovascular Disorders	158
Some Clinical Features of Complete Heart Block	158
Site of Reentry in Paroxysmal Supraventricular Tachycardia in Man	158
Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.	158
Serum Enzyme Determinations in the Diagnosis and Assessment of Myocardial Infarction	158
The clinical significance of exercise-induced ST-segment elevation.	158
Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers	158
Late Cardiac Complications of Chronic, Severe, Refractory Anemia with Hemochromatosis	158
Right ventricular performance in patients with coronary artery disease.	158
An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.	158
Sensitivity and specificity of hemodynamic criteria in the diagnosis of acute right ventricular infarction.	158
Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator	158
Prominent Role of P-Selectin in the Development of Advanced Atherosclerosis in ApoE-Deficient Mice	158
Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.	158
Long-Term Thiazide Therapy in Essential Hypertension	158
Premature ventricular complexes in the absence of identifiable heart disease.	158
Expression of NADH/NADPH Oxidase p22 ^phox in Human Coronary Arteries	158
Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal Disease	158
Overexpression of Heat Shock Protein 72 in Transgenic Mice Decreases Infarct Size In Vivo	158
Augmented Sympathetic Activation During Short-Term Hypoxia and High-Altitude Exposure in Subjects Susceptible to High-Altitude Pulmonary Edema	158
Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography.	158
Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.	158
Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted freehand in the aortic position.	158
Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction	158
Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community.	158
Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury.	158
Early and Intermediate Outcomes After Repair of Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries	158
Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese.	158
Alternation in the Coronary Blood Flow Velocity Pattern in Patients With No Reflow and Reperfused Acute Myocardial Infarction	158
Disparate Effects of Deficient Expression of Connexin43 on Atrial and Ventricular Conduction	158
Cardiogenic Shock in Patients With Acute Ischemic Syndromes With and Without ST-Segment Elevation	158
Bridge Experience With Long-term Implantable Left Ventricular Assist Devices	158
Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia	158
Clearance of Tissue Plasminogen Activator (TPA) and TPA/Plasminogen Activator Inhibitor Type 1 (PAI-1) Complex	158
Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation.	158
Final Results of the Balloon vs Optimal Atherectomy Trial (BOAT)	158
Increased Formation of the Isoprostanes IPF _2α -I and 8-Epi-Prostaglandin F _2α in Acute Coronary Angioplasty	158
Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease	158
Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hy	158
Assessment of Myocardial Reperfusion by Intravenous Myocardial Contrast Echocardiography and Coronary Flow Reserve After Primary Percutaneous Transluminal Coronary Angiography in Patients With Acute M	158
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging	158
Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions	158
Stem Cell Therapy in Perspective	157
Effect of endothelin-1 in man.	157
Cryosurgical treatment of atrioventricular node reentrant tachycardia.	157
Ultrasonic Cardiac Echography for Determining Stroke Volume and Valvular Regurgitation	157
Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy	157
Role of adenosine in pathogenesis of anginal pain.	157
Effect of myocardial fiber direction on epicardial potentials.	157
Heritability of Heart Rate Variability	157
Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects	157
Asymptomatic Peripheral Arterial Disease Is Independently Associated With Impaired Lower Extremity Functioning	157
Endothelial Release of Nitric Oxide Contributes to the Vasodilator Effect of Adenosine in Humans	157
Troponin I Phosphorylation in the Normal and Failing Adult Human Heart	157
A simplified, single-lead unipolar transvenous cardioversion-defibrillation system.	157
Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events.	157
Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation	157
Angiotensin II Type 2 Receptor–Mediated Vasodilation in Human Coronary Microarteries	157
Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. A paradoxic and unexpected response.	157
Predictive Power of the Relative Lymphocyte Concentration in Patients With Advanced Heart Failure	157
Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium.	157
High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.	157
Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias.	157
Noninvasive prediction of transvalvular pressure gradient in patients with pulmonary stenosis by quantitative two-dimensional echocardiographic Doppler studies.	157
Allopurinol Attenuates Left Ventricular Remodeling and Dysfunction After Experimental Myocardial Infarction	157
Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty.	157
Endothelial Cell Markers and the Risk of Coronary Heart Disease	157
Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease	157
Altered Stoichiometry of FKBP12.6 Versus Ryanodine Receptor as a Cause of Abnormal Ca ²⁺ Leak Through Ryanodine Receptor in Heart Failure	157
Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study	157
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice	157
Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality	157
Unstable Angina	156
Ernest Henry Starling, His Predecessors, and the “Law of the Heart”	156
Hemodynamic effects of nitroglycerin in acute myocardial infarction.	156
The Degree of Coronary Atherosclerosis in Bilaterally Oophorectomized Women	156
Cardiac Membrane Fatty Acid Composition Modulates Myocardial Oxygen Consumption and Postischemic Recovery of Contractile Function	156
Comparative Ultrastructure of the Sinus Node in Man and Dog	156
Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure.	156
Long-Term Survival After Surgical Treatment of Patients With Takayasu’s Arteritis	156
Rest and exercise hemodynamics after the Fontan procedure.	156
Ultrasound-Guided Thrombin Injection for the Treatment of Postcatheterization Pseudoaneurysms	156
Fas-Mediated Apoptosis in Adriamycin-Induced Cardiomyopathy in Rats	156
Adverse Events With Transvenous Implantable Cardioverter-Defibrillators	156
Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.	156
Radiofrequency Ablation of Intra-Atrial Reentrant Tachycardia After Surgical Palliation of Congenital Heart Disease	156
Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism	156
Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia.	156
Mobile Thromboses of the Aortic Arch Without Aortic Debris	156
Lipoprotein Oxidation and Progression of Carotid Atherosclerosis	156
Prevention of Rat Cerebral Aneurysm Formation by Inhibition of Nitric Oxide Synthase	156
Basic structure-function relations of the epicardial coronary vascular tree. Basis of quantitative coronary arteriography for diffuse coronary artery disease.	156
Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function.	156
Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.	156
Crucial Role of Stromal Cell–Derived Factor-1α in Neointima Formation After Vascular Injury in Apolipoprotein E–Deficient Mice	156
Two Types of Ventricular Fibrillation in Isolated Rabbit Hearts	156
Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.	156
Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.	156
Additive Protection of the Ischemic Heart Ex Vivo by Combined Treatment With δ-Protein Kinase C Inhibitor and ε-Protein Kinase C Activator	156
Effect of the ACE Inhibitor Lisinopril on Mortality in Diabetic Patients With Acute Myocardial Infarction	156
Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells	156
Deletion Allele of Angiotensin-Converting Enzyme Gene Increases Risk of Essential Hypertension in Japanese Men	156
Effects of Beta Adrenergic Blockade on the Circulation, with Particular Reference to Observations in Patients with Hypertrophic Subaortic Stenosis	156
Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin.	156
Recombinant Human Antibodies Against Aldehyde-Modified Apolipoprotein B-100 Peptide Sequences Inhibit Atherosclerosis	156
Failure to Improve Left Ventricular Function After Coronary Revascularization for Ischemic Cardiomyopathy Is Not Associated With Worse Outcome	156
Requirement of Nuclear Factor-κB in Angiotensin II– and Isoproterenol-Induced Cardiac Hypertrophy In Vivo	156
Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up.	156
Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance.	156
Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling	156
Overexpression of Transforming Growth Factor-β1 and Insulin-Like Growth Factor-I in Patients With Idiopathic Hypertrophic Cardiomyopathy	156
Local Inhibition of Tissue Factor Reduces the Thrombogenicity of Disrupted Human Atherosclerotic Plaques	156
Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone.	156
Maximally Recommended Doses of Angiotensin-Converting Enzyme (ACE) Inhibitors Do Not Completely Prevent ACE-Mediated Formation of Angiotensin II in Chronic Heart Failure	156
Stroke Complicating Percutaneous Coronary Interventions	156
Heart Failure and Echocardiographic Changes During Long-term Follow-up of Patients With Sick Sinus Syndrome Randomized to Single-Chamber Atrial or Ventricular Pacing	156
Functional Variant of CYP4A11 20-Hydroxyeicosatetraenoic Acid Synthase Is Associated With Essential Hypertension	156
Sex, Age, and Disease Affect Echocardiographic Left Ventricular Mass and Systolic Function in the Free-Living Elderly	156
Outcomes in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in the Current Era	155
Coronary Revascularization in Diabetic Patients	155
True 3-Dimensional Reconstruction of Coronary Arteries in Patients by Fusion of Angiography and IVUS (ANGUS) and Its Quantitative Validation	155
Pulmonary Vein Morphology in Patients With Paroxysmal Atrial Fibrillation Initiated by Ectopic Beats Originating From the Pulmonary Veins	155
Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E–Deficient Mice	155
Some unexpected lessons from large multicenter randomized clinical trials.	155
Coronary Heart Disease and Iron Status	155
Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.	155
Phosphatidylinositol-3-Kinase Signaling Is Required for Erythropoietin-Mediated Acute Protection Against Myocardial Ischemia/Reperfusion Injury	155
Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.	155
Plasma Adenosine Levels Increase in Patients With Chronic Heart Failure	155
Smoking Is Associated With Reduced Serum Paraoxonase Activity and Concentration in Patients With Coronary Artery Disease	155
Estrogen Reduces Myointimal Proliferation After Balloon Injury of Rat Carotid Artery	155
Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis.	155
Unstable Angina	155
Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men	155
Natural History of Rheumatic Aortic Regurgitation	155
Enhanced Sympathetic and Ventilatory Responses to Central Chemoreflex Activation in Heart Failure	155
Apelin Has In Vivo Inotropic Effects on Normal and Failing Hearts	155
Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation	155
Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion deficits.	155
Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry.	155
Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging–Monitored Therapy	155
Enlarged Waist Combined With Elevated Triglycerides Is a Strong Predictor of Accelerated Atherogenesis and Related Cardiovascular Mortality in Postmenopausal Women	155
Reactivity of the Human Fetal Pulmonary Circulation to Maternal Hyperoxygenation Increases During the Second Half of Pregnancy	155
Combined Use of Computed Tomography Coronary Calcium Scores and C-Reactive Protein Levels in Predicting Cardiovascular Events in Nondiabetic Individuals	155
A Comparison of Regional Blood Flow and Oxygen Utilization During Dynamic Forearm Exercise in Normal Subjects and Patients with Congestive Heart Failure	155
Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina.	155
Taurine Supplementation Reduces Oxidative Stress and Improves Cardiovascular Function in an Iron-Overload Murine Model	155
Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients.	155
Postnatal Recapitulation of Embryonic Hedgehog Pathway in Response to Skeletal Muscle Ischemia	155
Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation	155
Induction of Atherosclerotic Plaque Rupture in Apolipoprotein E ^−/− Mice After Adenovirus-Mediated Transfer of p53	155
Prevention Conference VII	155
Papillary Muscle Displacement Causes Systolic Anterior Motion of the Mitral Valve	155
Sex differences in the management and long-term outcome of acute myocardial infarction. A statewide study. MIDAS Study Group. Myocardial Infarction Data Acquisition System.	155
Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography	155
Endothelial Dysfunction and Damage in Congestive Heart Failure	155
AT ₁ Receptor Agonistic Antibodies From Preeclamptic Patients Cause Vascular Cells to Express Tissue Factor	155
Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial Fibrillation	155
Addition of Angiotensin II Receptor Blockade to Maximal Angiotensin-Converting Enzyme Inhibition Improves Exercise Capacity in Patients With Severe Congestive Heart Failure	155
Integrated Analysis of Myocardial Blush and ST-Segment Elevation Recovery After Successful Primary Angioplasty	155
Differential Effects of the Cyclin-Dependent Kinase Inhibitors p27 ^Kip1 , p21 ^Cip1 , and p16 ^Ink4	155
N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary Syndromes	155
Exercise capacity in patients with severe left ventricular dysfunction.	154
Maximal Treadmill Exercise Electrocardiography	154
Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?	154
Effects of Metoprolol CR in Patients With Ischemic and Dilated Cardiomyopathy	154
Sequence of retrograde atrial activation in patients with dual atrioventricular nodal pathways.	154
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events	154
External noninvasive temporary cardiac pacing: clinical trials.	154
Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction.	154
Myocardial Revascularization With Laser	154
Endothelial dysfunction in patients with chest pain and normal coronary arteries.	154
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.	154
LDL subclass phenotypes and the insulin resistance syndrome in women.	154
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.	154
Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina Pectoris	154
Pulsed Doppler: diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension.	154
Reat-time inferior vena caval ultrasonography: normal and abnormal findings and its use in assessing right-heart function.	154
Effects of Exercise and Respiration on Blood Flow in Total Cavopulmonary Connection	154
Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice	154
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.	154
Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation.	154
Wine and Your Heart	154
Heterozygosity for a Hereditary Hemochromatosis Gene Is Associated With Cardiovascular Death in Women	154
Angiotensin II Stimulates Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Human Vascular Endothelial Cells and Increases Soluble ICAM-1 Release In Vivo	154
Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults.	154
Gene Expression of Brain Natriuretic Peptide in Isolated Atrial and Ventricular Human Myocardium	154
Biological Pacemaker Implanted in Canine Left Bundle Branch Provides Ventricular Escape Rhythms That Have Physiologically Acceptable Rates	154
Reverse Remodeling of Sinus Node Function After Catheter Ablation of Atrial Fibrillation in Patients With Prolonged Sinus Pauses	154
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial	154
Utstein-Style Guidelines for Uniform Reporting of Laboratory CPR Research	154
Coronary Physiology Revisited	153
Diagnosis of Atrial Tumors by Ultrasound	153
Expansion of acute myocardial infarction: an experimental study.	153
The Syndrome of Severe Mitral Regurgitation with Normal Left Atrial Pressure	153
Treatment of Acute Bacterial Endocarditis by Valve Excision and Replacement	153
Systolic Hypertension in the Elderly	153
Cardiac imaging using a phased array ultrasound system. II. Clinical technique and application.	153
Cardiac performance and mortality early after intracardiac surgery in infants and young children.	153
Enalapril Does Not Enhance Exercise Capacity in Patients After Fontan Procedure	153
CD40 Ligand Inhibits Endothelial Cell Migration by Increasing Production of Endothelial Reactive Oxygen Species	153
Right Bundle Branch Block, Right Precordial ST-Segment Elevation, and Sudden Death in Young People	153
The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis.	153
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia	153
Transient Triglyceridemia Decreases Vascular Reactivity in Young, Healthy Men Without Risk Factors for Coronary Heart Disease	153
Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators.	153
Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects	153
Blood Lipids and Human Atherosclerosis	153
Relationship to Blood Pressure of Combinations of Dietary Macronutrients	153
Effects of Autonomic Neuropathy on Coronary Blood Flow in Patients With Diabetes Mellitus	153
Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology.	153
Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.	153
Epicardial Activation of Left Ventricular Wall Prolongs QT Interval and Transmural Dispersion of Repolarization	153
Effects of Ramipril on Plasma Fibrinolytic Balance in Patients With Acute Anterior Myocardial Infarction	153
Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area.	153
Double-Blind, Randomized Controlled Trial on the Effect of Leukocyte-Depleted Erythrocyte Transfusions in Cardiac Valve Surgery	153
Drug Therapy in the Heart Transplant Recipient	153
Genetic and Environmental Contributions to Platelet Aggregation	153
Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials.	153
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.	153
Dobutamine Echocardiography Predicts Improvement of Hypoperfused Dysfunctional Myocardium After Revascularization in Patients With Coronary Artery Disease	153
Outcomes of Coronary Artery Bypass Graft Surgery in 24 461 Patients Aged 80 Years or Older	153
Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries	153
Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval.	153
Common Carotid Artery Intima-Media Thickness and Brain Infarction	153
Aldosterone Induces Angiotensin-Converting-Enzyme Gene Expression in Cultured Neonatal Rat Cardiocytes	153
Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease	153
Human Endothelial Nitric Oxide Synthase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation After Balloon Injury in Rats	153
In Vivo Induction of Endothelial Apoptosis Leads to Vessel Thrombosis and Endothelial Denudation	153
Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients	153
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II	153
Increased Oxidative Stress and Platelet Activation in Patients With Hypertension and Renovascular Disease	153
Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis	153
Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method.	153
Endotoxin-Induced Mortality Is Related to Increased Oxidative Stress and End-Organ Dysfunction, Not Refractory Hypotension, in Heme Oxygenase-1–Deficient Mice	153
Prognostic Impact of Early ST-Segment Resolution in Acute ST-Elevation Myocardial Infarction	152
Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry?	152
Endogenous Cell Seeding	152
Modulation of Doxorubicin-Induced Cardiac Dysfunction in Toll-Like Receptor-2–Knockout Mice	152
Sustained Effects of Nitroglycerin Ointment in Patients with Angina Pectoris	152
False positive diagnostic tests and coronary angiographic findings in 105 presumably healthy males.	152
Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.	152
Mechanisms Underlying Spontaneous and Induced Ventricular Arrhythmias in Patients With Idiopathic Dilated Cardiomyopathy	152
Determinants of hemodynamic compromise with severe right ventricular infarction.	152
Combined doppler and phased-array echocardiographic estimation of cardiac output.	152
Quantification of relative coronary arterial stenosis by cinevideodensitometric analysis of coronary arteriograms.	152
The Pathophysiology of Malignant Ventricular Arrhythmias During Acute Myocardial Ischemia	152
Extent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy	152
Clinical course of patients with normal or slightly or moderately abnormal coronary arteriograms: 10-year follow-up of 521 patients.	152
Effects of ergonovine in patients with and without coronary artery disease.	152
Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease.	152
β-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes	152
Coronary Heart Disease in Smokers	152
Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection	152
Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood	152
Indications, complications, and short-term clinical outcome of percutaneous transvenous mitral commissurotomy.	152
Cardiac Sympathetic Dysinnervation in Diabetes	152
Different Prognostic Impact of 24-Hour Mean Blood Pressure and Pulse Pressure on Stroke and Coronary Artery Disease in Essential Hypertension	152
Effects of Nonlipid Risk Factors on Atherosclerosis in Youth With a Favorable Lipoprotein Profile	152
Functional Role of Phosphodiesterase 3 in Cardiomyocyte Apoptosis	152
Coronary Sinus-Ventricular Accessory Connections Producing Posteroseptal and Left Posterior Accessory Pathways	152
Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients.	152
Design of a New Surgical Approach for Ventricular Remodeling to Relieve Ischemic Mitral Regurgitation	152
Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays	152
Single-Cell Analysis of the Normal Mouse Aorta Reveals Functionally Distinct Endothelial Cell Populations	152
Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Card	152
Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment–Elevation Myocardial Infarction	152
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Associat	152
Noninvasive assessment and differentiation of left ventricular outflow obstruction with Doppler ultrasound.	151
George Lyman Duff Memorial Lecture. Lifestyles, major risk factors, proof and public policy.	151
Survivors of Out-of-Hospital Cardiac Arrest With Apparently Normal Heart	151
Clinical Features and Prognosis in Dissecting Aneurysm of the Aorta	151
Temperature of the Great Toe as an Indication of the Severity of Shock	151
Hemodynamic Consequences of the Injection of Radiopaque Material	151
Differential Distribution of Inward Rectifier Potassium Channel Transcripts in Human Atrium Versus Ventricle	151
Human Atherosclerotic Plaques Contain Gamma-Glutamyl Transpeptidase Enzyme Activity	151
Exercise-induced ischemia: the influence of altered relaxation on early diastolic pressures.	151
Reduced Coronary Flow Reserve in Hypercholesterolemic Patients Without Overt Coronary Stenosis	151
Chronic Orthostatic Intolerance	151
The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis.	151
Circulating Adhesion Molecules in Humans	151
Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.	151
Ras Induces Vascular Smooth Muscle Cell Senescence and Inflammation in Human Atherosclerosis	151
Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.	151
Childhood Adiposity as a Predictor of Cardiac Mass in Adulthood	151
Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats	151
Cardiomyocytes of Noncardiac Origin in Myocardial Biopsies of Human Transplanted Hearts	151
Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children.	151
Beneficial Effects of Vagal Stimulation and Bradycardia During Experimental Acute Myocardial Ischemia	151
Postinfarction ventricular septal rupture: the importance of location of infarction and right ventricular function in determining survival.	151
Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure.	151
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.	151
Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion.	151
Endovascular Edge-to-Edge Mitral Valve Repair	151
Inactivation of Macrophage Scavenger Receptor Class B Type I Promotes Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice	151
Determination of stroke volume and cardiac output during exercise: comparison of two-dimensional and Doppler echocardiography, Fick oximetry, and thermodilution.	151
Novel Cardioprotective Role of a Small Heat-Shock Protein, Hsp20, Against Ischemia/Reperfusion Injury	151
Atrial Fibrillation Originating From Persistent Left Superior Vena Cava	151
Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization	151
Nesiritide Does Not Improve Renal Function in Patients With Chronic Heart Failure and Worsening Serum Creatinine	151
Electrophysiological and Electrocardiographic Characteristics of Focal Atrial Tachycardia Originating From the Pulmonary Veins	151
Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.	151
Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb	151
Relations of Plasma Matrix Metalloproteinase-9 to Clinical Cardiovascular Risk Factors and Echocardiographic Left Ventricular Measures	151
Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart Failure	151
Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II	151
Do Hospitals and Surgeons With Higher Coronary Artery Bypass Graft Surgery Volumes Still Have Lower Risk-Adjusted Mortality Rates?	151
Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction	151
Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI)	151
American Heart Association Guide for Improving Cardiovascular Health at the Community Level	151
The Lewis A. Connor Memorial Lecture	150
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.	150
Critical Pathways	150
Chronic β-Adrenergic Stimulation Induces Myocardial Proinflammatory Cytokine Expression	150
Epidemiological Study of Sudden and Unexpected Deaths due to Arteriosclerotic Heart Disease	150
American College of Cardiology/American Heart Association Clinical Practice Guidelines: Part I	150
Immediate Hemodynamic Effects of Beta-Adrenergic Blockade with Propranolol in Normotensive and Hypertensive Man	150
Hemodynamic Observations One and Two Years after Cardiac Transplantation in Man	150
A comparative analysis of antegrade and retrograde conduction patterns in man.	150
Detection of Residual Myocardial Function in Coronary Artery Disease Using Post-extra Systolic Potentiation	150
Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery Disease	150
Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. The VA Coronary Artery Bypass Surgery Cooperative Study Group.	150
Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.	150
Pathological Effects of Extensive Radiofrequency Energy Applications in the Pulmonary Veins in Dogs	150
Noninvasive visualization of the left main coronary artery by cross-sectional echocardiography.	150
Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography.	150
Myocardial lactate metabolism: evidence of lactate release during net chemical extraction in man.	150
Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.	150
Role of Dobutamine Stress Echocardiography in Predicting Outcome in 860 Patients With Known or Suspected Coronary Artery Disease	150
Oxidized LDL Upregulates Angiotensin II Type 1 Receptor Expression in Cultured Human Coronary Artery Endothelial Cells	150
Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.	150
Laser recanalization of occluded atherosclerotic arteries in vivo and in vitro.	150
Outmigration For Coronary Bypass Surgery in an Era of Public Dissemination of Clinical Outcomes	150
Cyclooxygenases, Thromboxane, and Atherosclerosis	150
Increased Carotid Artery Intimal-Media